Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,28244,0.127033021013376,0.0034512055469085,0.120268658141435,0.133797383885317,9.6708458663232e-290
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,28439,-0.0593926703118757,0.00239845892060439,-0.0640936497962603,-0.0546916908274911,5.9374102276075e-134
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,27965,0.0484760576144829,0.00198652366786508,0.0445824712254674,0.0523696440034985,3.71267335031901e-130
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,28367,0.0765723542811728,0.00314861253410296,0.070401073714331,0.0827436348480146,2.58719329768936e-129
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,28174,0.0704770044927564,0.00307141207887498,0.0644570368181615,0.0764969721673514,1.84840421352896e-115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,28299,0.0350078882342487,0.00156254274910752,0.031945304445998,0.0380704720224995,3.24704587768188e-110
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,28176,0.0675355586422837,0.0031315457138393,0.0613977290431587,0.0736733882414087,2.51335384823782e-102
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,28194,0.0440736678600365,0.00213666793795719,0.0398857987016404,0.0482615370184326,7.71605073322621e-94
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,28411,0.0274258600483124,0.00134713233725681,0.024785480667289,0.0300662394293357,1.75127016144886e-91
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28521,0.05167493251187,0.00260708684504966,0.0465650422955726,0.0567848227281673,7.56073356530157e-87
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,28127,0.0385486633885529,0.00197892260859343,0.0346699750757098,0.042427351701396,5.85477900288527e-84
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,27734,0.0571494781544783,0.00294792290023327,0.0513715492700211,0.0629274070389356,3.58014846284418e-83
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,28291,0.0415986411227517,0.00220949597763155,0.0372680290065939,0.0459292532389096,1.36849908861416e-78
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,28521,0.0652136425129667,0.00348221130504591,0.0583885083550767,0.0720387766708566,8.64191579142623e-78
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,23845,-0.0458101828691711,0.00249410235341608,-0.0506986234818666,-0.0409217422564756,7.87466883207881e-75
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,28291,-0.034096645400873,0.00185842956791804,-0.0377391673539924,-0.0304541234477537,9.4772479571813e-75
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,28381,0.0457001351655266,0.00250438778857381,0.0407915350999219,0.0506087352311312,5.68988476344144e-74
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,28143,0.0501617879066742,0.0027576205638491,0.04475685160153,0.0555667242118185,1.62889437743841e-73
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,28237,0.0373335728175537,0.00205432543570699,0.033307094963568,0.0413600506715395,2.20939849498448e-73
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,27682,0.0798703935503146,0.00443491820459341,0.0711779538693116,0.0885628332313177,4.24351804394683e-72
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,28320,0.0500061651706702,0.00278278765463737,0.044551901367581,0.0554604289737594,8.42498767651702e-72
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,28274,0.0339621246118917,0.00190221750683708,0.030233778298491,0.0376904709252924,6.6072476971208e-71
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,28291,0.0217418630876049,0.00122086580120378,0.0193489661172454,0.0241347600579643,1.47425890205847e-70
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,28187,-0.0375904671873729,0.00213777298636657,-0.0417805022406514,-0.0334004321340945,7.63381176900366e-69
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,28320,0.0318394687192393,0.00181358676167632,0.0282848386663537,0.0353940987721249,1.23595118957349e-68
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,28452,0.0397246984717749,0.00226821609265189,0.0352789949301772,0.0441704020133726,2.57715961680496e-68
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,28452,0.0762150644501258,0.00436105291668093,0.0676674007334312,0.0847627281668205,4.92805606661653e-68
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27965,0.0384268309890217,0.00220580128974447,0.0341034604611225,0.0427502015169209,1.30674824310119e-67
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,28553,0.0516599363974665,0.00298786410443091,0.0458037227527819,0.057516150042151,1.22544670543013e-66
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,28044,0.085649097228935,0.00498387388455658,0.0758807044152042,0.0954174900426659,7.45451734007522e-66
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,28187,0.0343773989671605,0.00200741349798582,0.0304428685111083,0.0383119294232128,2.06442779870768e-65
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28307,0.0400191254485307,0.00233954982531685,0.0354336077909097,0.0446046431061518,2.87817816208856e-65
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,28224,0.0348884726087529,0.00204377092073626,0.0308826816041098,0.0388942636133959,5.210532809724e-65
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,28521,0.0388085240707288,0.00230363579612692,0.03429339791032,0.0433236502311375,2.25117858282066e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,23893,-0.0762127728637542,0.00452503506694545,-0.0850818415949673,-0.0673437041325411,2.76486009612575e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,28122,0.0608090195738666,0.00361497599365764,0.0537236666262976,0.0678943725214355,3.46690359131125e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,28182,-0.0508408636664474,0.00302379634635948,-0.056767504505312,-0.0449142228275828,3.94553490426593e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,28452,0.0366845237592591,0.00218774387442488,0.0323965457653863,0.0409725017531318,8.35770701059943e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,27374,0.0433031610153611,0.0025835328012625,0.0382394367248866,0.0483668853058356,9.64668105122949e-63
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,28553,0.0582490826045966,0.00349844972902989,0.051392121135698,0.0651060440734951,5.93855644938746e-62
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,23662,0.038542483209693,0.00231605198794005,0.0340030213133305,0.0430819451060555,7.84807302804697e-62
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,28187,0.0404253623451596,0.00246664657587402,0.0355907350564465,0.0452599896338727,4.3649632697519e-60
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,28428,0.0664789879896987,0.00405856501150588,0.0585242005671471,0.0744337754122502,5.01634484528807e-60
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,28091,0.0347527749079452,0.00213521784583628,0.030567747930106,0.0389378018857843,2.73213348838242e-59
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,28470,0.0221785068312619,0.00137120805186637,0.0194909390496038,0.02486607461292,1.39521542611033e-58
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),23428,0.194522272541864,0.0120205902863309,0.170961915580655,0.218082629503073,1.39568531215264e-58
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,28521,0.0284436736168101,0.00176449276922463,0.0249852677891298,0.0319020794444904,3.33923844382191e-58
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,23893,0.0278113733069831,0.00173510542399913,0.0244105666759448,0.0312121799380214,1.60996941355339e-57
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,28187,0.0814798045292179,0.00509551108985178,0.0714926027931084,0.0914670062653273,2.66107478995535e-57
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,23775,0.0816692698208826,0.00510854563554068,0.0716565203752229,0.0916820192665424,3.14190694773942e-57
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,28199,0.0545912759661638,0.00341994274444875,0.0478881881870443,0.0612943637452834,4.14374264647563e-57
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,28023,0.0245008970912247,0.00154758581933714,0.0214676288853239,0.0275341652971255,3.29918069328338e-56
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",28195,0.0994392485051935,0.00632765094100304,0.0870370526608276,0.111841444349559,2.0521561163227e-55
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,23893,0.0553452325638903,0.00354957424187148,0.0483880670498222,0.0623023980779584,1.53145463179621e-54
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,28135,0.029635161174881,0.00190317292426015,0.0259049422433311,0.0333653801064309,1.92173397736498e-54
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,28037,0.0739663743466103,0.00476057146740671,0.0646356542704932,0.0832970944227275,3.26744456659013e-54
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,28428,-0.0223934368302387,0.00145329625149139,-0.0252418974831619,-0.0195449761773156,2.3517716134288e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,28307,0.0309797488418538,0.0020127657412879,0.0270347279889295,0.034924769694778,3.06292713267184e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,28187,0.0296811628711882,0.00193049365173692,0.0258973953137838,0.0334649304285925,3.96562364645382e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,22663,0.0240779057549988,0.00157111096616982,0.020998528261306,0.0271572832486917,9.51999092883826e-53
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23194,0.0400433635548618,0.00261762048144771,0.0349128274112243,0.0451738996984993,1.43307685928375e-52
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,28521,0.0259684066851256,0.00170465033099267,0.02262729203638,0.0293095213338713,3.38513407506323e-52
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,28291,0.0238846324626138,0.00157087644140349,0.020805714637463,0.0269635502877646,5.29105884007278e-52
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,28187,0.0239013207723042,0.00158099048659449,0.020802579418579,0.0270000621260294,1.96371485357238e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,28176,0.0336785773238067,0.00223095286521577,0.0293059097079838,0.0380512449396296,2.73049343125061e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,28237,0.0342664645226478,0.00227066500204711,0.0298159611186354,0.0387169679266601,2.9457739239106e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,28553,0.0225675125931679,0.00149579094209254,0.0196357623466666,0.0254992628396693,3.09357458286903e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,28224,-0.0474929917599489,0.00314945585028613,-0.0536659252265097,-0.0413200582933881,3.48618096280168e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,23147,0.0279519759259632,0.00185552886616885,0.0243151393482723,0.0315888125036542,4.86838354739131e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,28320,0.0348312373672136,0.00231774007762272,0.0302884668150731,0.0393740079193542,7.55241653876402e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27965,0.0580084944933866,0.00386385967836983,0.0504353295237817,0.0655816594629915,9.50845996932845e-51
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,28120,0.0203634145732185,0.00135965711990878,0.0176984866181973,0.0230283425282397,1.62952484142615e-50
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27702,0.0436342158960993,0.00294820557314952,0.0378557329727262,0.0494126988194723,2.25406189466727e-49
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,28091,0.0408565407212285,0.00276206612068263,0.0354428911246905,0.0462701903177664,2.53015410927496e-49
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,23337,0.0399243287036286,0.00270683737244258,0.0346189274536412,0.0452297299536161,5.16014725619787e-49
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,23353,0.0304873205558898,0.00207425547933701,0.0264217798163892,0.0345528612953903,1.09686346480353e-48
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,28120,0.0365128955539858,0.00249040149688618,0.0316317086200888,0.0413940824878827,1.71969452557869e-48
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,28336,0.0589866397075035,0.00403046804943745,0.0510869223306061,0.0668863570844009,2.51591262529702e-48
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,28195,0.0273242585488511,0.00186715915937905,0.0236646265964682,0.0309838905012341,2.55989242939918e-48
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",28091,0.0593550901590664,0.00407028333258642,0.051377334827197,0.0673328454909357,5.43520213150718e-48
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,28224,0.0336213861917459,0.00231537948187757,0.0290832424072658,0.0381595299762259,1.32708817254089e-47
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",27544,0.0512283021258785,0.00353297118504311,0.044303678603194,0.058152925648563,1.81148640513634e-47
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,28377,0.03965372877898,0.00273923911848271,0.0342848201067539,0.0450226374512061,2.52792364563468e-47
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,28182,0.0289159597053493,0.0020054654819252,0.0249852473607759,0.0328466720499227,5.81321339866139e-47
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,28117,0.0407001016199664,0.00282277326964169,0.0351674660114687,0.0462327372284641,5.82649547204236e-47
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,28224,0.0588922071769837,0.00410169399356815,0.0508528869495901,0.0669315274043773,1.38552544492517e-46
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,28224,0.0309183919241061,0.00215990654990317,0.0266849750862959,0.0351518087619163,2.57478791749988e-46
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,28320,-0.0268506108468043,0.00187893678857975,-0.0305333269524206,-0.023167894741188,3.64080488870713e-46
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,28195,0.0524267192820765,0.00368023897291131,0.0452134508951703,0.0596399876689827,6.9056045409191e-46
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,23337,0.0408767835604102,0.00288153498317607,0.0352289749933851,0.0465245921274353,1.73547317973862e-45
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28452,0.0326107720450289,0.00230044863692516,0.0281018927166556,0.0371196513734023,1.84751165336194e-45
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28553,0.0277285345712092,0.00195855046694485,0.0238897756559973,0.0315672934864211,2.3849209835268e-45
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,23845,0.0266453302246065,0.00189542492448115,0.0229302973726234,0.0303603630765896,1.04264927864987e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,28195,0.0365511429481895,0.0026074960830049,0.0314404506254999,0.0416618352708791,1.71397078845652e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,23862,0.0383352242075587,0.00273434832174355,0.0329759014969414,0.0436945469181761,1.76982940614486e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,28187,0.0320395347647152,0.00228626100717528,0.0275584631906516,0.0365206063387788,1.80703637179919e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,28307,0.0315102029194799,0.00225161219275592,0.0270970430216783,0.0359233628172815,2.36772711681467e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,23852,0.0183923244392287,0.00131392792786059,0.0158170257006219,0.0209676231778355,2.40356552836738e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28307,0.0336287666696747,0.0024127506899588,0.0288997753173554,0.0383577580219939,5.209984767593e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,28187,0.0400779618072782,0.00287638499537315,0.0344402472163468,0.0457156763982095,5.55354787671205e-44
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,22764,-0.0404578329930736,0.00291317634719501,-0.0461676586335759,-0.0347480073525714,1.13131790359885e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,28553,-0.0317300562676383,0.00229010330649135,-0.0362186587483614,-0.0272414537869153,1.63507275825808e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23337,0.0268293005144186,0.00193704821909499,0.0230326860049925,0.0306259150238448,1.87499651935018e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,27918,0.0285187362513093,0.00207211987474734,0.0244573812968045,0.0325800912058141,5.87365107966982e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,23893,0.0183550021807417,0.00133472918278986,0.0157389329824735,0.0209710713790098,7.23271060041874e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,28187,0.032569378773127,0.00237014796359184,0.027923888764487,0.0372148687817671,7.87500132279659e-43
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,28320,0.0609458901268185,0.00446692662763173,0.0521907139366603,0.0697010663169767,2.99048618348125e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,28286,0.028075518783339,0.00205823538227102,0.0240413774340878,0.0321096601325902,3.12622475679594e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,28176,0.0266444264966235,0.00195372037263619,0.0228151345662566,0.0304737184269904,3.25113237224596e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,22802,0.029540172360915,0.00216535627134545,0.025296074069078,0.0337842706527521,3.29303943132593e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,28187,-0.0342935119744176,0.00251479549821597,-0.0392225111509209,-0.0293645127979143,3.29931941132247e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,28320,0.0612571881193697,0.00450371857463698,0.0524298997130812,0.0700844765256582,5.32018089138382e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28452,0.0573269121687416,0.00421835742961415,0.0490589316066978,0.0655948927307853,6.21938350647156e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,28176,0.0535107443348661,0.00394502570538848,0.0457784939523046,0.0612429947174275,8.84593297202162e-42
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,28553,0.0398181017381907,0.00295860083526911,0.0340192441010633,0.0456169593753182,3.66896159907471e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,28176,0.03410465302717,0.00254189324410068,0.0291225422687326,0.0390867637856073,6.42055020915595e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,28091,0.0612776387455526,0.00457406632235682,0.0523124687537332,0.0702428087373719,8.4313250491915e-41
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,28362,0.0611302902192171,0.00456790166368021,0.0521772029584039,0.0700833774800303,1.01643511802599e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,22397,0.0219476349910839,0.00163948098568875,0.0187342522591339,0.0251610177230338,1.03409022319571e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,23872,0.0234409378093565,0.00175645893820847,0.0199982782904679,0.0268835973282451,1.75644022470905e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28050,0.0939233675098869,0.00705863699889233,0.0800884389920579,0.107758296027716,2.82453327519219e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,23846,0.0646831616278881,0.00486669407492321,0.0551444412410386,0.0742218820147376,3.62992846643529e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",28553,0.044577135112249,0.00335700489488455,0.0379974055182753,0.0511568647062227,4.04042014539941e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,27920,0.0459142745671154,0.00346968621418435,0.0391136895873141,0.0527148595469167,7.46425554455502e-40
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,28187,-0.0228582495966867,0.00173692501302418,-0.0262626226222141,-0.0194538765711593,1.94464279612105e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,28411,0.0373806440612071,0.00284225961760328,0.0318098152107047,0.0429514729117096,2.16856542969841e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,27638,0.0338321469612966,0.00258060755623164,0.0287741561510826,0.0388901377715106,3.77068172799011e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,27632,0.046307562033108,0.00353733877274823,0.0393743780385215,0.0532407460276945,4.8408395059369e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,23545,0.0280755458859082,0.00214736525090844,0.0238667099941277,0.0322843817776887,6.30278837562052e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,28156,0.0531718314233959,0.00407312747689986,0.0451885015686721,0.0611551612781196,7.78891445032538e-39
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,28091,0.0926213565781464,0.00710851557747204,0.0786886660463012,0.106554047109992,1.07502127931294e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,28086,-0.0552070558447054,0.00424226051554587,-0.0635218864551753,-0.0468922252342355,1.32473217714802e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,22744,0.0407485216892746,0.00313163502680457,0.0346105170367376,0.0468865263418115,1.43823140190771e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,28336,0.0508352782368067,0.00391608284025643,0.0431597558699041,0.0585108006037093,2.01480283714032e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,23480,0.02858739189725,0.00220453737400129,0.0242664986442075,0.0329082851502925,2.53240743953654e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,28428,0.0686395778465713,0.00529510279203105,0.0582611763741904,0.0790179793189521,2.55297263303411e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,23893,0.0161082313116351,0.00124410049537888,0.0136697943406925,0.0185466682825777,3.2563959156183e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,28187,0.0338280398424973,0.00261396444148164,0.0287046695371932,0.0389514101478013,3.38268122039156e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,28176,0.0578123994561537,0.00447645188356611,0.0490385537643642,0.0665862451479433,4.76500627829517e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27850,0.0411930045317475,0.00319079427631277,0.0349390477501744,0.0474469613133205,5.08629091492156e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,28521,0.028391065659211,0.00220467955913952,0.0240698937232976,0.0327122375951245,7.67034577892638e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,28202,0.0459449505331777,0.00357068321354714,0.0389464114346253,0.0529434896317301,8.78949965669606e-38
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,28521,0.0651235060161801,0.00507355671191145,0.0551793348608336,0.0750676771715265,1.31245179035175e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,27713,0.0355140444662732,0.00277974067103357,0.0300657527510474,0.0409623361814989,2.84414936591863e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",23738,0.0888010013456882,0.00695106562314315,0.0751769127243276,0.102425089967049,2.99437455985302e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,27531,0.0272980897902472,0.00213955415787262,0.0231045636408169,0.0314916159396775,3.55078414453205e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,28320,0.0405415654012837,0.00319110293422963,0.0342870036501937,0.0467961271523738,7.03501208614839e-37
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,28521,-0.0337395148214396,0.00266430197030842,-0.0389615466832441,-0.0285174829596351,1.18195670048697e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,28046,0.0260437719559057,0.00205936601731193,0.0220074145619743,0.0300801293498371,1.47233441607361e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,28428,0.0575943132987122,0.00456600638363834,0.0486449407867811,0.0665436858106434,2.22121235258213e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,28452,-0.0140831098354787,0.00111800313556949,-0.0162743959811949,-0.0118918236897625,2.75373403885103e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,27702,0.0721208847706316,0.00572748856871688,0.0608950071759465,0.0833467623653167,2.93581554940428e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,28176,0.0520567569726482,0.00413432633951587,0.043953477347197,0.0601600365980993,2.95081287040889e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23775,0.0338942775630129,0.00269463640106704,0.0286127902169215,0.0391757649091043,3.61908493958222e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,28064,0.0327403191175035,0.00260865914618548,0.0276273471909799,0.037853291044027,4.92924327819297e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,28307,0.0350945926097459,0.00280166180563637,0.0296033354706986,0.0405858497487932,6.67229231287966e-36
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,27562,0.0394892795441223,0.00316332520723782,0.0332891621379362,0.0456893969503085,1.14775745510963e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",28091,0.0582656262831431,0.00467161520164938,0.0491092604879104,0.0674219920783759,1.31464704882769e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,28438,0.022282302833227,0.00178872008703882,0.0187764114626309,0.0257881942038231,1.5838574546178e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,28091,0.070587098130299,0.00566955002882165,0.0594747800738086,0.0816994161867894,1.73085479282538e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",28320,0.0230973948657316,0.00185888700517292,0.0194539763355927,0.0267408133958705,2.35347226224915e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,28187,0.0232010850956626,0.00186742855441704,0.0195409251290052,0.02686124506232,2.39444764041827e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,28224,-0.0226773691613509,0.00182543518149782,-0.0262552221170867,-0.0190995162056152,2.42639873666878e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,28123,-0.0527308091520699,0.00424818518057857,-0.0610572521060039,-0.0444043661981359,2.76482638405234e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27562,0.052993681866829,0.00427676962176697,0.0446112134081657,0.0613761503254923,3.625930095844e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",23738,0.0731948801743249,0.00590832441864587,0.0616145643137789,0.0847751960348708,3.87767094799401e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,28091,0.0270810716836641,0.00218766363518625,0.022793250958699,0.0313688924086291,4.19368623236501e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,28428,0.0249406625499628,0.00201484181168446,0.0209915725990613,0.0288897525008644,4.21031740070373e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,28452,0.0918701339052826,0.00742999079062342,0.0773073519556607,0.106432915854904,4.98805057561619e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27702,0.0598316144880952,0.00484903698674317,0.0503275019940786,0.0693357269821118,6.90972290211127e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,23893,0.0141698736901773,0.00114920428967802,0.0119174332824084,0.0164223140979462,7.9555116088807e-35
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,28428,0.0286181825293166,0.00232914676652755,0.0240530548669226,0.0331833101917106,1.30285548891021e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,28239,0.0384902542724062,0.00313800093689802,0.0323397724360861,0.0446407361087263,1.69149962039362e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,28091,0.0705517400432984,0.00576373640334698,0.0592548166927383,0.0818486633938584,2.30748093936654e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,27702,0.0655507687369851,0.00535712075188269,0.055050812063295,0.0760507254106752,2.4431373005768e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,28176,0.0487989346203406,0.00399144500340623,0.0409757024136644,0.0566221668270168,2.76252726039031e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,28194,0.041139445953262,0.00336927885533767,0.0345356593968001,0.0477432325097238,3.34783713504896e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,26744,0.0329717690261,0.00270048241033887,0.0276788235018358,0.0382647145503642,3.40808474739013e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27965,0.0460420780979776,0.00377600897421005,0.0386411005085259,0.0534430556874293,4.11958364736833e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,28336,-0.0272644401543983,0.00223780124009346,-0.0316505305849815,-0.0228783497238151,4.6271848824908e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,28082,0.064034905731746,0.0052708510587039,0.0537040376566864,0.0743657738068057,7.07522075667475e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,27562,0.0901260470733104,0.00742638275328975,0.0755703368768625,0.104681757269758,8.31191096379868e-34
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,23872,0.0518896842895329,0.00428281328296159,0.0434953702549282,0.0602839983241377,1.09417650336051e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,28320,-0.0351130303152862,0.00289939177481161,-0.040795838193917,-0.0294302224366555,1.12610036587255e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,28521,0.0368683269136832,0.00305052190488706,0.0308893039801046,0.0428473498472619,1.51464735080296e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,23337,0.0292089886258255,0.00242854986947928,0.0244490308816461,0.0339689463700048,3.20135917023957e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,27977,0.032641078372197,0.00272273600280678,0.0273045158066957,0.0379776409376983,4.92938912006822e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,28022,0.0222182501845207,0.00185418892293849,0.0185840398955613,0.0258524604734802,5.27094899038086e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,28276,0.0462672510048754,0.0038612980270817,0.0386991068717952,0.0538353951379555,5.28925535278776e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,28363,0.0585210522038515,0.00488448782491659,0.048947456067015,0.0680946483406881,5.36969106938199e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27562,0.0666247070691748,0.00556066822233468,0.0557257973533988,0.0775236167849508,5.37117702715227e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,28195,0.021330799018711,0.00178065430359085,0.017840716583673,0.0248208814537491,5.49354433509526e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,27863,0.032134760023948,0.00268406575754943,0.0268739911391511,0.0373955289087449,5.97158567225716e-33
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,23755,0.0246252742438203,0.00206475618915595,0.0205783521130746,0.0286721963745659,1.06820102035991e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,28428,0.11119373070202,0.00934892280554571,0.0928698420031502,0.129517619400889,1.52396073909191e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,27544,0.0244887466821602,0.00206061671411523,0.0204499379224943,0.0285275554418261,1.71760245675356e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,23365,0.0177832606874403,0.00149692700077122,0.0148492837659287,0.0207172376089519,1.86854056698731e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,27562,0.098990612080273,0.00834405311825094,0.0826362679685011,0.115344956192045,2.19355320726876e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,28182,0.0255443498414603,0.00215807401088908,0.0213145247801177,0.0297741749028029,3.00953394528016e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,28176,0.0270766414559703,0.00229312006137535,0.0225821261356746,0.0315711567762659,4.23688793087021e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,28452,0.022557054947741,0.00191136069181336,0.0188107879917868,0.0263033219036952,4.55187205399834e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,28521,0.0440196926767249,0.00373186934375026,0.0367052287629744,0.0513341565904754,4.88187126448763e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,27082,0.0183342797452558,0.00155628854031658,0.0152839542062353,0.0213846052842763,5.87048796824191e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,28422,0.045649987801576,0.00387598125569967,0.0380530645404046,0.0532469110627473,6.03888506470067e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,28087,0.0226973117770408,0.0019319581875773,0.0189106737293893,0.0264839498246923,8.54917127293293e-32
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,28452,0.0462806094976109,0.00394631710000229,0.0385458279816064,0.0540153910136154,1.08955979163202e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,28187,0.044335663660084,0.00378078758952515,0.0369253199846147,0.0517460073355533,1.10387357853105e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23198,0.0721501931270769,0.00616178153601323,0.060073101316491,0.0842272849376628,1.40173733120187e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,27562,0.0648731332642653,0.00554356365758948,0.0540077484953899,0.0757385180331407,1.47125828324609e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,28378,0.0569271447063214,0.00486925505617549,0.0473834047962174,0.0664708846164253,1.67109410239198e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",27682,0.0722950239653491,0.00618450761362441,0.0601733890426452,0.0844166588880529,1.70669603415726e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28363,0.027154789222622,0.00232304823319032,0.022601614685569,0.031707963759675,1.70783426521521e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,28176,0.0401788882064645,0.00344582937753903,0.033425062626488,0.046932713786441,2.40454527137202e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,23337,0.0243484596659835,0.00208773718381201,0.020256494785712,0.0284404245462551,2.41805926267475e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,23188,0.0671795098473023,0.00576166928324375,0.0558866380521445,0.07847238164246,2.50389759202699e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,28187,-0.0410777793482273,0.00352697024886085,-0.0479906410359946,-0.03416491766046,2.81146653281559e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,28440,0.063914392039857,0.00549359429063106,0.0531469472302201,0.0746818368494939,3.24490493749855e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",23795,0.0716404154358185,0.00615965734366222,0.0595674870422406,0.0837133438293965,3.49963830101317e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,28187,0.0341660286850789,0.00294184593793792,0.0284000106467206,0.0399320467234372,4.12855351032578e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,28277,0.025902727460037,0.00223252946279539,0.0215269697129581,0.030278485207116,4.71149438046137e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,23188,0.072961867784639,0.00629434264006838,0.0606249562101049,0.085298779359173,5.53108526655098e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,23872,0.0220969156133296,0.00190788872503192,0.018357453712267,0.0258363775143922,6.16191314258929e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,28176,-0.0360508115804887,0.0031154718430648,-0.0421571363928957,-0.0299444867680817,6.74769939391796e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,28307,0.0260172961296363,0.002249184467472,0.0216088945733911,0.0304256976858814,7.07160348640293e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,28224,0.0594051037763307,0.00513670800568237,0.0493371560851933,0.0694730514674681,7.29278577802364e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,28521,0.0365237357196945,0.00315867992666795,0.0303327230634254,0.0427147483759637,7.43811619392906e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,28276,0.0405103838685243,0.00350716211166149,0.0336363461296678,0.0473844216073808,8.58088003726341e-31
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,28307,0.0552826461620467,0.00479376095099231,0.0458868746981018,0.0646784176259916,1.06338850637015e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,23337,0.029093535247846,0.00252381433929606,0.0241468591428257,0.0340402113528663,1.15972791681721e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,23893,0.0240333510490047,0.00208498486270934,0.0199467807180944,0.028119921379915,1.16442418975695e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,23862,0.0196216113828172,0.00170297983822437,0.0162837708998975,0.022959451865737,1.23310317052603e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,28336,0.0778101721077994,0.00675727097811443,0.0645659209906951,0.0910544232249036,1.2966640313271e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,28411,0.0265858404208038,0.00231653361920502,0.0220454345271619,0.0311262463144456,2.01946248745786e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,28291,0.0198892403955188,0.00173888352677037,0.0164810286830489,0.0232974521079887,3.14959959939478e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,27900,0.026434420097068,0.00231287037475545,0.0219011941625473,0.0309676460315887,3.48613140032414e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,28336,0.0237655288711803,0.00208175725105485,0.0196852846591128,0.0278457730832478,4.04469010480277e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,28078,0.0339420159312774,0.0029768102722737,0.0281074677976209,0.0397765640649338,4.75115943320222e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,28146,0.0230994926507138,0.00202634741801461,0.0191278517114051,0.0270711335900224,4.89111894992713e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,23872,0.0170376618084232,0.0014966106079417,0.0141043050168574,0.0199710185999889,5.99199599127194e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",28452,0.0561216376864826,0.00493688966504221,0.0464453339429999,0.0657979414299654,7.01759270303094e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,27965,0.0262098735194435,0.00230597966276291,0.0216901533804282,0.0307295936584588,7.17880145038069e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,23846,0.076174915467281,0.00671475117907091,0.063014003156302,0.08933582777826,9.42487884439466e-30
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,28176,-0.0260946296043001,0.00230771951639709,-0.0306177598564384,-0.0215714993521618,1.39480433039257e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",23738,0.078237287182688,0.00692057925420138,0.0646729518444533,0.0918016225209227,1.47505675065348e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,23893,0.019819406215712,0.00175426750205532,0.0163810419116835,0.0232577705197404,1.59852564345136e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,28176,0.0258338885451789,0.00228832185200129,0.0213487777152564,0.0303189993751014,1.71226721502864e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27965,0.0317810140258967,0.00281655928393668,0.0262605578293808,0.0373014702224126,1.83084035700887e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23198,0.073432423322174,0.00652852285342049,0.0606365185294699,0.0862283281148782,2.82318175362694e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27965,0.0297282203430423,0.00264471092799002,0.0245445869241819,0.0349118537619027,2.97603685219586e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,27682,-0.017716895997227,0.00157779536244154,-0.0208093749076124,-0.0146244170868416,3.40200192857025e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,23393,0.0973906407049694,0.00867879461317433,0.0803802032631477,0.114401078146791,3.78916687133099e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,27682,0.040404000362744,0.00360273240994802,0.0333426448392459,0.0474653558862421,3.9860177481592e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,23738,0.105429651421954,0.00940839009743823,0.0869892068309754,0.123870096012933,4.51241129890425e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,28266,-0.0267067749087371,0.00238434625515063,-0.0313800935688324,-0.0220334562486419,4.6487384458305e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,27516,-0.0900666114916457,0.00805551449896558,-0.105855419909618,-0.0742778030736731,5.85064914355433e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,23738,0.0887132133174661,0.00795022018163652,0.0731307817614586,0.104295644873474,7.67131303105972e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,28307,0.0685506706681449,0.00614584783853604,0.0565048089046142,0.0805965324316755,7.86484540017799e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,23337,-0.0229849877583194,0.0020604514367502,-0.0270234725743498,-0.018946502942289,7.97961626737804e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,28553,0.0317889272188874,0.0028543027621243,0.0261944938051238,0.0373833606326511,9.47792515108517e-29
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",28176,0.0617327412830611,0.00554753580563446,0.0508595711040175,0.0726059114621046,1.05275292328806e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,27968,0.043696879426879,0.00393261578984043,0.0359889524787917,0.0514048063749662,1.26763953878757e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,27500,0.0676266106108731,0.00609049433934829,0.0556892417057504,0.0795639795159957,1.38557349978763e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,27935,0.0212397813868136,0.00191521841429389,0.0174859532947976,0.0249936094788297,1.60914246905687e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28277,-0.0483602973527344,0.00436308300836438,-0.0569119400491286,-0.0398086546563402,1.71799121723545e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,28187,0.037887125818208,0.0034210997847625,0.0311817702400735,0.0445924813963425,1.90870133654304e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,28082,0.0342506433737846,0.00309413599261684,0.0281861368282556,0.0403151499193136,2.01903570200199e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,28320,0.0216753553895139,0.00195892550347062,0.0178358614027115,0.0255148493763163,2.12278285955651e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,28091,0.0644482678519469,0.00582700311910585,0.0530273417384995,0.0758691939653944,2.23754737466856e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,28091,0.0504991941256064,0.00456829122409491,0.0415453433263804,0.0594530449248325,2.39139194960285e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,23795,0.0326872280543033,0.00296169161434306,0.0268823124901909,0.0384921436184157,2.97788483607102e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,27702,0.0280212773359622,0.00254452734242394,0.0230340037448112,0.0330085509271131,3.81111549305121e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,27544,0.0780568617618374,0.00709309830916016,0.0641543890758835,0.0919593344477913,4.15499453450784e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,28152,0.0342503540880232,0.00311809517662162,0.0281388875418448,0.0403618206342016,5.17975487406293e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",28091,0.0255948221468813,0.00233354339350519,0.0210210770956112,0.0301685671981515,6.19115902129608e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,28187,0.031274768068877,0.00285423098506423,0.0256804753381511,0.0368690607996029,6.97606803186781e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",28121,0.049990678422647,0.00456280240364593,0.041047585711501,0.058933771133793,7.07099888541226e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28496,0.0281236915203749,0.00256743677345062,0.0230915154444117,0.0331558675963382,7.22699170870837e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,28428,0.0166233460721205,0.00151980493443066,0.0136445284006364,0.0196021637436046,8.63600456119238e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,27910,0.0590658546580237,0.00540294106558982,0.0484760901694676,0.0696556191465797,9.21020579146468e-28
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,27877,0.0264960138462571,0.00243668333794325,0.0217201145038883,0.0312719131886259,1.74502212558408e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,23738,0.0830175343152592,0.00765916919814547,0.068005562686894,0.0980295059436243,2.60718741694836e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,28184,0.0245414026390495,0.00226462722667494,0.0201027332747666,0.0289800720033324,2.6072396782889e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,28307,-0.0239693988873191,0.00221185501248386,-0.0283046347117874,-0.0196341630628507,2.60737229389711e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,27320,0.088844447164564,0.00823456584973249,0.0727046980990884,0.10498419623004,4.39016401049397e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,28224,0.0191081755754689,0.00177237300021037,0.0156343244950566,0.0225820266558813,4.77263240648888e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,28112,0.0141296758215145,0.00131238565150629,0.0115573999445621,0.0167019516984668,5.59938884669283e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,28091,0.0221234986291925,0.00205579758221272,0.0180941353680556,0.0261528618903294,5.90384780388758e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,28091,0.0563356440065803,0.00523651993609516,0.0460720649318338,0.0665992230813268,6.11779545876237e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",28187,0.0276948065916626,0.00257834816589012,0.0226412441865179,0.0327483689968072,7.34129870010398e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,28521,0.0529149283663603,0.00492867557279633,0.0432547242436795,0.0625751324890411,7.75086874738748e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,23775,0.0203091140645377,0.00189141799481018,0.0166019347947098,0.0240162933343657,7.81902266746639e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,23775,0.0780223501187916,0.0072670152127386,0.063779000301824,0.0922656999357593,7.90385549673372e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,28091,0.0540771803744182,0.0050438092118138,0.0441913143192632,0.0639630464295732,9.09176195199947e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28320,0.0194682480085924,0.00181705631329026,0.0159068176345435,0.0230296783826413,9.82853454413232e-27
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,28307,0.0288387274689597,0.00269221510214017,0.023561985868765,0.0341154690691544,1.00724549981586e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,27682,0.0360349572980441,0.00336627372687613,0.0294370607933669,0.0426328538027213,1.09116985720554e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,27528,0.0404030929912595,0.00378555660011222,0.0329834020550396,0.0478227839274795,1.53528439995995e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,23337,0.07753176000277,0.00729356667387671,0.0632363693219716,0.0918271506835684,2.47881773133027e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,28091,0.0211878927385996,0.00199938367221682,0.0172691007410546,0.0251066847361445,3.44060303731806e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,28428,0.0374946606058348,0.00353944824952947,0.0305573420367571,0.0444319791749126,3.57968174738491e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28521,0.0270333097867758,0.00255639095421711,0.0220227835165103,0.0320438360570413,4.35961960538767e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,28496,0.0271961139179079,0.0025757816194652,0.0221475819437561,0.0322446458920597,5.18950951894931e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,27965,0.0290305608706943,0.00275195518994615,0.0236367286983998,0.0344243930429887,5.7409714479543e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,23738,0.0680493512737455,0.00645414188501482,0.0553992331791164,0.0806994693683745,6.21139522308316e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,27969,-0.0238922787467279,0.00226718104942738,-0.0283359536036055,-0.0194486038898502,6.43326342128287e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23846,0.0437076075981419,0.00415014844154726,0.0355733166527093,0.0518418985435745,7.04365169344196e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,28288,0.0210909144499158,0.0020036436348497,0.0171637729256103,0.0250180559742212,7.29834961704961e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,28224,0.0275489539286479,0.00261829100842163,0.0224171035521415,0.0326808043051543,7.65997688233088e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,28091,0.0398502907253072,0.00379324379483193,0.0324155328874366,0.0472850485631778,9.08836491734061e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,28091,0.0877930689254033,0.00835788872253672,0.0714116070292313,0.104174530821575,9.22183293059611e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,28210,0.0669771899502859,0.00637804041861962,0.0544762307297914,0.0794781491707803,9.51395519081729e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28428,0.0368414942572156,0.00350990044921134,0.0299620893767614,0.0437208991376699,9.99642455738342e-26
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,28553,0.0277560444017765,0.00264550743662879,0.0225708498259841,0.032941238977569,1.04977122275601e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,28126,0.0231810544363713,0.00221194831254477,0.0188456357437835,0.027516473128959,1.19121962707099e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,27562,0.05248709090729,0.00501066520931964,0.0426661870970236,0.0623079947175565,1.25644338403936e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,28187,0.0855522333884734,0.00817552435814809,0.0695282056465031,0.101576261130444,1.40185643115102e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,28091,0.0594107730097848,0.00569671709658602,0.0482452075004762,0.0705763385190934,2.03552060336729e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,28307,-0.0203138988758149,0.00195121701688139,-0.0241382842289024,-0.0164895135227273,2.45745274665555e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,23561,0.0293776501315513,0.0028223397382945,0.0238458642444941,0.0349094360186085,2.56087879067031e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,23795,0.0441995833544837,0.00425856704633951,0.0358527919436583,0.0525463747653092,3.498151998395e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,28320,0.0737611797017247,0.00711394075424667,0.0598178558234012,0.0877045035800481,3.82424437195687e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,23644,0.0176436331889114,0.00170240151416932,0.0143069262211395,0.0209803401566833,4.09367438714744e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,28091,0.0572592726006562,0.00553812669402406,0.046404544280369,0.0681140009209433,5.1996622347633e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,23738,0.0540850199513575,0.0052304420880811,0.0438333534587186,0.0643366864439965,5.22649667874863e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,23188,0.0582810700631191,0.00563820646645741,0.0472301853888625,0.0693319547373756,5.44245297849965e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23198,0.0369327039791285,0.00357298384098502,0.0299296556507979,0.0439357523074591,5.45089462507276e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,23846,0.0680770978540476,0.00658620241752667,0.0551681411156953,0.0809860545923999,5.45140895459411e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28378,0.0201788824839654,0.00195534199699432,0.0163464121698566,0.0240113527980743,6.34251280180932e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,28521,0.0310256410756398,0.00301258973559609,0.0251209651938715,0.0369303169574081,7.89834079436657e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,28091,0.0621718390330287,0.00604283729538746,0.0503278779340693,0.0740158001319881,8.78607391069256e-25
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,28091,0.0251172134366892,0.0024481518850549,0.0203188357419816,0.0299155911313968,1.18373637552319e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,23795,0.0721832582330596,0.00704886656246682,0.0583674797706247,0.0859990366954946,1.46974121903427e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,27918,0.0352756279530621,0.00344815667679607,0.0285172408665418,0.0420340150395824,1.60310575294968e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,28224,0.0319017804853677,0.0031200156036502,0.0257865499022133,0.0380170110685221,1.69296049471568e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,27918,0.0613918537053835,0.00600606618094115,0.0496199639907389,0.0731637434200282,1.75213951369443e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,27840,0.0800724699906867,0.00783907159274529,0.064707889668906,0.0954370503124675,1.88539607342882e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,23795,0.0782849011470335,0.00768058225777811,0.0632309599217884,0.0933388423722786,2.40177563141366e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,23795,0.0362461430593148,0.00355751709967596,0.02927340954395,0.0432188765746797,2.50136895899698e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,28129,0.0280139571868788,0.00275232458055712,0.0226194010089869,0.0334085133647708,2.73136822256584e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",28091,0.0302898192567683,0.00297592125547012,0.0244570135960468,0.0361226249174897,2.73144120197957e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,28091,0.0641658168599991,0.00632525825575537,0.0517683106787186,0.0765633230412796,3.86326852222078e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,23163,0.055281264308574,0.005456685939258,0.0445861598676283,0.0659763687495196,4.5220862101563e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,28553,0.0161979816572508,0.00160102029138126,0.0130599818861435,0.0193359814283581,5.08381255090002e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,23738,0.0607008354880917,0.005998770644058,0.048943245025738,0.0724584259504454,5.09753636116874e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,28053,0.0453236664969845,0.00448680700739156,0.0365295247624971,0.054117808231472,5.97656067268569e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,28363,0.0330039220424161,0.00326728910553501,0.0266000353955675,0.0394078086892647,5.98405207448453e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,28091,0.0304027367891465,0.00301306152165295,0.0244971362067068,0.0363083373715863,6.69757614060943e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,28176,0.0380536694681984,0.00377590922051738,0.0306528873959843,0.0454544515404125,7.58547210987199e-24
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,28428,0.0198135544732965,0.00197145520240885,0.0159495022765752,0.0236776066700179,1.00429317688017e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,28224,0.0164852147535482,0.00164043271449448,0.013269966633139,0.0197004628739573,1.01423681063997e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,23795,0.0673083350405951,0.00670150577065178,0.0541733837301177,0.0804432863510726,1.09115002326396e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,23725,0.0263464643250598,0.00262464982295537,0.0212021506720673,0.0314907779780524,1.15586683802575e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,23198,0.0517838004775022,0.00517170388914265,0.0416472608547826,0.0619203401002218,1.49347737616072e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,28428,0.0449159949559795,0.00448913709333666,0.0361172862530397,0.0537147036589194,1.57717544669935e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,23140,0.0293640928004416,0.00294147254427911,0.0235988066136545,0.0351293789872287,2.02220433778722e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,28176,0.0596427140980209,0.00597714146047324,0.0479275168354934,0.0713579113605485,2.07110530573933e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,23846,0.0301881174719043,0.00302521765402462,0.0242586908700161,0.0361175440737926,2.09745778751949e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",23198,0.0585316963409038,0.00587070862930208,0.0470251074274717,0.0700382852543359,2.29547038982108e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,28452,0.0858233190784506,0.00862205381422879,0.0689240936025622,0.102722544554339,2.64671966094594e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,28437,0.0159854706292824,0.0016073031116461,0.0128351565304561,0.0191357847281088,2.8792944889352e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28307,0.0637243241636087,0.00641437310920266,0.0511521528695715,0.0762964954576459,3.21258706276034e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28319,0.0748897573912649,0.0075447105275469,0.060102124757273,0.0896773900252569,3.49685112821764e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,28261,0.017964590874326,0.00181091836659589,0.014415190875798,0.0215139908728539,3.71243615886998e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,28224,0.0533631504657602,0.00538429602555489,0.0428099302556726,0.0639163706758478,4.07264143991365e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,23775,-0.0280768476731702,0.00283425937011323,-0.0336319960385921,-0.0225216993077483,4.33568602690433e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27682,0.0324352584033371,0.00327608826428911,0.0260141254053305,0.0388563914013438,4.51990932288869e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,23744,0.0495484722453975,0.00500695196484072,0.0397348463943097,0.0593620980964853,4.80481559570835e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,27786,0.0283132532687214,0.00286350633237201,0.0227007808572723,0.0339257256801705,5.14233668249955e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,23337,0.0478128288087355,0.00483969665021905,0.0383270233743062,0.0572986342431648,5.67924465218961e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,28320,0.0864648914090026,0.00875955820471386,0.0692961573277634,0.103633625490242,6.06117259295241e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,23846,0.0552083185785838,0.00560074399664436,0.0442308603451609,0.0661857768120068,7.04870199988641e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,27965,0.024009464264763,0.00243769488913394,0.0192315822820605,0.0287873462474656,7.52371736548393e-23
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,28187,0.0337775486543189,0.00344256230480501,0.027030126536901,0.0405249707717367,1.08973814757214e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,23163,0.0801448859039304,0.00817542948453327,0.0641210441142452,0.0961687276936157,1.2080069200466e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,28415,0.0179551696267689,0.0018346157442017,0.0143593227681336,0.0215510164854043,1.39176032074268e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,23738,0.0181371567426429,0.00185443434710147,0.014502465422324,0.0217718480629618,1.50728632045292e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28521,0.0649074910485568,0.00664522383165523,0.0518828523385126,0.077932129758601,1.68317668497266e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,28144,0.0577560600198072,0.00591922834367258,0.0461543724662089,0.0693577475734054,1.86228977402637e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28320,0.0783427496251953,0.00802946005769038,0.0626050079121222,0.0940804913382685,1.86957581803685e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,28194,0.061884191448243,0.00634263157352826,0.0494526335641276,0.0743157493323584,1.87117759165707e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,28358,0.0388739800453569,0.00398456564520716,0.0310642313807508,0.0466837287099629,1.88363766803552e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,23846,0.0428003065353659,0.00440195910364689,0.034172466692218,0.0514281463785138,2.64654641928299e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,28521,0.0356256002246155,0.00366634901785045,0.0284395561496286,0.0428116442996023,2.76579441149785e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23862,-0.0172865135072005,0.00177934262689567,-0.020774025055916,-0.0137990019584849,2.85899791334996e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,23862,-0.0329747196945118,0.00339438014837335,-0.0396277047853235,-0.0263217346037,2.87605166487479e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,28553,-0.0163048844842294,0.00168088885947264,-0.0195994266487957,-0.013010342319663,3.25791759355877e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27562,0.0443474928351944,0.00457239641995926,0.0353855958520743,0.0533093898183146,3.30554697256979e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,23795,0.0549750921098674,0.00567273589472818,0.0438565297562002,0.0660936544635347,3.6152387018968e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,28091,0.0666792171347954,0.00689385824126161,0.0531672549819227,0.0801911792876682,4.28219965237685e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,23738,0.069678974430121,0.00721058510066582,0.055546227632816,0.083811721227426,4.73497133935355e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,28521,0.049898591508055,0.00516589108644862,0.0397734449786157,0.0600237380374943,4.85517341733231e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,28266,0.0246578263431071,0.00255356907296319,0.0196528309600993,0.029662821726115,5.00347855161234e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,28152,-0.0114663219799852,0.00118748105731458,-0.0137937848523217,-0.00913885910764859,5.01561432146332e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,28452,0.0250643680119505,0.00260035783372292,0.0199676666578536,0.0301610693660474,5.92248829130273e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",28091,0.0216756194105023,0.00225030540849219,0.0172650208098576,0.026086218011147,6.31524221290442e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,28140,0.0187372283344443,0.00194527759858887,0.0149244842412101,0.0225499724276785,6.32293580460161e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,28187,-0.0261249276316182,0.00271363305622435,-0.0314436484218179,-0.0208062068414184,6.62813638712553e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,28428,0.0393529650519521,0.00408769305462314,0.0313410866648907,0.0473648434390134,6.63060656680847e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28336,0.0246589963210402,0.00256202414019274,0.0196374290062624,0.0296805636358179,6.78654666017671e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,28553,0.0206514321331619,0.00214688437244005,0.0164435387631794,0.0248593255031444,7.15765795895042e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,28428,0.0383249081807517,0.00398831468789613,0.0305078113924753,0.0461420049690282,7.88495631808471e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,23623,0.0608329320764378,0.00633042758740433,0.0484252940051253,0.0732405701477503,7.98435394876946e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,28553,0.0226999039134062,0.00236289184330476,0.0180686359005288,0.0273311719262835,8.07282696500645e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,28237,0.032236502742234,0.00335766413440006,0.0256554810388099,0.0388175244456581,8.5592266433875e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,23872,0.0173869073438139,0.00181170788433285,0.0138359598905215,0.0209378547971063,9.01337676725032e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,23775,0.0598858115391983,0.00624364404857164,0.0476482692039979,0.0721233538743987,9.50743318721517e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,28220,0.0368822331102092,0.00384671139059342,0.0293426787846461,0.0444217874357723,9.69442170604098e-22
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,28521,0.0266464757769559,0.00278205303376455,0.0211936518307774,0.0320992997231344,1.06684952833086e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27682,0.06193564962692,0.00646795388053408,0.0492584600210732,0.0746128392327668,1.09240953756787e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,28320,0.0170871756155008,0.00178543558568779,0.0135877218675528,0.0205866293634489,1.14946617118011e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,27702,0.0354021856236725,0.00370012295896445,0.0281499446241022,0.0426544266232428,1.17916417783293e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,28176,0.020104999211885,0.0021024469606156,0.0159842031690784,0.0242257952546916,1.23783805948495e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,23287,0.0243076415987506,0.00254270697089139,0.0193239359358034,0.0292913472616977,1.29343767984244e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,23198,0.0206065327024425,0.0021556311718682,0.0163814956055808,0.0248315697993042,1.29829548900639e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,23577,0.0639716817174081,0.00669356003386435,0.050852304051034,0.0770910593837822,1.3240971737022e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,23872,0.0311441682382322,0.00326081839392896,0.0247529641861314,0.037535372290333,1.40350891595058e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23198,0.0496850037146071,0.00520229880653354,0.0394884980538014,0.0598815093754129,1.41312136885412e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,23738,0.0303272512693558,0.00318577722195456,0.0240831279143249,0.0365713746243868,1.89922365398549e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27965,0.0606230857845255,0.00637019904957581,0.048137495647357,0.0731086759216941,1.9270767178975e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,23188,0.056677184134585,0.00595778774476626,0.0449999201548431,0.0683544481143269,2.02454878569643e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,27562,0.0229347934247612,0.00241301287586255,0.0182052881880706,0.0276642986614518,2.16511823922289e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,23337,0.0743521936711475,0.00782180131030237,0.0590214631029548,0.0896829242393401,2.17117456180274e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,23846,0.0580379844891428,0.00610590942231007,0.0460704020214151,0.0700055669568706,2.17845102216693e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27910,0.0614789354377819,0.00647212875773784,0.0487935630726157,0.0741643078029481,2.28224221270418e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,28232,0.0254304495509002,0.00267752819320754,0.0201824942922134,0.030678404809587,2.3087446729749e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,28320,0.080027481302274,0.00843360608514047,0.0634976133753987,0.0965573492291493,2.50652130934601e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,23738,0.048735363726585,0.00514599295838576,0.0386492175281489,0.0588215099250211,3.03517320092349e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,23337,0.075928654065645,0.00802649486522389,0.0601967241298061,0.0916605840014838,3.36906777043656e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",23795,0.0493608060428143,0.00521839150771336,0.0391327586876961,0.0595888533979324,3.38735147944191e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,23007,0.0352408802997208,0.00372755836724859,0.0279348658999136,0.0425468946995281,3.55829976178386e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28428,0.0289422028954169,0.00307289212694949,0.0229193343265959,0.0349650714642379,4.90816411550735e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,23135,0.0538262290170534,0.00572451178121051,0.0426061859258808,0.065046272108226,5.79333976607221e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,23862,0.0385076270888853,0.00410066043678098,0.0304703326327946,0.0465449215449761,6.48377093467101e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,28176,0.0304998614276994,0.00325165661169292,0.0241266144687813,0.0368731083866175,7.09050127114184e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,28091,0.0557400864557183,0.00594321588271277,0.0440913833256013,0.0673887895858354,7.1604721124751e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,23738,0.0435488125064683,0.00464443521172753,0.0344457194914824,0.0526519055214543,7.4068008920935e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,28091,0.0734452179649289,0.00783460589773178,0.0580893904053746,0.0888010455244831,7.45838910695915e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,23703,0.0553408111597316,0.00590533323192501,0.0437663580251586,0.0669152642943046,7.78273392903461e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,28091,0.0465272571398845,0.00496673382727187,0.0367924588384317,0.0562620554413374,7.94453932596064e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,28129,0.018256339164228,0.00195043603554424,0.0144334845345613,0.0220791937938947,8.53823039147502e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,23846,0.0617273514608024,0.00659667524998446,0.0487978679708328,0.0746568349507719,8.87592923115627e-21
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,28428,0.0602581164979971,0.00645071360835047,0.0476147178256302,0.0729015151703641,1.01883538249521e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,23872,0.0153367822612982,0.00164523641071719,0.0121121188962925,0.0185614456263039,1.23847554550065e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,28521,0.0217527153600639,0.00233641259021791,0.0171733466832368,0.026332084036891,1.36334619643707e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,28494,0.0187884799753152,0.00201879620671877,0.0148316394101464,0.022745320540484,1.40938146428401e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,28320,0.0535462978624033,0.00576375278564453,0.0422493424025401,0.0648432533222666,1.64729910896731e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,28176,0.0511974303102852,0.00551238256548644,0.0403931604819318,0.0620017001386386,1.686363554735e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,28174,0.0527445354599341,0.00567968361185968,0.0416123555806891,0.063876715339179,1.70521210113249e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,23198,0.0563993298854468,0.00608135166828674,0.0444798806156048,0.0683187791552888,1.94238821354988e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,27682,0.0692247547358073,0.00747581800737205,0.0545721514413581,0.0838773580302565,2.1914276151986e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,23521,0.0162976118577011,0.00176447769262032,0.0128392355801652,0.0197559881352369,2.75614619766484e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,28044,0.0160675164230024,0.00174111287875271,0.0126549351806471,0.0194800976653577,2.93732200882349e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,23188,0.0278189578678791,0.00301608769367287,0.0219074259882803,0.033730489747478,3.11346296091059e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,27965,0.0491452667823446,0.00533257477937917,0.0386934202147615,0.0595971133499278,3.29250204662204e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,28411,0.0375027424063673,0.00407015142815797,0.0295252456071777,0.0454802392055569,3.3495036291104e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,28281,0.031913796667635,0.00346535399954799,0.025121702828521,0.0387058905067491,3.50003842517784e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,27910,0.0384643081911594,0.00418289909809713,0.030265825958889,0.0466627904234298,3.98096537036651e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,23846,0.0175974316646495,0.00191496769135241,0.0138440949895988,0.0213507683397002,4.26340147563744e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,27702,0.0572178447986441,0.00622872342011215,0.0450095468952242,0.0694261427020639,4.34884644550322e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,23337,0.0177159169700366,0.00192977921101347,0.0139335497164502,0.021498284223623,4.64726096066448e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,27785,0.090756959986982,0.00989304148353699,0.0713665986792495,0.110147321294714,4.87284717334402e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,28237,0.0210137119863214,0.00229307216816729,0.0165192905367135,0.0255081334359293,5.33045920872262e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,27918,0.0153878429050564,0.00168164694458159,0.0120918148936765,0.0186838709164363,6.0449271233234e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,28115,0.0409673114864359,0.00448031158231629,0.032185900785096,0.0497487221877759,6.42198335214686e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,27477,0.0466138687236618,0.00510128053500911,0.036615358875044,0.0566123785722797,6.8081187800343e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,28224,0.0748720279380342,0.00819950370682824,0.0588010006726509,0.0909430552034176,7.20878727922222e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,28224,0.0784038118027246,0.00861023038219894,0.0615277602536147,0.0952798633518345,9.10591898108481e-20
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",23738,0.0896318528827398,0.00987319519929605,0.0702803902921196,0.10898331547336,1.18649018047397e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23071,0.0416545506718602,0.0045914066280371,0.0326553936809075,0.0506537076628129,1.25629856126069e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,28091,0.0485565825395398,0.00535890639607224,0.0380531260032382,0.0590600390758413,1.3754892275857e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,23725,0.0576446029524783,0.00636625441858993,0.045166744292042,0.0701224616129145,1.47213480119747e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,23738,0.0468358211464139,0.0051728224727951,0.0366970890997355,0.0569745531930923,1.47884468450976e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,23585,0.019423779972997,0.00214657932620572,0.0152164844936338,0.0236310754523603,1.5556696974559e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,27702,0.0400900887882547,0.00443123072896941,0.0314048765594747,0.0487753010170348,1.56084196787006e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,28452,0.033852737329818,0.00374447785263852,0.0265135607386465,0.0411919139209895,1.65290402474394e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,23795,0.0594966999739089,0.00658507428681061,0.0465899543717601,0.0724034455760577,1.76039988783037e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,22395,-0.0676594097847539,0.00749050642048453,-0.0823408023689035,-0.0529780172006042,1.80729574934388e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,23287,0.0626993396966071,0.00694347824774497,0.049090122331027,0.0763085570621873,1.8473693155922e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,27528,0.0664471328938014,0.00735984507191123,0.0520218365528554,0.0808724292347474,1.85403906100364e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,23795,0.0465589007607702,0.0051613519948102,0.0364426508509422,0.0566751506705982,2.00710910114093e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,28452,0.0200382715789602,0.00222197982001563,0.0156831911317295,0.0243933520261908,2.02906967927098e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",28187,0.0468391710261067,0.00519563529788835,0.0366557258422455,0.0570226162099678,2.08839711336004e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,27879,0.0633313348962662,0.00702854577820422,0.0495553851709859,0.0771072846215465,2.17730085327056e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,23337,0.0279213499567809,0.00309851609935944,0.0218482584020364,0.0339944415115254,2.19081835376023e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,23725,0.0269587659230779,0.00299361650205794,0.0210912775790443,0.0328262542671115,2.30628920511233e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,23738,0.0549891285446204,0.00610841979356205,0.0430166257492388,0.066961631340002,2.37488595187001e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,28336,0.0324198787993751,0.00360375577171913,0.0253565174868056,0.0394832401119446,2.4804055406549e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,28521,0.0470566431250445,0.00523376037697679,0.03679847278617,0.057314813463919,2.59822141326245e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,28307,0.0437921551033915,0.00487077460936045,0.034245436869045,0.053338873337738,2.60368287617311e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,23872,0.0441006697350939,0.00491241312602269,0.0344723400080894,0.0537289994620984,2.97234945672033e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,28428,0.0349376083680341,0.00389404800641357,0.0273052742754635,0.0425699424606047,3.08511616618089e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,27965,0.0487684892380126,0.0054359332497175,0.0381140600685663,0.0594229184074589,3.10354404069536e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,28348,-0.0249959394527285,0.00278818795469996,-0.0304607878439404,-0.0195310910615166,3.2908314008258e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,28091,0.0686764806566211,0.00766335752765706,0.0536562999024132,0.0836966614108289,3.39146075404068e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23198,-0.0222763594587377,0.00248626828924187,-0.0271494453056517,-0.0174032736118236,3.49355705042326e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,28224,0.0465501944338714,0.00520109121370389,0.0363560556550118,0.056744333212731,3.76492191133686e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,28061,0.0148998844034571,0.00166545401292126,0.0116355945381314,0.0181641742687828,3.89214458297965e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28336,0.0255871594906315,0.00286056984327744,0.0199804425978077,0.0311938763834552,3.94879076580497e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",28320,0.0662284714372903,0.00740847943999859,0.051707851734893,0.0807490911396875,4.139693513319e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,27928,0.0422608092904285,0.00473031178397743,0.0329893981938327,0.0515322203870243,4.35403520367951e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,28224,0.0256896456461643,0.00287679812187497,0.0200511213272894,0.0313281699650392,4.51520146271574e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,28176,0.0220698836200884,0.00247179211605692,0.0172251710726169,0.02691459616756,4.56666398915257e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,27965,0.0578842087839704,0.0064885009347767,0.0451667469518081,0.0706016706161327,4.89470695506269e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,28276,0.0302938740001863,0.0034005721933377,0.0236287525012444,0.0369589954991282,5.47797870003638e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,28111,0.0203359112932672,0.00228345556651664,0.0158603383828946,0.0248114842036398,5.61456630769719e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,23337,0.0180073781138565,0.00202218645411437,0.0140438926637923,0.0219708635639207,5.72451807699602e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,28176,0.0716964257080765,0.00806826033093241,0.055882635459449,0.0875102159567041,6.69009144442961e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",27682,0.0555811365871734,0.00625641518976201,0.0433185628152398,0.0678437103591069,6.8405991385752e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,27965,0.0228695092762872,0.00257514363919668,0.0178222277434617,0.0279167908091127,7.02275838295396e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28452,0.0193226906382438,0.00217633073704334,0.0150570823936388,0.0235882988828487,7.16234284649985e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,23725,0.0475503546879456,0.00536536065261644,0.0370342478088174,0.0580664615670739,8.36449737369484e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,28336,0.033932762768425,0.00382952381757735,0.0264268960859734,0.0414386294508766,8.396870511281e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,23775,0.0318780287314099,0.00360036319699744,0.0248213168652949,0.0389347405975249,9.01198584414899e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,23893,-0.0430618180212651,0.00486385190473924,-0.052594967754554,-0.0335286682879762,9.06356925140164e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,28320,0.0253390867411045,0.00286270522110011,0.0197281845077483,0.0309499889744607,9.1320183606297e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,28224,0.0343522303226137,0.00388153659171676,0.0267444186028488,0.0419600420423785,9.23926311369009e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,28238,0.0556320621085554,0.00628742834490114,0.0433087025525492,0.0679554216645616,9.40728168988264e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,28307,0.0131770788090452,0.00149016761157423,0.0102563502903597,0.0160978073277307,9.87606320836655e-19
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,23795,0.0460657375596857,0.00521840619933068,0.0358376614089976,0.0562938137103738,1.14216904271262e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,23198,-0.0360657468005963,0.00409150973992866,-0.0440851058908565,-0.0280463877103361,1.28184780360895e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23337,0.0508157824667192,0.00576524626575199,0.0395158997858453,0.0621156651475931,1.28843534700944e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,27832,0.0280424692382829,0.00318211613586882,0.0218055216119801,0.0342794168645858,1.29342447544649e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,28320,0.0242029895119896,0.0027487368537051,0.0188154652787276,0.0295905137452516,1.37999583078934e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,28091,0.0165624273407208,0.00188213826251436,0.0128734363461927,0.020251418335249,1.44769806036268e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27682,0.0495536312614748,0.00563582738219119,0.03850740959238,0.0605998529305695,1.54432245625316e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,28224,0.0513339449626295,0.00584215942963273,0.0398833124805494,0.0627845774447097,1.62418536289933e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27863,0.0197202901797829,0.00224611678822086,0.0153179012748701,0.0241226790846958,1.73072244336733e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,27532,0.0233988633241501,0.00266723635518383,0.0181710800679898,0.0286266465803104,1.84313390655123e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,23373,0.0227011879831369,0.00258885408434192,0.0176270339778268,0.0277753419884471,1.92634986257765e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,28452,-0.0147103447322865,0.001677984997613,-0.017999195327608,-0.011421494136965,1.94074323579884e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,27544,0.0502026611062542,0.00573371294873956,0.0389645837267246,0.0614407384857837,2.14238133182297e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,28091,0.0452913389692029,0.00517975321533689,0.0351390226671426,0.0554436552712632,2.37490564450808e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,27965,0.0589826861978507,0.00674576788593243,0.0457609811414231,0.0722043912542783,2.38094601828689e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,28176,0.0660013063618602,0.00755471856605151,0.0511940579723992,0.0808085547513212,2.53668970308925e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,23846,0.0310710997421304,0.00355714383372269,0.024099097828034,0.0380431016562269,2.59733122374579e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,23198,0.0181161118441962,0.0020740940910919,0.014050887425656,0.0221813362627363,2.61048833450624e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,23738,0.060493173845468,0.00693451759280932,0.0469015193635617,0.0740848283273742,2.87157712501869e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,23841,0.0329193053326975,0.00377464118616996,0.0255210086078043,0.0403176020575906,2.92985649544341e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,27702,0.028433870569665,0.00326628474498699,0.0220319524694905,0.0348357886698395,3.34121266200158e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23337,0.0373948894787759,0.00429748021706933,0.02897182825332,0.0458179507042318,3.48538793944291e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,27702,0.0228788836457123,0.00263130783187887,0.0177215202952297,0.0280362469961949,3.66073024569078e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,28470,0.0293088518311709,0.00337464408383152,0.0226945494268611,0.0359231542354807,3.98573816309503e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,28521,0.0344759003110881,0.00396980183471266,0.0266950887150513,0.0422567119071249,4.0022203231811e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,23188,0.0290105198424231,0.00334078285944709,0.0224625854379068,0.0355584542469394,4.07762974076072e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,28142,0.0388706268119199,0.00448112297698003,0.0300876257770391,0.0476536278468008,4.38099426948229e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,23738,0.0378290064312812,0.00436278299548034,0.0292779517601397,0.0463800611024227,4.55918020950512e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,23795,0.0442057444893657,0.00509966431480153,0.0342104024323547,0.0542010865463767,4.65854255624879e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,28176,0.0607444364710534,0.00701146696310296,0.0470019612233716,0.0744869117187352,4.81195238848803e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27682,0.0319894903649504,0.00369642348565789,0.0247445003330609,0.0392344803968399,5.22963201775211e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,23846,0.0398284721574002,0.00460218456512844,0.0308081904097485,0.048848753905052,5.26975496375268e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,23775,0.0526345159062906,0.00608222172427606,0.0407133613267095,0.0645556704858717,5.29022477815554e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,23735,0.0342071839556991,0.00395307677105888,0.0264591534844237,0.0419552144269745,5.31505672901154e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,23692,0.0165744965905249,0.00191660986306014,0.0128179412589271,0.0203310519221228,5.57661366699318e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,28176,0.0704149586868281,0.00814781256406235,0.0544452460612659,0.0863846713123903,5.80154743383314e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,23747,0.0634979088232365,0.0073514161640322,0.0490891331417334,0.0779066845047397,6.10098875794702e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23149,0.0209815264646128,0.00242911637107764,0.0162204583773006,0.0257425945519249,6.11008202765327e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,28144,0.0534335268283865,0.00618867009058598,0.041303733450838,0.065563320205935,6.22705863109641e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,28428,0.0201175788177413,0.00233132572891628,0.0155481803890654,0.0246869772464173,6.49253245310871e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,27562,0.0443878963067414,0.00514573644950527,0.0343022528657111,0.0544735397477718,6.6804833722515e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,23163,0.0763235580363475,0.0088612780794766,0.0589554530005734,0.0936916630721216,7.55402895233703e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,28138,0.0455848712546686,0.00530961684868812,0.0351780222312399,0.0559917202780974,9.51642704677432e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",23198,0.0369939986128794,0.00430841631853877,0.0285495026285434,0.0454384945972154,9.52514654403749e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,28378,0.0402112567283059,0.00468555264914197,0.0310275735359877,0.0493949399206242,9.79500252929199e-18
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,28187,0.0139793636951962,0.00162982050661615,0.0107849155022285,0.0171738118881639,1.02080431755251e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,23188,0.0461785627706017,0.00539014876419698,0.0356138711927757,0.0567432543484278,1.12524784374203e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,23795,0.0491673740973058,0.00574240050722257,0.0379122691031495,0.060422479091462,1.17372962543569e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,27544,0.0193608530389303,0.00226190496592162,0.0149275193057239,0.0237941867721366,1.19132259296912e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,27481,0.0402035775843882,0.00469785173137037,0.0309957881909023,0.0494113669778741,1.20879361089282e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,28091,0.0236147639639677,0.00276071588967197,0.0182037608202106,0.0290257671077247,1.25007633490787e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,28521,0.0174495661785306,0.00204050804707133,0.0134501704062708,0.0214489619507904,1.27397674024513e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27084,-0.0217236608787308,0.00254313646373662,-0.0267082083476546,-0.016739113409807,1.3865097014594e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,27544,0.0388886869867512,0.00455694667297561,0.029957071507719,0.0478203024657834,1.48614426568794e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,23736,0.0466087100630869,0.00546316881552272,0.0359008991846624,0.0573165209415114,1.53048634179247e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,28452,0.0163803850957311,0.00192106873598204,0.0126150903732063,0.0201456798182559,1.57926154148158e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,28080,0.0196761358624872,0.00230889500476717,0.0151507016531435,0.0242015700718308,1.64727007184473e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",28521,0.0387947022921146,0.00455742334819984,0.0298621525296429,0.0477272520545863,1.7857833971271e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,28307,0.0317896662169981,0.00374204734196573,0.0244552534267453,0.039124079007251,2.070368907269e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,23188,0.0445289130673904,0.00524668230564435,0.0342454157483275,0.0548124103864533,2.24448575151018e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,28224,0.0436518746046657,0.00514468334878042,0.0335682952410561,0.0537354539682753,2.26415563380889e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,28233,0.0605544331541024,0.0071383211209125,0.0465633237571139,0.0745455425510909,2.30021217814532e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,28176,0.0480067928441031,0.00566074817793107,0.0369117264153582,0.0591018592728479,2.34752253278238e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,28176,0.0413238878567169,0.00487444028111024,0.0317699849057408,0.0508777908076929,2.40818367323069e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",28187,0.0215827926949062,0.00254686359923201,0.0165909400404115,0.026574645349401,2.47943836872123e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,23846,0.0161577063110385,0.00190653564589202,0.0124208964450901,0.0198945161769868,2.48701039835317e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,28276,0.0256752871497583,0.00303500785664298,0.0197266717507381,0.0316239025487785,2.80797164559276e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,27682,0.0415922338129301,0.00491811395013751,0.0319527304706606,0.0512317371551996,2.87795525970083e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,28215,0.0222548142342094,0.00263240494792355,0.0170953005362792,0.0274143279321395,2.94433993034182e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,23337,0.0541469397771507,0.0064106193246556,0.0415821259008257,0.0667117536534757,3.17594415290941e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,27682,0.0431828044029704,0.00511353149518503,0.0331602826724078,0.0532053261335331,3.19243292761116e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,23337,-0.0189198077836724,0.00224129568168609,-0.0233127473197772,-0.0145268682475677,3.31394079587848e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,23198,0.0544153374776511,0.00644750028394791,0.0417782369211132,0.067052438034189,3.36354554761073e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,23700,0.0399602012692012,0.0047349068102621,0.0306797839210874,0.0492406186173149,3.36720697986933e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,28134,0.0646109366535715,0.00766403264840485,0.049589432662698,0.079632440644445,3.60702706010739e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,23738,0.0649572954226768,0.00770453252039112,0.0498564116827102,0.0800581791626434,3.61812653109469e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,23846,0.0262118920302649,0.00311241934823267,0.0201115501077289,0.0323122339528009,3.91671393122667e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28276,0.0489181946685259,0.00580974856232342,0.037531087486372,0.0603053018506798,3.93997569654735e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,23337,0.0713445192437108,0.00847610642618808,0.0547313506483822,0.0879576878390394,4.07704131724785e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,28091,0.0778376333033609,0.0092488555556887,0.0597098764142111,0.0959653901925108,4.08108764071184e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,23846,0.0406667915045769,0.00483194231699458,0.0311961845632675,0.0501373984458863,4.10327938996064e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,23846,0.0518335182696975,0.00616422275375926,0.0397516416723293,0.0639153948670656,4.37248324155629e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23337,0.0505459575279457,0.00601545950223137,0.0387556569035722,0.0623362581523192,4.61013893256597e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",28187,0.0137311488719946,0.0016355976704579,0.0105253774378972,0.0169369203060921,4.86681899903851e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,28187,0.0231955871817811,0.00276399325134691,0.0177781604091412,0.028613013954421,4.99789784905203e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,23337,0.0327411797919203,0.00390254165974193,0.0250921981388261,0.0403901614450145,5.14652802256422e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,23862,0.0474120705152719,0.00565272924439007,0.0363327211962673,0.0584914198342764,5.2390001483163e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,28195,-0.0224228726121387,0.00267373776438892,-0.027663398630341,-0.0171823465939364,5.24621458643778e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,28187,0.0203065063499391,0.00242190313760341,0.0155595762002364,0.0250534364996418,5.32765288352425e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,23198,0.0579967900156731,0.00691817879012973,0.0444371595870188,0.0715564204443274,5.43804717299794e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,28307,-0.0135439294219072,0.00161617633068431,-0.0167116350300485,-0.010376223813766,5.52413562628109e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,28187,0.0140939011571289,0.00168487138432874,0.0107915532438446,0.0173962490704132,6.28724255386979e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,27544,0.0253339344761499,0.0030293293919161,0.0193964488679943,0.0312714200843055,6.40583325665496e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",23775,0.0549852715436356,0.00657738408332031,0.0420935987403277,0.0678769443469434,6.62566525004677e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,28176,0.0317806973074205,0.00380367295285307,0.0243254983198285,0.0392358962950125,6.82511977673324e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27965,0.052899057173172,0.00633259555588597,0.0404871698836355,0.0653109444627085,6.93260640446471e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,28176,-0.0220437352374635,0.00263937057050104,-0.0272169015556455,-0.0168705689192815,7.02251590155365e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,23872,0.0266808997436137,0.00319572214589873,0.0204172843376522,0.0329445151495752,7.2572480283806e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,28176,0.0240908456107164,0.00288693896804448,0.0184324452333492,0.0297492459880836,7.45764397063734e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,28521,0.0529829786632144,0.00635039212753046,0.0405362100932547,0.0654297472331741,7.54928849546162e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",28176,0.0538781636325072,0.00646169397019735,0.0412132434509204,0.066543083814094,7.89035229187573e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,28176,0.029307632244965,0.00351736092569084,0.022413604830611,0.0362016596593191,8.2863186287395e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23675,0.061262099678342,0.00735893191504139,0.0468385931248609,0.0756856062318231,8.89417150934892e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,28553,0.0146812811279898,0.00176625063297103,0.0112194298873666,0.0181431323686131,9.81357440153064e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,24857,-0.0175177263321828,0.00210735109627359,-0.0216481344808791,-0.0133873181834866,9.83005180165246e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,28496,0.0287649621032645,0.00346097339311215,0.0219814542527647,0.0355484699537643,9.88746172652628e-17
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,23337,-0.0127513181057209,0.00153509625179366,-0.0157601067592365,-0.00974252945220531,1.0384517950572e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,23460,0.00759281101307873,0.000918217533388435,0.0057931046476374,0.00939251737852006,1.42093215127106e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,27682,0.0470243312846924,0.00568844028697135,0.0358749883222286,0.0581736742471563,1.43882898852494e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,28187,0.023535168845245,0.00284719172073638,0.0179546730726017,0.0291156646178883,1.44432418392336e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,28276,0.0482944038157561,0.00584436066935739,0.0368394569038157,0.0597493507276966,1.47685532283368e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",28307,0.0341002362579285,0.00413001324303822,0.0260054103015736,0.0421950622142834,1.56223413549773e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,23725,0.0317635402945836,0.0038470554051543,0.0242233117004811,0.039303768888686,1.57637189365042e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,28268,0.0664083765544345,0.00804977592503736,0.0506308157413613,0.0821859373675078,1.65598656688875e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,28223,-0.0289843533713314,0.00351873306495468,-0.0358810701786425,-0.0220876365640202,1.83903714643336e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,23725,0.0462094275897599,0.0056123023340325,0.0352093150150562,0.0572095401644636,1.90949438555179e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,28307,0.0139845816535097,0.00170201902662739,0.01064862436132,0.0173205389456994,2.18444874425624e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,28176,0.046362107312354,0.00564444956497452,0.035298986165004,0.0574252284597041,2.23473344484851e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,23664,0.0257122654310608,0.00313509716725122,0.0195674749832484,0.0318570558788732,2.4951988086059e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,28266,-0.0250037333547047,0.00304929774133479,-0.0309803569277208,-0.0190271097816885,2.50825727364969e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,23846,0.0495249390861727,0.00604019415084427,0.0376861585505179,0.0613637196218274,2.5401119009765e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,27965,0.0488223926409407,0.00596264534242914,0.0371356077697795,0.0605091775121018,2.76712569153153e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,28224,0.0199199741257256,0.00243420743047503,0.0151489275619945,0.0246910206894566,2.87569980820788e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27965,0.0431569920320648,0.0052760866745169,0.0328158621500117,0.053498121914118,2.96422504011434e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,28091,0.0495172067568023,0.00605395438666123,0.0376514561589463,0.0613829573546583,2.97397889890101e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,23337,0.0285867485655767,0.00349688021478652,0.0217328633445951,0.0354406337865582,3.10969687735861e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,27702,0.0193845612195501,0.00237193952409191,0.0147355597523299,0.0240335626867702,3.14960526272271e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",28091,0.0449244377897087,0.00550005169583091,0.0341443364658801,0.0557045391135373,3.26576660807599e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,28176,0.0361135374630471,0.00442478627503623,0.0274409563639761,0.0447861185621182,3.44150790139481e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,28238,0.0358249273839113,0.00439653838038509,0.0272077121583565,0.0444421426094661,3.83754770385544e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,27638,0.0275364096687112,0.00338102002769946,0.0209096104144203,0.0341632089230022,3.9706939606805e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,23337,0.0480139790419084,0.00590058141917181,0.0364488394603317,0.0595791186234852,4.24685934026002e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,28224,0.0474655151632378,0.00583952765602148,0.0360200409574357,0.0589109893690399,4.52970070500082e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,27917,0.0319471466277982,0.00393164197829998,0.0242411283503302,0.0396531649052661,4.63210291389215e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,23725,0.0381120850879414,0.00469524846806688,0.0289093980905303,0.0473147720853525,5.00215507280684e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,23775,0.0544431277235101,0.00671552625578832,0.041280696262165,0.0676055591848552,5.43436571684895e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,23775,0.0253572319051595,0.00312853375051649,0.0192253057541472,0.0314891580561719,5.51991883719111e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,27544,0.0397333485839081,0.00490299889868071,0.0301234707424939,0.0493432264253223,5.54188682220947e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",23775,0.057906616061962,0.00714515362891394,0.0439021149492906,0.0719111171746333,5.55754523287893e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,28553,0.0321847696011503,0.00397252119186313,0.0243986280650986,0.039970911137202,5.62727853887643e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,27702,-0.0215619823811514,0.00266145388772926,-0.0267784320011008,-0.0163455327612021,5.6464500710062e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28276,0.0486266240848848,0.00600454463789475,0.036857716594611,0.0603955315751585,5.79554324921306e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,28452,0.0329348172400498,0.00406786139848202,0.024961808899025,0.0409078255810746,5.88782622447348e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,28521,0.0229091973763915,0.00282969567044091,0.0173629938623274,0.0284554008904557,5.90436210629113e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,28521,0.0344478443815289,0.00425716153260656,0.0261038077776201,0.0427918809854378,6.11379560343641e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,23846,-0.0205337627013844,0.0025384257684144,-0.0255090772074766,-0.0155584481952921,6.29117882051247e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,28404,0.0168538253084773,0.00208490243046466,0.0127674165447666,0.0209402340721881,6.52835989363536e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,23337,0.0367317046002796,0.00454362104090485,0.0278262073601061,0.0456372018404531,6.55711633470389e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,23846,0.0419877176560374,0.00519560701622552,0.0318043279042354,0.0521711074078394,6.7049272529157e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,28224,0.045278994130297,0.00560356767667307,0.0342960014840178,0.0562619867765762,6.71206110757482e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,27544,0.0254090715283867,0.00314629836698635,0.0192423267290934,0.0315758163276799,6.97179312660249e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,28553,-0.0148262248371415,0.00183598739292385,-0.0184247601272723,-0.0112276895470108,6.9917270343748e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,23775,0.0447878081930138,0.00555004068813067,0.0339097284442777,0.0556658879417499,7.37107751744696e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,27702,0.0442905597468294,0.00548966341426432,0.0335308194548714,0.0550503000387875,7.43329475906569e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28520,0.0149624204731844,0.0018548876459692,0.0113268406870848,0.0185980002592841,7.51697396181308e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23198,0.0378729295510292,0.00471033636623431,0.02864067027321,0.0471051888288485,9.38049159639306e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,28155,0.0492847520856922,0.00613055719346475,0.0372688599865013,0.0613006441848831,9.39498938026137e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23846,0.0406829540520507,0.0050600548631803,0.0307652465202173,0.050600661583884,9.39657924329403e-16
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,22833,0.0438437315260724,0.00545981776448326,0.0331424887076852,0.0545449743444596,1.01937791128215e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,27562,0.0290467339726785,0.00361866242758135,0.021954155614619,0.0361393123307379,1.03897270535135e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,23846,0.0149109982063438,0.00185942775185301,0.0112665198127119,0.0185554765999757,1.11355880056579e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,28404,0.0227569514292484,0.00283925371647036,0.0171920141449665,0.0283218887135303,1.14226266721688e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,23795,0.0390995982391423,0.00487804003036118,0.0295386397796344,0.0486605566986502,1.14762477972759e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,28307,0.017313657202139,0.00216214272020555,0.0130758574705361,0.0215514569337419,1.21388175507931e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,28428,0.01545187419858,0.0019299480920894,0.0116691759380848,0.0192345724590752,1.22626077786172e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,28187,0.0641642198193746,0.00802018575480851,0.04844465573995,0.0798837838987993,1.28806737558235e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23337,0.0561763519879023,0.0070244922217089,0.0424083472333529,0.0699443567424518,1.331425760414e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,28307,0.0177041258111608,0.00221488563777251,0.0133629499611267,0.0220453016611949,1.36404137390382e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,28320,-0.0348388731335626,0.00435965948837494,-0.0433838057307775,-0.0262939405363477,1.38689633817571e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,28291,-0.0158669765909254,0.0019873557030524,-0.0197621937689081,-0.0119717594129427,1.4704682995125e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,27682,0.0291140166560338,0.00365044473199322,0.0219591449813271,0.0362688883307405,1.57623697624274e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,27431,0.0310584960708521,0.00389440013103014,0.023425471814033,0.0386915203276712,1.58064311949174e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,23198,0.0389671138188765,0.00488743447090188,0.0293877422559088,0.0485464853818442,1.62080336236802e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,23738,0.0527501078560294,0.00662125353818475,0.0397724509211873,0.0657277647908715,1.70129567605845e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,23862,-0.0215579979853654,0.00270630730711091,-0.0268623603073028,-0.016253635663428,1.71400128130835e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,28091,0.0388510980573305,0.0048813701092562,0.0292836126431884,0.0484185834714726,1.79854322709742e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,23893,0.00815430984401123,0.00102445511637913,0.00614637781590813,0.0101622418721143,1.80146854541425e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,28553,-0.014743825763856,0.001853351098543,-0.0183763939170003,-0.0111112576107117,1.85384426988958e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23198,0.0139426264001703,0.00175300198644065,0.0105067425067466,0.0173785102935939,1.89442358521079e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,23198,0.0343099035661064,0.00431384869602805,0.0258547601218915,0.0427650470103214,1.89654641507544e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,28277,0.0379890947256066,0.00478012046424958,0.0286200586156774,0.0473581308355358,1.97660831698584e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,28187,0.0392918011832117,0.00494557471998021,0.0295984747320504,0.0489851276343729,2.01651870850888e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,27562,0.031707244235869,0.00399669802224798,0.0238737161122629,0.039540772359475,2.21340605061376e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,23337,0.0458797238044616,0.00578415666378545,0.0345427767434421,0.0572166708654811,2.2534010308203e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,28195,0.0412778412757936,0.00521043157368233,0.0310653953913762,0.0514902871602109,2.41986448782954e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,28125,0.055131441597566,0.00696002460938511,0.0414897933631712,0.0687730898319609,2.43954144981274e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,28091,0.0151633527342433,0.00191509668821085,0.01140976322535,0.0189169422431366,2.50623796687132e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,27544,0.0328127267226004,0.0041466429551617,0.0246853065304835,0.0409401469147173,2.60474330194513e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,23738,0.0342965177867432,0.00433457935200882,0.0258007422568059,0.0427922933166804,2.6364412635336e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,28307,0.0197058187860023,0.00249297842505771,0.0148195810728892,0.0245920564991154,2.7868023489711e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,28091,0.0301141811782706,0.0038106679399018,0.0226452720160631,0.0375830903404782,2.83096719204393e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,23170,0.0302906416378162,0.00383455799876869,0.0227749079602296,0.0378063753154029,2.92690613073766e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,28320,0.0109091503548809,0.0013815432220692,0.0082013256396253,0.0136169750701366,2.97529334005222e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,23056,0.0529316710025169,0.00670308874439921,0.0397936170634944,0.0660697249415393,2.99321501868878e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,23846,0.0435767076590957,0.00551939887092855,0.0327586858720757,0.0543947294461156,3.02300725691026e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,23198,0.0325771366423595,0.00412715440623031,0.0244879140061481,0.0406663592785709,3.0710568590973e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,28187,0.0141420416310824,0.00179257144093924,0.0106286016068415,0.0176554816553233,3.1497274930294e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,28320,0.0491091478011857,0.00622492593639864,0.0369082929658443,0.061310002636527,3.15260361100398e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,28224,0.0355970600559239,0.00451578993594235,0.0267461117814769,0.0444480083303709,3.31619566581351e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,23337,0.0340103354683226,0.00431478845662537,0.0255533500933369,0.0424673208433084,3.3548097581508e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,28132,0.0255314081092994,0.00324067655044092,0.0191796820704352,0.0318831341481636,3.43461125213914e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",28187,0.0244813432102964,0.00310870467262933,0.0183882820519429,0.0305744043686499,3.52673606559691e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,28307,-0.0224589818876077,0.00285635795323127,-0.028057443475941,-0.0168605202992744,3.88934364094218e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,28182,0.0158897709363972,0.00202396429216835,0.0119228009237472,0.0198567409490471,4.27956603233083e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,28070,0.0151071260265412,0.00192456715985494,0.0113349743932256,0.0188792776598569,4.32098468574026e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,28428,0.0242881034093708,0.0030975334396579,0.0182169378676413,0.0303592689511003,4.62153873103223e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,28470,0.017258079774907,0.0022015238411944,0.0129430930461659,0.021573066503648,4.69381308255023e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,23687,0.0466525668560875,0.00595074455315024,0.034989107531913,0.0583160261802619,4.70254085731936e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,28253,-0.0195382057682454,0.00249825517279753,-0.0244347859069285,-0.0146416256295622,5.43375081361124e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27965,0.0552088510218572,0.00706185085978435,0.0413676233366799,0.0690500787070345,5.55938677586289e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,28187,0.0169260653913158,0.00216642381034541,0.0126798747230388,0.0211722560595928,5.78223011161913e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,23795,0.0314467932272457,0.00402742992619094,0.0235530305719114,0.0393405558825799,6.04168466820936e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,27910,0.0397288197309524,0.0050927815762813,0.0297469678414411,0.0497106716204638,6.35537844483396e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,28452,-0.0240741016755136,0.00308626136380796,-0.0301231739485772,-0.0180250294024501,6.38128475015202e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,23725,0.0255913354065699,0.00328396599902621,0.0191547620484785,0.0320279087646613,6.82135807390802e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,28176,0.0529629214121382,0.00679902713086327,0.0396368282356462,0.0662890145886302,6.94275987633744e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,28224,0.0346548868219969,0.00445091183278204,0.0259310996297441,0.0433786740142497,7.15153513211069e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,28224,0.0257514595659367,0.00330910968410974,0.0192656045850816,0.0322373145467918,7.38258954074865e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,28174,0.0321408044184829,0.00413147480097398,0.0240431138085739,0.0402384950283919,7.52955383290419e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,28176,0.03200307898784,0.00411403321947041,0.023939573877678,0.040066584098002,7.5590209595029e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,23100,0.0263391324126864,0.00338877100574216,0.0196971412414317,0.032981123583941,8.01693714265155e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,27544,0.0321191524623409,0.00413373678284237,0.0240170283679699,0.040221276556712,8.1209027380348e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,28553,0.0295391137248532,0.0038017825882019,0.0220876198519775,0.0369906075977289,8.1237906104609e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,28093,0.0377087353040114,0.00485811466407849,0.0281868305624175,0.0472306400456052,8.64274081966423e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,23469,0.0292492684697124,0.00376812084676486,0.0218637516100533,0.0366347853293716,8.68010654463361e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27910,0.0583207013633888,0.00751512242324342,0.0435910614138317,0.0730503413129459,8.75169123198891e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,28404,0.0299597107980569,0.00386254052728037,0.0223891313645873,0.0375302902315264,9.0239187122423e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,28187,0.0143816866263275,0.00185477842633434,0.0107463209107122,0.0180170523419428,9.2141654356476e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,23893,0.0109289542641063,0.00140983145586482,0.00816568461061122,0.0136922239176013,9.40841358365145e-15
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27562,0.04064156945224,0.00525128510852243,0.0303490506395361,0.050934088264944,1.03334280425555e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,28320,0.0457024347508691,0.00590613165404227,0.0341264167089463,0.057278452792792,1.0423747693451e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,27544,0.0411689304806888,0.0053208553288246,0.0307400540361926,0.051597806925185,1.05036960550954e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,23846,0.047564372225111,0.00615236964553858,0.0355057277198553,0.0596230167303666,1.10853495981942e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,28176,0.0290750879020609,0.00376334321659598,0.0216989351975328,0.036451240606589,1.14780112628372e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,23846,0.0331139536767198,0.00428784573261273,0.0247097760407988,0.0415181313126407,1.18315433174426e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,28091,0.028726707689004,0.00372116836437825,0.0214332176948226,0.0360201976831853,1.20368911386226e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,23893,-0.0142722033912038,0.00184920580706628,-0.0178966467730537,-0.0106477600093539,1.22768623943138e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23337,0.0303041453725824,0.00392680100481017,0.0226076154031544,0.0380006753420103,1.23611070805447e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27562,0.0339692329251633,0.00440837796129337,0.0253288121210283,0.0426096537292983,1.34593026397801e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,23872,0.0474835334895843,0.0061677853943566,0.0353946741166454,0.0595723928625233,1.42850248175023e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,23589,0.0140921137179597,0.00183051006632522,0.0105043139879623,0.0176799134479572,1.43108348635102e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,28307,0.0324835191029636,0.00422077807666969,0.024210794072691,0.0407562441332362,1.44845662997122e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,23795,0.0249861536208153,0.00324880123889376,0.0186185031925835,0.031353804049047,1.51774045760054e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,23813,0.0230423064861286,0.00299623725231529,0.0171696814715906,0.0289149315006665,1.52326338751494e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,23725,0.0367320770768877,0.00477764676304946,0.0273678894213107,0.0460962647324646,1.54855823577915e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27544,0.057931592175188,0.00753573520705233,0.0431615511693655,0.0727016331810106,1.54929879264573e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,27682,0.0199530101620275,0.00259731769307596,0.0148622674835986,0.0250437528404564,1.61592883990894e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,23775,0.0390381152167818,0.00508211276342791,0.0290771742004631,0.0489990562331005,1.63327672103763e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,23725,0.0430347494258028,0.00560302865227062,0.0320528132673524,0.0540166855842533,1.64426624348655e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,28103,0.0460545044715291,0.00600413870363691,0.0342863926124008,0.0578226163306575,1.76919317704326e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,23812,0.00766405215294323,0.000999078123819279,0.00570585903025744,0.00962224527562901,1.77018321679808e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,28091,0.0204238794177164,0.00266292502307709,0.0152045463724853,0.0256432124629475,1.77948083006805e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,23795,0.0409673896942581,0.00534470608402491,0.0304917657695692,0.0514430136189469,1.85597148274833e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,27544,0.0265744991709702,0.00346767836976127,0.0197778495662381,0.0333711487757023,1.86901904352684e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23198,0.0395982344151318,0.00516745349616792,0.0294700255626427,0.049726443267621,1.88734533089528e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,28187,-0.0139196441646109,0.00181671030515387,-0.0174803963627125,-0.0103588919665093,1.88923714090416e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,27562,0.02092578250038,0.0027311795925877,0.0155726704989081,0.0262788945018519,1.89344398303285e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,23846,0.036561835564616,0.00477659475146852,0.0271997098517377,0.0459239612774943,2.01614705039492e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,28411,0.0324655123319136,0.00424375989362996,0.0241477429403988,0.0407832817234283,2.07050779365089e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,28307,0.0431483373238207,0.00564089627697953,0.0320921806209408,0.0542044940267006,2.08651492369224e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,28389,0.0221981300228028,0.00290243620530676,0.0165093550604015,0.027886904985204,2.10414829370996e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,28224,0.0207799177924624,0.00271825852476567,0.0154521310839217,0.0261077045010031,2.16299607431985e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,23872,0.014270385551281,0.00186665551102475,0.0106117407496725,0.0179290303528895,2.16986739170809e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,28184,0.0204404216892614,0.00267432473898127,0.0151987452008581,0.0256820981776646,2.18605091711161e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,23393,0.0379291675437671,0.00497263442985647,0.0281828040612484,0.0476755310262858,2.48309074256458e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,27750,0.0175020142767759,0.00229558328687928,0.0130026710344925,0.0220013575190593,2.53374308021192e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,28224,0.031791863392846,0.00417149137831783,0.0236157402913431,0.0399679864943489,2.59164621360841e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,27965,0.0343181896518726,0.00450489697285316,0.0254885915850804,0.0431477877186648,2.65830313534029e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,23738,0.0438088377827993,0.00576223399205645,0.0325148591583686,0.0551028164072299,3.00632069775996e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,28521,0.0344908446614027,0.00454179520660462,0.0255889260564577,0.0433927632663478,3.19421016054474e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,28320,0.0208508828988919,0.00274720889388962,0.0154663534668682,0.0262354123309155,3.30140517408673e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,28091,0.0448228642820706,0.00590898851680134,0.03324124678914,0.0564044817750013,3.41346459917644e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,28031,0.0196728546886558,0.0025963814733209,0.0145839470009468,0.0247617623763648,3.64469460570679e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,28091,0.0273680392410808,0.00361225072524312,0.0202880278196043,0.0344480506625573,3.66066852920621e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,27682,0.0249377658640586,0.00329370303170418,0.0184821079219185,0.0313934238061988,3.8088399647353e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,28031,0.0233964587425469,0.00309164451245505,0.017336835498135,0.0294560819869588,3.9172797115332e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,23337,0.0378340844778109,0.00499915294534886,0.0280357447049271,0.0476324242506946,3.92734965309642e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,27126,0.0160842326127802,0.00212758480594728,0.0119141663931235,0.0202542988324368,4.16274311060332e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,27870,0.0291500585444335,0.00385815448658155,0.0215880757507337,0.0367120413381333,4.30251350685651e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,27562,0.026786621123078,0.00354606329953977,0.01983633705598,0.0337369051901759,4.35498881201188e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,28187,0.0265495422131788,0.00351553590955141,0.019659091830458,0.0334399925958995,4.41395277509697e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,23188,0.0222332470503372,0.00294418084726706,0.0164626525896938,0.0280038415109807,4.45845991787479e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,28553,0.0126946514038714,0.00168255554953252,0.00939684252678765,0.0159924602809551,4.66242112479697e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27702,0.0215585975365228,0.00285737990999363,0.0159581329129352,0.0271590621601103,4.66590757764327e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,27196,0.0465855656995103,0.00618338605489811,0.03446612903191,0.0587050023671106,5.07435773271908e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,23795,0.0600311771511627,0.00797033249586113,0.0444093254592749,0.0756530288430505,5.18147654210428e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,23337,-0.0165213849363009,0.0021940141093171,-0.0208216525905624,-0.0122211172820394,5.24958543074872e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,23779,0.0100993633482592,0.00134331802802906,0.00746646001332222,0.0127322666831961,5.74886844562446e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23198,0.0427731436890983,0.00569922147469933,0.0316026695986876,0.053943617779509,6.35981301175486e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,28134,0.0343042177469262,0.00457143686609585,0.0253442014893783,0.043264234004474,6.37133907500665e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,28176,0.0274937804055559,0.00367028351094024,0.020300024724113,0.0346875360869987,7.04009507205942e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,23795,0.0348762558271895,0.00465572062115133,0.0257510434097329,0.0440014682446462,7.07011165017748e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,28553,0.0361711540672478,0.00483179698172502,0.0267008319830668,0.0456414761514289,7.3016348334932e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,28452,0.0193880993729113,0.00258994799988686,0.014311801293133,0.0244643974526895,7.31146052555233e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,28428,0.0330548181009813,0.00441621581893391,0.0243990350958708,0.0417106011060917,7.36904574403678e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,23795,0.0638154775266788,0.00852813041141505,0.0471003419203053,0.0805306131330523,7.51980358656141e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,28176,0.0322439737012585,0.0043120097326139,0.0237924346253352,0.0406955127771817,7.78289720764489e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,23337,0.0186329014778768,0.00249529712435955,0.0137421191141321,0.0235236838416215,8.47863272981682e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,23198,0.0309190935959887,0.00414135208198087,0.0228020435153062,0.0390361436766712,8.56211314132322e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,27871,0.021750771684179,0.0029148891242563,0.0160375890006367,0.0274639543677214,8.77368041842784e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",23795,0.0237352451618522,0.00318062164196845,0.017501226743594,0.0299692635801104,8.78368776407511e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,27544,0.0311380903101796,0.00417452495996561,0.022956021388647,0.0393201592317122,8.97032387441212e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,28176,0.0188552376002611,0.00253200515948556,0.0138925074876694,0.0238179677128528,9.83994292004872e-14
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",23071,0.0283313486052659,0.00380984541591727,0.0208640515900681,0.0357986456204638,1.07115404320672e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,27682,0.0167663360082403,0.0022559217714549,0.0123447293361887,0.0211879426802919,1.09942622071458e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,23071,0.0342471761419933,0.00461472830871729,0.0252023086569074,0.0432920436270792,1.20010729580658e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",23846,0.0266693783755882,0.00360053087838258,0.0196123378539583,0.033726418897218,1.33409820981739e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,27544,0.0245899608458625,0.00332519738150598,0.0180725739781108,0.0311073477136143,1.45397573930594e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",23795,0.0399287628197645,0.00539968579138084,0.0293453786686581,0.050512146970871,1.46473110667414e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,27918,-0.0230218657965233,0.00311478092459121,-0.0291268364087221,-0.0169168951843245,1.49629686457214e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,23872,0.0263551902279411,0.00356964304757826,0.0193586898546877,0.0333516906011945,1.59656483772984e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,28320,0.0178331406386229,0.00241591670256547,0.0130979439015946,0.0225683373756512,1.60796434875633e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,23795,0.0273863712955615,0.00371167585937846,0.0201114866111797,0.0346612559799433,1.65405340268219e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,23893,0.0083297271342644,0.00112909141670039,0.00611670795753163,0.0105427463109972,1.66710230669522e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27489,0.0232918949094345,0.00316186134976516,0.0170946466638948,0.0294891431549742,1.80074266258633e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,23337,0.0252489610211629,0.0034273256026227,0.0185314028400224,0.0319665192023034,1.80364914543829e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,28521,0.0434336469365262,0.005902647192813,0.0318644584386127,0.0550028354344396,1.91243791094565e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,28096,0.0213692069939589,0.00290586003680447,0.0156737213218221,0.0270646926660957,1.97866056766526e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,23846,-0.0131211139656307,0.00178739936421564,-0.0166244167194934,-0.00961781121176807,2.18965520098677e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,28291,0.0135319849197141,0.00184473203784624,0.00991631012553548,0.0171476597138928,2.26872417431794e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,27562,0.0316880604809157,0.00432088294491634,0.0232191299088796,0.0401569910529517,2.30053011951302e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,28105,0.0243715825571885,0.00332408092001894,0.0178563839539513,0.0308867811604256,2.33165751908342e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,28428,0.0605243176295527,0.00826250288437736,0.0443298119761731,0.0767188232829323,2.44921277923644e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,27965,0.0301104328861289,0.00411290193318392,0.0220491450970884,0.0381717206751694,2.52823340527763e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,23337,0.0410628800654344,0.00561274774324783,0.0300618944886687,0.0520638656422002,2.63719503914013e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,23775,0.0414147523352459,0.00566518260280885,0.0303109944337406,0.0525185102367512,2.74766557773657e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,27562,0.0396283320609903,0.00543462301916757,0.0289764709434219,0.0502801931785588,3.14015639836486e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,28428,0.0311169028236397,0.00427023175578741,0.0227472485822963,0.039486557064983,3.2534051428243e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,28224,0.0140941834920766,0.00193441945872121,0.010302721352983,0.0178856456311701,3.27658451370977e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,28224,-0.0126037010583141,0.00173132950636705,-0.0159971068907936,-0.00921029522583472,3.43095386835986e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,28224,0.0173033049170957,0.00238186179368193,0.0126348558014791,0.0219717540327122,3.83799390557919e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,28187,0.0114813253341953,0.00158069951994014,0.00838315427511259,0.0145794963932779,3.87134910242537e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,23071,0.0289383933060739,0.00398419630291791,0.0211293685523548,0.036747418059793,3.89769918099694e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,27544,0.0253404446776946,0.00349067477831058,0.0184987221122059,0.0321821672431834,3.98904347261354e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,23775,0.0153578358425361,0.00211567394462142,0.0112111149110781,0.0195045567739941,4.01724327593837e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,23751,0.0414169318268598,0.00570992564530144,0.0302254775620689,0.0526083860916506,4.1860119378619e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23170,0.0390064971011356,0.0053803319803058,0.0284610464197362,0.0495519477825349,4.3038989941952e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,27806,0.0334728413679088,0.00461756790874635,0.0244224082667659,0.0425232744690516,4.30746275873585e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,28091,0.022205227519941,0.0030647911304692,0.0161982369042213,0.0282122181356606,4.42707663980381e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,26272,0.0198999080389527,0.00274810285621916,0.0145136264407631,0.0252861896371422,4.56540597872342e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,28187,0.025428337674863,0.00351298151245373,0.0185428939104537,0.0323137814392723,4.65646003389191e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,28187,-0.0223047611774933,0.00308145541195594,-0.0283444137849269,-0.0162651085700596,4.65669770285371e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,28307,0.0136537626020032,0.00188716772667511,0.00995491385771999,0.0173526113462864,4.77167147104538e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,23738,0.0427561363402974,0.00591252610775348,0.0311675851691006,0.0543446875114943,4.92351946058422e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,28396,0.0152574223118365,0.00211257660469264,0.0111167721666389,0.019398072457034,5.24452186401816e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,23775,0.0231204819151505,0.00320408355247371,0.0168404781523021,0.029400485677999,5.51692647063857e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23795,0.0346436355822826,0.0048050563868974,0.0252257250639637,0.0440615461006015,5.76963534977902e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,28307,0.0333017442219512,0.00462262193684158,0.0242414052257417,0.0423620832181606,5.98966250757818e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,23188,0.0438751743304581,0.00609540163414755,0.0319281871275289,0.0558221615333873,6.29286920879482e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23393,0.0548213329284611,0.00762036650163578,0.039885414585255,0.0697572512716673,6.47907848511664e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,28276,-0.0397074467503846,0.00553293264332988,-0.0505519947313111,-0.028862898769458,7.32462213274374e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,27544,-0.0173517468336723,0.00242056220092468,-0.0220960487474847,-0.01260744491986,7.7746160384019e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,27702,0.023371482818525,0.00326065100842281,0.0169806068420162,0.0297623587950337,7.81571869762532e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,23163,0.0204445368247583,0.00285230150602689,0.0148540258729457,0.026035047776571,7.85374052743366e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,27448,0.0216596649615039,0.00302597762775489,0.0157287488111043,0.0275905811119035,8.39768061078622e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,28091,0.026410646055003,0.00369101895925465,0.0191762488948639,0.0336450432151422,8.54862569258451e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,23893,0.0200226151956043,0.00279828627128216,0.0145379741038913,0.0255072562873173,8.58925437005144e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,23795,0.0212927997523126,0.00297610537626792,0.0154596332148274,0.0271259662897977,8.63587652097231e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28307,-0.0218083940104203,0.00305254857379752,-0.0277913892150635,-0.0158253988057772,9.26265458729292e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,23738,0.0285299906318042,0.00399512288901013,0.0206995497693444,0.0363604314942641,9.51844737734575e-13
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,23738,0.0533464326838074,0.00748616127425679,0.0386735565862641,0.0680193087813507,1.06277528173157e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,28176,0.0308853638253295,0.00434074429715109,0.0223775050029134,0.0393932226477457,1.1440203677728e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,27544,0.0216811809187873,0.0030495913095445,0.0157039819520801,0.0276583798854946,1.1927118121588e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,23337,-0.0136974916240594,0.00192725707276754,-0.0174749154866837,-0.00992006776143499,1.21788828662766e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27965,0.0210344473512466,0.00296198254734196,0.0152289615584563,0.0268399331440368,1.26381032121136e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,23337,0.0119601496735532,0.00168646247604235,0.00865468322051025,0.0152656161265962,1.36101715878857e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,28125,-0.0121997296412262,0.00172381558361206,-0.0155784081851059,-0.0088210510973466,1.50580130571586e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,23337,0.0395415673267907,0.00558694483030457,0.0285911554593938,0.0504919791941877,1.50940770969794e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,28404,0.0134839574663336,0.00190557051805986,0.00974903925093625,0.0172188756817309,1.51734908854688e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,28521,0.0221154880047902,0.00312927510133428,0.0159821088061751,0.0282488672034054,1.61621587761367e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,27639,0.0268538865390243,0.00380094658059534,0.0194040312410574,0.0343037418369911,1.6435926989194e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,23198,0.0437554716604997,0.00619893133170977,0.0316055662503486,0.0559053770706509,1.72989819183134e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27965,0.0349800709091112,0.00496267584775658,0.0252532262475084,0.0447069155707141,1.84877998560685e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,28176,0.0405284408696237,0.00575718698322069,0.0292443543825111,0.0518125273567362,1.97172200459879e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,28485,-0.0256120467272069,0.0036411166971964,-0.0327486354537118,-0.0184754580007019,2.05053117864668e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",23287,0.0406923188134092,0.00579238356095369,0.0293392470339399,0.0520453905928784,2.19739677110212e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,23738,0.032014187493286,0.00455829362870655,0.0230799319810211,0.0409484430055508,2.22563610969386e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,23775,0.0298724235577125,0.00425630213576649,0.0215300713716102,0.0382147757438148,2.30457419489919e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,27373,0.00930234490358713,0.00132570679082325,0.00670395959357357,0.0119007302136007,2.32135537745661e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23198,0.0234640975486879,0.00334616555745287,0.0169056130560803,0.0300225820412956,2.40981142700829e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27562,0.024141762073926,0.00344434800440693,0.0173908399852884,0.0308926841625636,2.45386569455822e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,28521,0.0127638892458389,0.0018219834743846,0.00919280163604508,0.0163349768556327,2.51583005993927e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,27562,0.0234105167690384,0.003343246950028,0.0168577527469835,0.0299632807910933,2.57514265800289e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,28174,0.0105241969541173,0.00150374950874264,0.00757684791698171,0.0134715459912529,2.64249642265805e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,23188,0.0145595876614594,0.00208178121444265,0.0104792964811518,0.018639878841767,2.74786452200461e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,23738,0.033381420985045,0.00477641040867068,0.0240196565840505,0.0427431853860396,2.84567138900263e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,23198,0.0252826413748329,0.00362386754040724,0.0181798609956347,0.0323854217540311,3.10322315321188e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,23071,0.028322551009528,0.0040618165489666,0.0203613905735535,0.0362837114455026,3.18905558689821e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,23795,0.0317544536474271,0.00455472614175923,0.022827190409579,0.0406817168852752,3.2118710464142e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,23846,0.0350944415971721,0.00504229879052975,0.0252115359677338,0.0449773472266104,3.49071706680777e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,28176,0.0224683699487958,0.00322966642667519,0.0161382237525125,0.0287985161450792,3.5551949443452e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,23846,0.0382962149396413,0.0055052252307685,0.027505973487335,0.0490864563919475,3.58260859513877e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,27910,0.0149443841004006,0.0021493605256964,0.0107316374700356,0.0191571307307655,3.65616376772771e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,27544,0.0315347518556737,0.00453704176603501,0.0226421499942451,0.0404273537171023,3.72079307756512e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,28553,0.0411589364781465,0.00592301141713491,0.029549834100562,0.0527680388557309,3.75813770035892e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",23846,0.0237276730224722,0.00341671381535412,0.0170309139443781,0.0304244321005662,3.89315632711496e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,28096,0.0149501581746064,0.00215410031520838,0.0107281215567979,0.0191721947924148,3.99690647576064e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,23188,0.0232594130414245,0.0033544914288265,0.0166846098409245,0.0298342162419244,4.20409401965692e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,27682,0.0161865894179745,0.00233851425792489,0.0116031014724417,0.0207700773635073,4.55856543057879e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,27544,0.0333007963851752,0.00481137960813212,0.0238704923532362,0.0427311004171141,4.57461797192864e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23198,0.0323320551105121,0.00467567387304547,0.023167734319343,0.0414963759016813,4.80181982827544e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,23845,0.0068885387667397,0.000996712444117173,0.00493498237627004,0.00884209515720936,4.92476768474986e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,23725,0.024382272004416,0.00353331190816477,0.017456980664413,0.0313075633444189,5.30557012029927e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,23795,0.0179772725959738,0.00260524106802478,0.0128710001026452,0.0230835450893023,5.31484846145981e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,28176,0.0464119709733188,0.00672758173224876,0.0332259107781112,0.0595980311685264,5.35675315549929e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,23337,0.052213963289992,0.0075695059094588,0.0373777317074527,0.0670501948725312,5.41126671197938e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,23795,0.0353695873624055,0.00512801624723222,0.0253186755178304,0.0454204992069807,5.43193258445862e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,28307,0.0325737799386001,0.00472580593187281,0.0233112003121294,0.0418363595650708,5.58731736585245e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,28187,0.0132948640176238,0.00193263447724998,0.00950690044221383,0.0170828275930338,6.14730641111416e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",23846,0.0341125773973082,0.00495972166861588,0.0243915229268211,0.0438336318677953,6.22337717205826e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,23327,-0.00992200986205463,0.00144323165577721,-0.012750743907378,-0.0070932758167313,6.36186610112791e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,28182,0.081889925411428,0.0119366376259608,0.0584941156645448,0.105285735158311,7.00953066249659e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,23198,0.0344282786569444,0.00501895876609178,0.0245911194754045,0.0442654378384843,7.07683602488532e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,27761,-0.0138490347892804,0.00201931864482918,-0.0178068993331455,-0.00989117024541517,7.11602474177716e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,28176,0.0313858426180937,0.00458244004778578,0.0224042601244336,0.0403674251117539,7.58137812824413e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,28553,0.0308368409467912,0.00450769112394569,0.0220017663438577,0.0396719155497248,8.02630611542586e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23337,0.0278897628323564,0.00407683848655426,0.0198991593987101,0.0358803662660028,8.05725652266379e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,23071,0.028422582320102,0.00415489131218569,0.0202789953482181,0.036566169291986,8.07497438195903e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,23769,-0.00883330532222976,0.00129229405022566,-0.0113662016606721,-0.00630040898378747,8.37747009349108e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,28452,-0.0276500199816233,0.00404711510601071,-0.0355823655894043,-0.0197176743738424,8.54066971009588e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,23738,0.0244511637064705,0.00357873503731026,0.0174368430333424,0.0314654843795986,8.55569659845024e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,28132,0.0218048150636715,0.00319283303842488,0.0155468623083588,0.0280627678189843,8.70658498354591e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,23725,0.0236841036008536,0.00347013661763646,0.0168826358302861,0.0304855713714211,8.99688429773691e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,28520,0.0108392126062668,0.00158829424669944,0.00772615588273593,0.0139522693297977,9.00375027596939e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,28307,0.0257755108601687,0.00378080994045608,0.0183651233768748,0.0331858983434626,9.4526459636114e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,23846,0.0259670612338494,0.00380922016132116,0.0185009897176599,0.0334331327500389,9.52484482185562e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,23393,0.0161576103783147,0.00237052225404597,0.0115113867603846,0.0208038339962448,9.58505628116446e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,27702,0.021825760133189,0.00320250090171175,0.015548858365834,0.0281026619005441,9.60461015847449e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,28191,0.0261013006091924,0.00383140704397695,0.0185917428029976,0.0336108584153873,9.78737437441976e-12
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,23163,0.0372702646918655,0.00547580137153602,0.0265376940036548,0.0480028353800761,1.02545933213059e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27562,0.0365328586441207,0.00537107597186068,0.0260055497392738,0.0470601675489677,1.05448958527888e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,23337,0.0125070643477961,0.00183915231404884,0.00890232581226036,0.0161118028833318,1.06812513421684e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22614,0.0496058730686322,0.0072990913443212,0.0352996540337627,0.0639120921035018,1.10109522971343e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,28091,0.0247469580075795,0.00364218535356095,0.0176082747146,0.0318856413005589,1.10831628727662e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,23846,0.0183968012561811,0.00270780855029565,0.0130894964976017,0.0237041060147606,1.11649508569169e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,27965,0.0263501862955993,0.00388304097804516,0.0187394259786308,0.0339609466125679,1.17613217070029e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,23188,0.0183763378229375,0.00270851865991177,0.0130676412495105,0.0236850343963646,1.19176457408853e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,23337,-0.0236653069429628,0.00348918564350489,-0.0305041108042324,-0.0168265030816932,1.2096081980057e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,28165,0.0435289701946363,0.00641871675571084,0.0309482853534431,0.0561096550358296,1.21227228685072e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,23862,-0.017296072569372,0.00255090324356788,-0.022295842926765,-0.0122963022119789,1.22665918010212e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,23725,0.0329620216399537,0.00487572133363173,0.0234056078260355,0.0425184354538719,1.40766989841025e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,28195,0.0237616444489139,0.00351682855419879,0.0168686604826843,0.0306546284151435,1.44061083745425e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,27910,0.0158968437245205,0.00235621545854984,0.0112786614257628,0.0205150260232781,1.54127259859469e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,23738,0.0232852756685684,0.0034576607098171,0.0165082606773269,0.0300622906598099,1.68367247885921e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,23467,0.0127110926469251,0.00188909033048727,0.00900847559917007,0.0164137096946802,1.7514831380694e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,28344,0.0271181738318193,0.00403209477164496,0.0192152680793952,0.0350210795842434,1.7821887272174e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,23738,0.0136184562195741,0.0020257270281559,0.00964803124438851,0.0175888811947597,1.82373421743392e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,28452,-0.0154180606004816,0.00229425240700756,-0.0199147953182164,-0.0109213258827468,1.84775647732954e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,27702,0.0360565320594537,0.00536987376616234,0.0255315794777755,0.0465814846411319,1.92232501953575e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",23795,0.0283003403721465,0.00422266056100705,0.0200239256725727,0.0365767550717203,2.10160132229454e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,23747,0.0290991203319067,0.00434884238942654,0.0205753892486307,0.0376228514151827,2.26224739784954e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,23687,0.0196426407672704,0.00293593920473163,0.0138881999259964,0.0253970816085444,2.27509963856825e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,23846,0.0329555491814231,0.00492774420412609,0.023297170541336,0.0426139278215103,2.31633780780374e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,23872,0.0104136575866651,0.00155726862198545,0.0073614110875736,0.0134659040857566,2.32618594680833e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,28224,0.03081292348858,0.00461173698092227,0.0217739190059723,0.0398519279711876,2.41048551961816e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,27682,0.0212139970505128,0.00317548686021468,0.0149900428044921,0.0274379512965336,2.42559906471661e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,28553,0.00880141413437401,0.00131773856905561,0.00621864653902503,0.011384181729723,2.44692141741137e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,23738,0.0263054934209368,0.00394511249499739,0.0185730729307419,0.0340379139111317,2.65246325145122e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,28553,0.0272507958971034,0.00408932632323797,0.019235716303557,0.0352658754906499,2.7153520227745e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,28091,0.0206400914839214,0.00309747774272029,0.0145690351081896,0.0267111478596532,2.7229635042606e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,27940,0.021332188800436,0.00320293658225419,0.0150544330992178,0.0276099445016543,2.78533990000719e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23071,0.0334916364869773,0.00502928880090508,0.0236342304372033,0.0433490425367513,2.81288919510448e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,28091,0.0126493147302944,0.00190146477862903,0.00892244376418153,0.0163761856964073,2.93636811581001e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28336,0.018860969491254,0.00283890515103973,0.0132967153952162,0.0244252235872919,3.11345000582973e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,23198,0.0238889508578921,0.00359899414097791,0.0168349223415754,0.0309429793742088,3.25709328676524e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,28091,0.0359260368966503,0.00541856584896894,0.0253056478326711,0.0465464259606294,3.41367633578971e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,23163,0.0310158112699191,0.00467801288127662,0.0218469060226169,0.0401847165172213,3.42787960650739e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,23188,0.0406825696699599,0.00613946408806604,0.0286492200573505,0.0527159192825693,3.51512149427223e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,27562,0.0336856656802541,0.00508726711015935,0.0237146221443418,0.0436567092161665,3.61950843408071e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,23509,0.0489436182766197,0.00739905469311921,0.034441471078106,0.0634457654751333,3.79930263703647e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,28233,-0.0287947511009423,0.00435650814082555,-0.0373335070569604,-0.0202559951449242,3.92239738762763e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,23188,0.0245170199283119,0.0037092704018949,0.0172468499405979,0.0317871899160259,3.93571286637701e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,28176,0.0212377251038767,0.00321616188284051,0.0149340478135093,0.0275414023942441,4.08875294695907e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,23846,0.0212579657191337,0.00321936849263149,0.014948003473576,0.0275679279646914,4.10987794848731e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,23775,0.00986749105999873,0.00149450473015623,0.00693826178889252,0.0127967203311049,4.12766560414355e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,23725,0.0254418794775482,0.00385563931957983,0.0178848264111717,0.0329989325439246,4.23770349749506e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,28187,0.0254642057871111,0.00385981928039005,0.0178989599975466,0.0330294515766756,4.26263084239977e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,28091,0.0145272345004167,0.00220321571633006,0.0102089316964098,0.0188455373044236,4.36751793733087e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,23337,0.0344382154170752,0.00522594634472492,0.0241953605814144,0.044681070252736,4.49656734462801e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,23775,0.0163293062387129,0.00247919133954117,0.0114700912132122,0.0211885212642136,4.5958509743256e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,28344,0.0144519706684418,0.00220317298802526,0.0101337516119123,0.0187701897249713,5.48751470583053e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,28091,0.0261557929667407,0.00400070058887785,0.0183144198125401,0.0339971661209413,6.34996273843624e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,23198,0.0322482651127899,0.00493337357641516,0.0225788529030162,0.0419176773225636,6.41739075443037e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,23862,-0.0239172699662763,0.0036618685904391,-0.0310945324035369,-0.0167400075290157,6.6452838087228e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,28115,0.0385254865946272,0.00590251610259879,0.0269565550335335,0.0500944181557208,6.82604901554593e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,23188,0.018594599736747,0.00285002506657273,0.0130085506062644,0.0241806488672296,6.97005545326447e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,28307,0.0118685983572546,0.00182004190833959,0.00830131621690898,0.0154358804976002,7.0989396629598e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,28061,0.0184286034832574,0.00282674362851639,0.0128881859713653,0.0239690209951496,7.17993011514496e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,23846,0.0470923049517,0.00723137999037877,0.0329188001705576,0.0612658097328424,7.55254722816212e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23198,0.0198791595896659,0.0030537664762451,0.0138937772962255,0.0258645418831063,7.68316468425413e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27562,0.0371962983815089,0.00571687248777474,0.0259912283054704,0.0484013684575474,7.82898052518439e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,28452,0.0116221969243573,0.00178815898992179,0.00811740530411056,0.015126988544604,8.19030052499929e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,23775,-0.0118706065731018,0.00182714205846024,-0.0154518050076839,-0.00828940813851974,8.36613373363395e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,28176,0.0415827058024665,0.0064091186062841,0.0290208333341497,0.0541445782707833,8.83948202286553e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,23893,0.0085886749861233,0.00132409424340761,0.00599345026904438,0.0111838997032022,8.9600723436451e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,23775,0.0178732725906451,0.00275620224727601,0.0124711161859841,0.0232754289953061,9.06276456707341e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,23828,0.0209091598834917,0.00322707839623492,0.0145840862268712,0.0272342335401121,9.39592485251062e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,28521,0.0245997381837968,0.00379982686259906,0.0171520775331027,0.032047398834491,9.70502333356161e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,28224,0.0295167229327077,0.00456167565948997,0.0205758386401074,0.0384576072253081,9.92220968113738e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,23846,0.0281082278561581,0.00434374986374338,0.0195944781232211,0.0366219775890952,9.92746060377046e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,27544,0.0215702263604353,0.00333391899001685,0.0150357451400022,0.0281047075808683,9.96935576053196e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,23198,0.0263318589969721,0.00406973970656399,0.0183551691721067,0.0343085488218375,9.98550406302107e-11
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,23725,0.0241474521624265,0.00373659451530181,0.016823726912435,0.0314711774124181,1.0504156161715e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,23337,0.0292933138403713,0.00453337173684259,0.0204079052361598,0.0381787224445828,1.05573262700244e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,23775,0.0198556573484625,0.00307450625700267,0.0138296250847372,0.0258816896121877,1.08031782692061e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,27544,0.0296124832141376,0.00458569811346491,0.0206245149117464,0.0386004515165288,1.08167700702807e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,23893,0.0112678248484809,0.00174800197309047,0.00784174098122362,0.0146939087157383,1.16943592261293e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,23757,0.0421853818932727,0.00655100435730198,0.0293454133529608,0.0550253504335846,1.2213743335458e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27702,0.0238168932943691,0.00369920377972589,0.0165664538861063,0.0310673327026318,1.22729480863934e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,27544,0.0319719158783975,0.00497727385844088,0.0222164591158534,0.0417273726409416,1.35278425950252e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,28320,0.0451212912982974,0.00702495147266046,0.0313523864118829,0.0588901961847119,1.3573041606876e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28411,0.0149528569624023,0.00233211812889617,0.0103819054297658,0.0195238084950388,1.46159217768334e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,23775,0.0299850608753904,0.00467973691845199,0.0208127765152245,0.0391573452355563,1.50772072795333e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,27702,0.0299715326496563,0.00468116836064623,0.0207964426627897,0.0391466226365229,1.5522483308552e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,23862,-0.0202108261768921,0.00315710898934918,-0.0263987597960164,-0.0140228925577677,1.56527897726124e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27562,0.0192276102581057,0.00300463818939302,0.0133385194068954,0.025116701109316,1.58588689499332e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,28428,0.0551412903757579,0.00863371199109517,0.0382192148732114,0.0720633658783044,1.72075976342749e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,23738,0.00924016712484272,0.0014484568498248,0.00640119169918611,0.0120791425504993,1.81159703973705e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,28144,0.0304664118022773,0.00477909754351416,0.0210993806169895,0.039833442987565,1.85883396501072e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,27562,0.0272475749163869,0.00427431292277198,0.0188699215877539,0.03562522824502,1.86190575108182e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,23862,-0.014169324234669,0.00222291431571223,-0.018526236293465,-0.009812412175873,1.8727200086077e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,28553,0.0265641256805044,0.00417300257270747,0.0183850406379977,0.034743210723011,1.97340132028494e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,28070,0.0338384108916871,0.00532057431124937,0.0234100852416383,0.0442667365417358,2.04970493830338e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,28206,-0.0164874865262,0.0025990311573954,-0.021581587594695,-0.011393385457705,2.27706434150428e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,28134,0.0275940957712942,0.00436787889580833,0.0190330531355099,0.0361551384070785,2.69797063947681e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,23337,0.0294821262672736,0.00466975370009368,0.02032940901509,0.0386348435194572,2.77848817861351e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,28091,0.0309733752459747,0.00491380323648948,0.0213423209024553,0.040604429589494,2.95624197854096e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,23163,0.0260665214335244,0.00413665683616364,0.0179586740346436,0.0341743688324051,3.00380654620915e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,23775,0.057944514247068,0.00919672421978115,0.039918934776297,0.0759700937178391,3.017736735761e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,28176,0.0345910705083968,0.00549058152990286,0.0238295307097872,0.0453526103070064,3.01899494103006e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,23872,0.0293546337838183,0.00466839249286132,0.0202045844978101,0.0385046830698265,3.27253651675641e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,28320,0.0164357032217261,0.00261413465006969,0.0113119993075895,0.0215594071358627,3.27863332237324e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,28187,-0.0114106816712238,0.00181534282974604,-0.014968753617526,-0.00785260972492153,3.3117948187758e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,23725,0.0366561201275793,0.00583150139530466,0.0252263773927821,0.0480858628623764,3.31678674123632e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28276,0.0322522114771759,0.00513470755175605,0.022188184675734,0.0423162382786177,3.40821574890375e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,28187,-0.010193154047942,0.00162309599999392,-0.0133744222079301,-0.00701188588795394,3.43360600063697e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,23188,-0.0521749626049966,0.00830813113035762,-0.0684588996204975,-0.0358910255894957,3.44612108176762e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,27702,0.0253761075765596,0.00404361254845552,0.0174506269815868,0.0333015881715324,3.53437141833031e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,27702,0.0480822873232291,0.00766826294711424,0.0330524919468852,0.063112082699573,3.65676424430502e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",28142,0.046207537519615,0.00737959572934753,0.0317435298900939,0.0606715451491362,3.8673156195707e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,23775,0.0364965334463293,0.00582920146873842,0.025071298567602,0.0479217683250566,3.89102900666158e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,23738,0.0440102719524693,0.00703686802025972,0.0302180106327602,0.0578025332721783,4.06268929301452e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23393,0.0209229236865618,0.0033495930410904,0.0143577213260246,0.027488126047099,4.27237900066902e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,28260,0.0128973627992723,0.00206709057533503,0.00884586527161565,0.016948860326929,4.45540129572783e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,23738,-0.0337481940979085,0.00541056871158787,-0.0443529087726207,-0.0231434794231962,4.52248365238173e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,23775,0.100704109111218,0.0161486050295229,0.0690528432533527,0.132355374969083,4.56208093670473e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,27965,0.0256444705083582,0.00411896412400756,0.0175713008253034,0.033717640191413,4.85444910307955e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,23071,0.0280005176157687,0.00449940076445771,0.0191816921174316,0.0368193431141058,4.95611948916807e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,28224,-0.0149295318008105,0.00240413357474852,-0.0196416336073176,-0.0102174299943034,5.37427442003092e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,28224,0.0110117414471496,0.00177398280541592,0.00753473514853436,0.0144887477457647,5.46335693296253e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,23846,0.0135476166024072,0.00218498119367125,0.00926505346281153,0.0178301797420028,5.72679254044594e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,23725,0.0121647078333744,0.00196363856007914,0.00831597625561924,0.0160134394111295,5.92499283601632e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,28276,0.0240081056747403,0.00387974975887163,0.0164037961473519,0.0316124152021287,6.17468016890683e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,23725,0.0414841396068803,0.00670372584542015,0.0283448369498568,0.0546234422639038,6.18432486364104e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23163,0.0225271461727003,0.00364838783179781,0.0153763060223766,0.029677986323024,6.74564848665819e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28336,0.024065903097689,0.00390566089960916,0.016410807734455,0.0317209984609229,7.28909378907862e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,23775,0.015721548268107,0.00255270431796446,0.0107182478048967,0.0207248487313174,7.4482419411128e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,22981,-0.0260985510396184,0.00423890700733352,-0.0344068087739921,-0.0177902933052447,7.54095633675262e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,23071,0.0258916673166165,0.00420556938812497,0.0176487513158915,0.0341345833173414,7.55887849964708e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,28072,0.0349238677648603,0.00567684359107116,0.0237972543263608,0.0460504812033598,7.75518049120448e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,23845,0.00937994480642834,0.0015262133794417,0.00638856658272261,0.0123713230301341,8.07756719671754e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,27544,0.021291858271397,0.00346490268808612,0.0145006490027482,0.0280830675400458,8.10550301217736e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,28224,0.0188412863793266,0.00306752699053259,0.0128289334778827,0.0248536392807705,8.2486089602798e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,28237,-0.0110202262911116,0.00179507864071723,-0.0145385804269174,-0.00750187215530583,8.40782751447932e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,23846,0.0272545758616464,0.0044430681685677,0.0185461622512537,0.0359629894720391,8.69473776438715e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23071,0.0232433135120519,0.00379006250771067,0.015814790996939,0.0306718360271648,8.78050179457402e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,28091,0.0246094975851037,0.00401628074327789,0.0167375873282791,0.0324814078419284,9.04940874582967e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,28091,0.0181057050284542,0.00295668495712303,0.012310602512493,0.0239008075444153,9.26678456835416e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,28326,0.0280941771728695,0.00459299670448885,0.0190919036320713,0.0370964507136676,9.67576343252781e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,28363,0.0253892966326985,0.00415368943710472,0.0172480653359733,0.0335305279294238,9.93803139605631e-10
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,28182,0.0159164699687191,0.00260438008627658,0.010811884999617,0.0210210549378212,1.00040869338157e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,22875,0.0293101346181662,0.00479636039134382,0.0199092682511323,0.0387110009852001,1.00665435335151e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,28404,0.0488016648059793,0.00800369492439005,0.0331144227541748,0.0644889068577838,1.09202731396291e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,28091,0.0215182885144059,0.00353122632726741,0.0145970849129617,0.02843949211585,1.11754295327346e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,27965,0.0213778236704716,0.00350839367389807,0.0145013720696314,0.0282542752713118,1.12025379152925e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",27965,0.0238592781993396,0.00391894381447201,0.0161781483229744,0.0315404080757047,1.15680077425183e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,28151,0.014529252831648,0.00238699301906574,0.00985074651427918,0.0192077591490169,1.16646208468779e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,28224,0.0115036777074462,0.00189094884602232,0.00779741796924244,0.0152099374456499,1.19063338056269e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,28264,0.0226165790827952,0.00372012943463895,0.0153251253909028,0.0299080327746875,1.22091118217395e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,28176,0.0151409533826261,0.00249104756586191,0.0102585001535368,0.0200234066117155,1.23139760285707e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28336,0.0175609448182575,0.00289106766725704,0.0118944521904337,0.0232274374460813,1.26187731063909e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,23775,0.0290908591400502,0.00479003547378881,0.0197023896114241,0.0384793286686762,1.27286854516041e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,23198,0.028075522186857,0.00462785956124437,0.0190049174468181,0.037146126926896,1.32643981856555e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27508,0.0238677581725165,0.00393634215360289,0.0161525275514548,0.0315829887935781,1.34979376635088e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,27965,0.021540666061121,0.0035536801504836,0.0145754529661732,0.0285058791560689,1.36575240328753e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,27562,0.0400561787619822,0.00660955991023565,0.0271014413379204,0.0530109161860441,1.37596470183565e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23198,-0.0142749311891289,0.00235990213120709,-0.0189003393662948,-0.00964952301196301,1.48025604417598e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,23188,0.0369387373682073,0.00611151665652137,0.0249601647214255,0.0489173100149892,1.52522982311669e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,28307,0.0231529254462847,0.00383301284807073,0.0156402202640661,0.0306656306285033,1.55650612169095e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,23725,0.0251511834296655,0.00416527319001958,0.0169872479772271,0.0333151188821039,1.58059139468702e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,23071,0.0207492093629122,0.0034423575887571,0.0140021884889483,0.0274962302368761,1.68923502831724e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,28452,0.026351418162361,0.00437615262715336,0.0177741590131404,0.0349286773115816,1.74822876497103e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,27682,0.0380193651046028,0.00631405140065727,0.0256438243593146,0.0503949058498911,1.75103469626907e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,28111,0.0109682174065579,0.00182315414162771,0.00739483528896759,0.0145415995241482,1.80914042442295e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23198,0.0194826278462473,0.00323859129427152,0.0131349889094751,0.0258302667830195,1.81714793106185e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,23737,0.0346087143631162,0.00575436219187064,0.0233301644670498,0.0458872642591827,1.83259609503064e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27965,0.0120680445884709,0.0020069101856806,0.00813450062453695,0.0160015885524049,1.84099612757291e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,23766,0.0127281920931304,0.00211661776758981,0.00857962126865434,0.0168767629176064,1.84259801098164e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",23846,0.0358355177204037,0.00596428950075345,0.0241455102989269,0.0475255251418804,1.9014446787589e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28428,0.0185623196377051,0.0030899076037549,0.0125061007343455,0.0246185385410647,1.90809276563979e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,23795,0.0195288965339741,0.00325555671999051,0.0131480053627927,0.0259097877051555,2.01858144753848e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23322,0.0192067420932175,0.00320505255756022,0.0129248390803995,0.0254886451060355,2.09487332375694e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,28321,0.0137997880055548,0.00230855388513875,0.00927502239068283,0.0183245536204267,2.2905024298754e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,27702,-0.0122532084238475,0.00205210735140617,-0.0162753388326036,-0.00823107801509137,2.38621415681577e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,28330,0.0451621042882656,0.00756489090652949,0.0303349181114678,0.0599892904650634,2.40133569524991e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,28428,0.017492216222534,0.00293067716737236,0.0117480889744841,0.0232363434705838,2.42043369897465e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,23775,0.0147474692478835,0.0024731898462628,0.00990001714920839,0.0195949213465586,2.51247476053753e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,23393,0.030160066255033,0.00505869633838012,0.020245021431808,0.0400751110782581,2.5270849545834e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27556,0.0316518343142733,0.00531003135042153,0.0212441728674471,0.0420594957610995,2.54116954806418e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,23738,0.0335653300278895,0.00563421110463223,0.0225222762628103,0.0446083837929687,2.59872580051496e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,28320,0.0134578601473295,0.00225954981642287,0.0090291425071407,0.0178865777875183,2.61547779278895e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,28063,0.0139561305476137,0.00234849474286851,0.00935308085159138,0.018559180243636,2.8387119303782e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,28307,0.0331725517123451,0.00558493798530276,0.0222260732611517,0.0441190301635385,2.88973085455849e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,23775,0.0318390953148217,0.00536183909440146,0.0213298906897948,0.0423482999398486,2.92365131410152e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,28142,0.0117007543421402,0.00197201720811661,0.00783560061423163,0.0155659080700487,3.00205881935054e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,28452,0.0159803577393286,0.00269364370160419,0.0107008160841844,0.0212598993944729,3.01588994324118e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,28091,0.0306973816349491,0.00518270435754633,0.0205392810941583,0.0408554821757399,3.197146592626e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,23071,0.0265383516017214,0.00448073191272027,0.0177561170527897,0.0353205861506532,3.21049213918262e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,28224,0.0269864931371297,0.00455814184526905,0.0180525351204023,0.035920451153857,3.24668289047465e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23071,0.0162160420005091,0.00273880536816236,0.0108479834789109,0.0215841005221074,3.24827588466677e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,23795,0.0270650299590221,0.00457723261455249,0.0180936540344992,0.036036405883545,3.40586105094293e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,23071,0.0158683893422997,0.00268433150088973,0.0106070996005558,0.0211296790840435,3.43805785835117e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,27940,0.014743597358144,0.00249447244867861,0.00985443135873391,0.0196327633575541,3.45012441553484e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,28176,0.025981088092835,0.00440083674884824,0.0173554480650925,0.0346067281205775,3.59573698153952e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,23725,0.0139897301207394,0.00236998254732987,0.00934456432797285,0.0186348959135059,3.62063303987472e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,23775,0.0231917450473303,0.00392921500506039,0.015490483637412,0.0308930064572487,3.6314373611201e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23393,0.0265181274064118,0.0044941595510417,0.01770957468637,0.0353266801264535,3.67227286039917e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23337,0.0197273984231619,0.00334503413691453,0.0131711315148094,0.0262836653315144,3.74097034222093e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,28274,-0.0154182712816278,0.00261550827505515,-0.0205446675007359,-0.0102918750625197,3.79063858383242e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,23502,0.00950013968321749,0.00161277129038976,0.00633910795405356,0.0126611714123814,3.90112851148818e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27562,0.0268304195495278,0.00456331062121998,0.0178863307319366,0.0357745083671189,4.1600939342931e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,27777,0.0296511514694005,0.0050447981152423,0.0197633471635256,0.0395389557752754,4.21087126058864e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,27682,0.0164408303345566,0.00279721566355314,0.0109582876339924,0.0219233730351207,4.21102706659464e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,23795,0.0192697759902921,0.0032792711746671,0.0128424044879445,0.0256971474926396,4.25289721838269e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,23337,0.0175488891178139,0.00299199573381455,0.0116845774795373,0.0234132007560904,4.54428021339777e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,28331,-0.0095893871806046,0.00163541996819127,-0.0127948103182595,-0.00638396404294971,4.58063666295085e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,23198,0.0463556089731996,0.00790896226821397,0.0308540429275002,0.061857175018899,4.6589628129937e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,23893,-0.0140598017407887,0.00239933889518876,-0.0187625059753586,-0.00935709750621871,4.69325458970555e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,23738,0.0405872604826881,0.00693034511675258,0.027003784053853,0.0541707369115232,4.79083290582342e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28428,0.02235903186963,0.00382713526677344,0.014857846746754,0.0298602169925059,5.20654929319165e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,28224,0.021261800328186,0.0036454263973113,0.0141167645894559,0.0284068360669161,5.52117911549133e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,28553,0.0284811904604536,0.00488466444239538,0.0189072481533586,0.0380551327675485,5.5777239748439e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",28224,0.0308199260741382,0.00529045390825028,0.0204506364139676,0.0411892157343087,5.75345443114724e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28029,0.0103185362759221,0.00177183033969667,0.0068457488101166,0.0137913237417275,5.82011674917546e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,27544,0.0110032179421841,0.00188980742859126,0.00729919538214528,0.014707240502223,5.86516261106742e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",28091,0.0382633791429086,0.00657182590205792,0.0253826003748751,0.0511441579109421,5.86620224168923e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,23872,-0.0235695787031116,0.0040566529195838,-0.0315206184254958,-0.0156185389807273,6.32271681469277e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,28187,0.0140607669399165,0.0024246316392643,0.00930848892695844,0.0188130449528745,6.73692325114611e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,28307,0.0107754061771205,0.00186033968026329,0.00712914040380449,0.0144216719504366,7.02172297243852e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,28428,0.0141451794869256,0.00244349270622063,0.00935593378273315,0.018934425191118,7.15857285641776e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,23795,0.0261034559275073,0.00451217755480724,0.0172595879200851,0.0349473239349295,7.33721482473635e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,23893,0.00761003963072404,0.00131587992449743,0.00503091497870908,0.010189164282739,7.41923490502884e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,23862,0.0439458629924862,0.00761176448121095,0.0290268046093127,0.0588649213756597,7.86449872929935e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,28176,0.0262114510339757,0.00456109464186382,0.0172717055359226,0.0351511965320288,9.1915010802048e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,23188,0.0157411773341187,0.00274210495847789,0.010366651615502,0.0211157030527353,9.55503265204919e-09
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,28428,-0.00894905790529141,0.0015614081486287,-0.0120094178766037,-0.00588869793397915,1.00610653619323e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,23071,0.0475709958407957,0.00830329553028767,0.0312965366014319,0.0638454550801595,1.02179407885615e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,28521,-0.00344105508823116,0.000601173308595034,-0.00461935477307742,-0.00226275540338489,1.05150396504053e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,23188,0.0223987103527247,0.00391408101974762,0.0147271115540194,0.0300703091514301,1.06201241585014e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,23725,0.020371529939131,0.00356203991347864,0.0133899317087128,0.0273531281695491,1.08400880505222e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,23846,-0.0106159150660442,0.00185679613042188,-0.0142552354816711,-0.00697659465041733,1.09503941096174e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,23815,-0.018852096329541,0.0032980368337261,-0.0253162485236441,-0.0123879441354378,1.10262382783155e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,27562,0.0286235631678146,0.00502794526836717,0.0187687904418149,0.0384783358938142,1.26171957991383e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23188,0.0308592948172752,0.00542056057176126,0.0202349960966231,0.0414835935379272,1.26328854357584e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,23872,-0.0101518352377932,0.00178440003806257,-0.0136492593123958,-0.00665441116319055,1.29118685995617e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,23795,0.0145336051159886,0.0025551124911962,0.00952558463324401,0.0195416255987331,1.30006747347326e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,27781,0.00860246713208382,0.00151270574472771,0.0056375638724175,0.0115673703917501,1.30734584983801e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,23862,-0.0107586200525695,0.00189310954298984,-0.0144691147568296,-0.00704812534830944,1.33863109462113e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,23872,0.00995749462736776,0.0017542687204893,0.00651912793520874,0.0133958613195268,1.39357067809001e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28452,0.0128283431566192,0.00226741090038268,0.00838421779186917,0.0172724685213693,1.54883103727106e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,27562,0.0145654261352902,0.00258253710237709,0.00950365341463114,0.0196271988559493,1.71747524519624e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,23795,0.0146075469112948,0.00259354685711669,0.00952419507134613,0.0196908987512436,1.79864801855208e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,23725,0.0150746046018488,0.0026772433123661,0.00982720770961125,0.0203220014940864,1.81568615769105e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,27773,0.0209191610780513,0.00371570637058286,0.0136363765917089,0.0282019455643938,1.8202424521411e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23198,0.017454696793622,0.00310053545740426,0.0113776472971096,0.0235317462901343,1.8274288172383e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,23795,0.0252552826927921,0.00448644265473276,0.0164618550895159,0.0340487102960684,1.83040054820053e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,23337,-0.00972718774568541,0.00172798741253925,-0.0131140430742623,-0.00634033241710849,1.83126864966683e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,28135,0.0191194229146212,0.00339842154191928,0.0124585166924594,0.025780329136783,1.86219160576859e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23393,0.0145249584510114,0.00258343974955603,0.00946141654188157,0.0195885003601412,1.90544766211892e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,23071,0.0253493205228179,0.0045097120290581,0.016510284945864,0.0341883560997718,1.91992922200291e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,23488,0.00308390838412881,0.000549536874294904,0.00200681611051079,0.00416100065774682,2.02454088409418e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,28428,0.0101053365057523,0.00180419111628507,0.00656912191783356,0.013641551093671,2.15045282195841e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,28325,0.015571889395447,0.0027812392514227,0.0101206604626585,0.0210231183282355,2.17709682587603e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",23795,0.0179117416307194,0.00320683248798549,0.0116263499542678,0.024197133307171,2.35584630398672e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,23071,0.0250747803294141,0.00449727126111539,0.0162601286576279,0.0338894320012002,2.49505426499116e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,28260,0.0184685355707479,0.00331553823490381,0.0119700806303364,0.0249669905111593,2.56617835049258e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,23893,0.00867867252342404,0.00155928854929437,0.00562246696680708,0.011734878080041,2.6376903687243e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,27268,0.0150970142016108,0.00271325055129609,0.00977904312107046,0.0204149852821511,2.65861349012979e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,27544,0.0268234413087391,0.00482195701567209,0.0173724055580218,0.0362744770594564,2.67990426997694e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,27562,0.0181788038170273,0.00327061745037508,0.0117683936142922,0.0245892140197625,2.7506454632224e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,28553,0.00593289316868046,0.00106917390520882,0.00383731231447117,0.00802847402288975,2.89783778741396e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,23845,0.00702888333929524,0.00126712212205861,0.00454532398006036,0.00951244269853012,2.93490311030339e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,23725,0.0402588533608252,0.0072738303268723,0.0260021459201555,0.0545155608014949,3.14964442525907e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,27373,0.0313957368520611,0.00567469358313509,0.0202733374291163,0.0425181362750059,3.18428331831338e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,28176,0.0340966054214952,0.00616894797965565,0.0220054673813701,0.0461877434616203,3.28384949778264e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,27562,0.0147516067139143,0.00267071607518941,0.0095170032065431,0.0199862102212856,3.35379082804279e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,23795,0.0215355373654971,0.00390517244478542,0.0138813993737177,0.0291896753572765,3.5317138734313e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,23843,0.00931373794473957,0.00169035118583959,0.00600064962049398,0.0126268262689852,3.62663496994922e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,23071,0.0257973397882044,0.00468741705206318,0.0166100023661606,0.0349846772102482,3.76223243156336e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,27544,0.030430314080559,0.00553326876397912,0.0195851073031599,0.0412755208579581,3.84212127010873e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23862,0.0232119359947129,0.00422423630218378,0.0149324328424327,0.0314914391469931,3.948341048613e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,28224,0.0299522762835101,0.00545920481204903,0.019252234851894,0.0406523177151262,4.13346569843747e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,27562,0.0339414071494642,0.00618629228002802,0.0218162742806093,0.0460665400183192,4.13462060179274e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,28091,0.0332732892363121,0.00607419942803682,0.02136785835736,0.0451787201152643,4.34323269369683e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,28276,0.0110985234323607,0.00202610156327663,0.00712736436833855,0.0150696824963829,4.3438240050151e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,23738,0.018762738683315,0.00342646196650215,0.0120468732289708,0.0254786041376592,4.39870361800177e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,28176,0.0299520156045133,0.00547317767119939,0.0192245873689625,0.0406794438400641,4.47486514945656e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,23071,0.0249677276121038,0.00456380808346407,0.0160226637685142,0.0339127914556934,4.52641171430891e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,23862,0.0103539430959464,0.00189453977762214,0.00664064513180698,0.0140672410600858,4.67147291501155e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,28091,0.0130717924447841,0.00239379468893786,0.00837995485446586,0.0177636300351023,4.78280932610364e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,23795,0.0111858937301443,0.00204888884546364,0.00717007159303561,0.0152017158672531,4.82271550518863e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,23493,-0.0227398757335681,0.00416537199514274,-0.0309040048440479,-0.0145757466230884,4.82947383404727e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,28320,-0.0125993081693743,0.00231033799167288,-0.0171275706330531,-0.00807104570569542,4.98153484781679e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",28155,0.0204833270510567,0.00375956903804855,0.0131145717364815,0.0278520823656318,5.12744178861368e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27965,0.0196172557223774,0.00360150383036485,0.0125583082148623,0.0266762032298925,5.16690596329566e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,23795,0.0243496986349341,0.00447293647445779,0.0155827431449968,0.0331166541248713,5.2676303344279e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23198,-0.00767515537554069,0.00141320833945329,-0.0104450437208691,-0.00490526703021225,5.6597699614457e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,28422,0.0207055503430371,0.00381783621956606,0.0132225913526876,0.0281885093333866,5.89614817363605e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,28496,0.00752422780137721,0.00138778169629205,0.00480417567664479,0.0102442799261096,5.94923056721207e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,23893,0.0111084534525562,0.00205001061455417,0.00709043264802998,0.0151264742570823,6.0604511315946e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,23071,0.0355285994485697,0.00656842640146374,0.0226544837017008,0.0484027151954387,6.40091467207364e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23198,0.0372735200387887,0.00689192339369394,0.0237653501871486,0.0507816898904289,6.42585413502097e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,23775,0.0174449270269353,0.00322715289627736,0.0111197073502316,0.0237701467036389,6.5187907314482e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23393,0.0317882930581413,0.00588386367223382,0.020255920260563,0.0433206658557196,6.63149935170151e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,27918,0.016611131064127,0.0030793702609094,0.0105755653527445,0.0226466967755094,6.93397862085397e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,23337,0.019287093079029,0.0035758778848738,0.0122783724246764,0.0262958137333817,6.97056972096657e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,28176,0.0332570260099244,0.00617253153285433,0.0211588642055299,0.0453551878143189,7.1854310275234e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,23163,0.029270034076674,0.00543878372979208,0.0186100179662816,0.0399300501870665,7.44924947163273e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,27910,0.023099420855182,0.00430171283482759,0.0146680636989199,0.0315307780114441,7.94450921071403e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,23056,0.0198663700076094,0.00370381391036232,0.0126068947432993,0.0271258452719196,8.22923333386369e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,28428,-0.0113790174401879,0.00212210591179802,-0.015538345027312,-0.00721968985306374,8.28855730409962e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28428,0.0257216754652388,0.00480066316622305,0.0163123756594416,0.035130975271036,8.48295873047023e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,23725,0.0151614738986588,0.00282963481452453,0.00961538966219074,0.0207075581351269,8.48845325766116e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,27562,0.0108504172759193,0.00202642433739603,0.0068786255746231,0.0148222089772156,8.6496558901805e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,23862,0.0170668801343364,0.00319615048160586,0.0108024251903889,0.0233313350782838,9.3888028940222e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,22706,0.0178562119215062,0.00334415213596427,0.0113016737350162,0.0244107501079961,9.40819118731106e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,23738,0.0214821465629671,0.00402559061407518,0.0135919889593798,0.0293723041665545,9.5681732232956e-08
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,28307,0.00954175514033149,0.00179277597837111,0.00602791422272412,0.0130555960579389,1.03222822327034e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",23893,0.00597303705481474,0.00112262233406805,0.00377269728004137,0.00817337682958811,1.04350779026647e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,23163,0.0260978766189883,0.00490637281197812,0.0164813859075112,0.0357143673304654,1.05204067782528e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,23738,0.0247275487657542,0.00464889819793438,0.0156157082978028,0.0338393892337056,1.05276721350627e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,28176,0.038003672357814,0.0071520369309347,0.023985679973182,0.052021664742446,1.08246143766841e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,28176,0.0370546472308307,0.0069880725114485,0.0233580251083917,0.0507512693532698,1.15052585116526e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,23775,0.0384478462224798,0.00725229009581934,0.0242333576346739,0.0526623348102857,1.15895234975433e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23725,0.0194289993342336,0.00366686759452034,0.0122419388489738,0.0266160598194935,1.17782309295983e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,28428,0.00962971000413429,0.00181924822347885,0.00606398348611574,0.0131954365221528,1.21061910576862e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,28224,0.0385654504946287,0.0072999515112311,0.0242575455326158,0.0528733554566417,1.28046064894263e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,23795,0.0234506320125593,0.00444726379159774,0.0147339949810278,0.0321672690440909,1.35349081571087e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,23872,-0.0087450899427537,0.00165973421434439,-0.0119981690028687,-0.0054920108826387,1.38382241084624e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27965,-0.0101379191182392,0.00192456454396866,-0.0139100656244178,-0.00636577261206066,1.39208819183457e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,27562,0.0202472513963778,0.00384487561634314,0.0127112951883453,0.0277832076044104,1.40446617995682e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,28091,0.0138599521399208,0.00263374110182205,0.00869781958034959,0.019022084699492,1.43184995354358e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,23198,0.0200581743743663,0.00381374562954803,0.0125832329404522,0.0275331158082805,1.45774977494975e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,27562,0.0271857789301504,0.0051740747472785,0.0170445924254846,0.0373269654348163,1.49749908297892e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,28187,0.0196347993515238,0.00373849413829669,0.0123073508404623,0.0269622478625853,1.51497982482228e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23846,-0.0115410942340266,0.00220370235616429,-0.0158603508521086,-0.00722183761594459,1.64469702405049e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,27702,0.023337695758834,0.00445741002778374,0.0146011721043779,0.0320742194132902,1.6555286471873e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,23188,0.0426594401652896,0.00814945067006435,0.0266865168519635,0.0586323634786157,1.667472389123e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,23163,0.0219748927971109,0.0041982696815495,0.0137462842212739,0.0302035013729479,1.67079318750464e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23188,0.0198032344600451,0.00378359559178248,0.0123873871001515,0.0272190818199388,1.67350312647471e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,28187,-0.0100873018801206,0.0019303740239833,-0.0138708349671279,-0.0063037687931133,1.74856076922252e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,28173,-0.0260135318872401,0.00497918433274473,-0.0357727331794197,-0.0162543305950604,1.7590977487292e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,28452,-0.0129673558394483,0.00248880359781301,-0.0178454108911618,-0.00808930078773481,1.8987308915579e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,23337,0.0274744119806559,0.00527858907447414,0.0171283773946866,0.0378204465666253,1.95768080275938e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23337,0.0148334446646295,0.00285185609139809,0.00924380672548924,0.0204230826037698,1.99538626152505e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,23775,0.0094898496888082,0.00182551039584749,0.00591184931294712,0.0130678500646693,2.02604502093781e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,28553,0.0143807468856712,0.00277122991358359,0.00894913625504733,0.019812357516295,2.12527733536901e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,27562,0.0250802410552753,0.00483473042521045,0.0156041694218628,0.0345563126886878,2.14625239209491e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,23846,0.0186616876894744,0.00361605305978987,0.0115742236922863,0.0257491516866626,2.47882650695717e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,28176,0.0184200453485051,0.00358610811982876,0.0113912734336407,0.0254488172633695,2.81765814211907e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,23725,0.0394347379400836,0.00769388569426755,0.0243547219793192,0.054514753900848,2.99134242097623e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,28187,0.0158559847856918,0.00309472835323508,0.00979031721335105,0.0219216523580326,3.01818017078893e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,27431,0.0105053895414475,0.00205258206030501,0.00648232870324966,0.0145284503796453,3.10655436879537e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,28521,0.0168985872894231,0.00331131789215362,0.010408404220802,0.0233887703580442,3.35955320207407e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,27562,0.011553823252394,0.00226606424368885,0.00711233733476383,0.0159953091700241,3.44383740017114e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,23862,0.00830768723306234,0.00163181534740981,0.00510932915213912,0.0115060453139856,3.58753713080662e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,27682,-0.00785763331745826,0.0015436386524562,-0.0108831650762724,-0.00483210155864411,3.59776565212772e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,23163,0.0168734923328759,0.00331510963507867,0.0103758774481217,0.0233711072176301,3.61103856668966e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,23198,-0.0136032975962844,0.00267352866392949,-0.0188434137775862,-0.00836318141498264,3.64406835775855e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27562,0.0198447970197842,0.00390130466418139,0.0121982398779887,0.0274913541615797,3.66720911994237e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,23188,0.0139763487823507,0.00274761911870018,0.00859101530969831,0.019361682255003,3.67163957282946e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,28288,-0.0106308831725028,0.00209062156498532,-0.014728501439874,-0.00653326490513154,3.6990351513799e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,23862,0.0284334265908799,0.00559833950697454,0.0174606811572098,0.03940617202455,3.82478254206623e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,23163,-0.0115036376872787,0.00226502234850185,-0.0159430814903424,-0.00706419388421509,3.82735758334441e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,27965,0.0113069684508658,0.0022264155635146,0.00694319394637717,0.0156707429553544,3.82763284340738e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,27544,0.0229485332832882,0.00452288136110718,0.0140836858155181,0.0318133807510583,3.9232801025463e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,23188,0.0192909159038502,0.00380727778284301,0.0118286514494779,0.0267531803582225,4.07553003981968e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,27562,0.0149988663680139,0.00296039681274062,0.00919648861504231,0.0208012441209856,4.0780102410253e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,28091,0.0107123721020656,0.00211472277615814,0.00656751546079568,0.0148572287433356,4.09659807698113e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23725,-0.0129681266601665,0.0025620454607433,-0.0179897357632234,-0.00794651755710968,4.18794198741113e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,23795,0.0364637845577195,0.00721996763373279,0.0223126479956032,0.0506149211198357,4.4412454146093e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,28304,0.0106612157880544,0.00211327582359408,0.00651919517380998,0.0148032364022988,4.56619889302203e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,28176,0.0292113155088071,0.00579163507880718,0.017859710754345,0.0405629202632692,4.59429491839419e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,23893,0.00909917609489581,0.00180450064706403,0.00556235482665031,0.0126359973631413,4.62874471606491e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,27562,0.0159374122371344,0.00316095323434323,0.00974194389782167,0.0221328805764471,4.63697351205392e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,23778,0.0221099984410534,0.00438970610196747,0.0135061744811972,0.0307138224009097,4.76884707357223e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,23198,-0.00773912728040229,0.00153693903123756,-0.0107515277816279,-0.00472672677917668,4.80385503122979e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,23163,0.0166814617736232,0.00332655848407483,0.0101614071448365,0.0232015164024098,5.35279251727562e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,28553,0.0137567070849171,0.00274731777631044,0.00837196424334865,0.0191414499264856,5.55209234537874e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,23188,0.0173507739423012,0.00346512554857432,0.0105591278670955,0.0241424200175069,5.56162409662575e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,27544,0.0125253360612025,0.00250356635760628,0.0076183460002942,0.0174323261221108,5.67929570516061e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,27871,-0.0226653344713891,0.00453698356267036,-0.031557822254223,-0.0137728466885552,5.89821430937805e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,23188,0.0329219464257146,0.00659026414721012,0.0200050286971827,0.0458388641542464,5.90970498044843e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,23301,-0.0194757665922036,0.00389919429226546,-0.0271181874050439,-0.0118333457793633,5.93170330579583e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,23188,0.0176504021218993,0.00354294792071091,0.0107062241973059,0.0245945800464927,6.34353172198587e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23278,-0.0163841092405598,0.00329081086168219,-0.0228340985294569,-0.00993411995166275,6.44552403303314e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,28135,0.00774230456060031,0.00155558140433625,0.00469336500810127,0.0107912441130993,6.49205983589431e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,23198,0.010061804154276,0.00202171140511046,0.00609924980025945,0.0140243585082925,6.50819774268266e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",28224,0.0245700080650134,0.00493862047011454,0.0148903119435889,0.0342497041864379,6.56055102576579e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,23862,0.0173599720745068,0.00349290565878767,0.0105138769832829,0.0242060671657306,6.73936056939559e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,27833,0.0120891252631125,0.00243283483791778,0.00732076898079366,0.0168574815454314,6.76452630409819e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,27434,0.0235584598442337,0.00475679665712953,0.0142351383962598,0.0328817812922076,7.36674503266222e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],28091,0.0189084013225563,0.00383315308092825,0.0113954212839369,0.0264213813611757,8.1497761364377e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27562,0.016722978388508,0.00339156616929972,0.0100755086966805,0.0233704480803354,8.2388929671849e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,23198,0.0105157239440146,0.00213636106234341,0.00632845626182147,0.0147029916262077,8.61377443756032e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,28176,0.0132605853603484,0.00270349009094572,0.00796174478209483,0.0185594259386021,9.39537864107607e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,28404,0.0170748777286012,0.00348650985396578,0.0102413184148283,0.0239084370423742,9.76402020952823e-07
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,28452,-0.0147214693208327,0.00300976392372052,-0.0206206066113249,-0.0088223320303405,1.00750986832109e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,27966,0.0150376146036064,0.00307495389386508,0.00901070497163084,0.021064524235582,1.01213057854599e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,27562,0.022005455789131,0.00450012890384163,0.0131852031376015,0.0308257084406606,1.0142353454552e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,28187,-0.0144680322371853,0.00295940016406201,-0.0202684565587468,-0.00866760791562376,1.01989922875352e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,27702,0.0164908705604387,0.00337336055698798,0.0098790838687423,0.0231026572521352,1.02145210930127e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,23549,0.0213234891053277,0.00436204307292768,0.0127738846823894,0.0298730935282659,1.02318764071272e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,23642,0.0238546908566619,0.0048802725073266,0.0142893567423018,0.033420024971022,1.02541887853437e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,27562,0.0201131267249806,0.00411607521296954,0.0120456193075603,0.0281806341424009,1.03230018576902e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,27682,0.0170804450406148,0.0035070479273271,0.0102066311030537,0.0239542589781759,1.12032545800642e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,23348,0.0213868212174483,0.00439777409868213,0.0127671839840314,0.0300064584508653,1.16312701014483e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,23795,0.0255375564671275,0.00527188198360974,0.0152046677792524,0.0358704451550026,1.27982804694979e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,28452,-0.0116357695457367,0.00240215566694784,-0.0163439946529544,-0.00692754443851889,1.27992938531217e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,28470,0.00902034753098094,0.0018633119988916,0.00536825601315341,0.0126724390488085,1.29845498958399e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,23198,0.0124235106930302,0.00256860341504518,0.00738904799954168,0.0174579733865188,1.32873066696574e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,28036,0.0183275072536622,0.00379241280155425,0.0108943781626159,0.0257606363447086,1.35421307977379e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,23600,0.00976767086144727,0.00202187581196287,0.00580479427000005,0.0137305474528945,1.3670537317993e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,23738,0.0130794036771166,0.00271061459892988,0.00776659906321406,0.0183922082910192,1.40693435102783e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,27562,-0.0099602573724521,0.00206542357911774,-0.0140084875875229,-0.00591202715738132,1.4261209539292e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,28176,-0.0127380680950844,0.00264650669371985,-0.0179252212147753,-0.00755091497539348,1.49329506861654e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,23198,0.0166261217143536,0.00345937761758296,0.00984574158389099,0.0234065018448162,1.54864667554432e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,28522,0.0138944454731181,0.00289462239553598,0.00822098557786754,0.0195679053683686,1.59398049518293e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,28307,0.00886985444305158,0.00184838670218351,0.0052470165067719,0.0124926923793313,1.60512128119507e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,23738,0.0154888023252181,0.00322831151624689,0.00916131175337416,0.021816292897062,1.61390140517958e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,28176,0.0185208475396547,0.00386109729045096,0.0109530968503708,0.0260885982289386,1.62057984015768e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,23738,0.0152392832235613,0.00318357170227104,0.00899948268711003,0.0214790837600125,1.70438850128467e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,28452,-0.0102425856108425,0.00214044394429218,-0.0144378557416552,-0.00604731548002983,1.71620705169992e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,27489,0.0148248552868231,0.0031071159079448,0.0087349081072513,0.0209148024663949,1.84017615559737e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,23795,0.0194818330092049,0.00408618576399778,0.0114729089117692,0.0274907571066405,1.87414869543001e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,27562,0.0092665455448504,0.00194427587872506,0.00545576482254929,0.0130773262671515,1.88816306746184e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,28187,-0.00936085116319976,0.00196530172325888,-0.0132128425407872,-0.00550885978561236,1.91626817877177e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,28187,-0.0130702975800962,0.00274813642032445,-0.0184566449639321,-0.00768395019626027,1.98385463298457e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,28307,0.00882124377620618,0.00185934924247063,0.00517691926096375,0.0124655682914486,2.10286338316443e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,23846,-0.00883212148400819,0.00186250660488784,-0.0124826344295884,-0.00518160853842803,2.12777177261835e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,28239,0.025845980208266,0.00546880386029776,0.0151271246420824,0.0365648357744496,2.30003154555612e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,28252,0.00718588226110671,0.00152636162892354,0.00419421346841657,0.0101775510537969,2.5153025287997e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,23725,0.0189498769632896,0.00402641126217145,0.0110581108894335,0.0268416430371456,2.53560522130254e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,23198,0.0163071353320081,0.00346563803681763,0.00951448477984557,0.0230997858841707,2.54858344482992e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,27597,0.0122933134982753,0.0026129622658123,0.00717190745728323,0.0174147195392674,2.55418485826867e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,23056,0.0150757993132724,0.00320542186140338,0.00879317246492176,0.021358426161623,2.57575934093396e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",27544,0.00878073930141622,0.00187117926755815,0.00511322793700224,0.0124482506658302,2.7102020226699e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,23846,0.0107813637144082,0.00230172974871125,0.00626997340693411,0.0152927540218822,2.82844353318231e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23393,0.011556019328915,0.00246809908866705,0.00671854511512756,0.0163934935427024,2.8546973749083e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,28553,0.0100353434038474,0.00214624767850982,0.00582869795396815,0.0142419888537267,2.94202996813521e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,28452,0.0198472621794202,0.00424539358254268,0.0115262907576366,0.0281682336012039,2.95285494511785e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,28553,0.00907301519371711,0.00194312504624558,0.00526449010307576,0.0128815402843584,3.03616306279442e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,28404,0.0210386448155344,0.00451668913531899,0.0121859341103091,0.0298913555207596,3.20774464318433e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23393,0.0227112788580239,0.00489019291847106,0.0131265007378206,0.0322960569782272,3.43170616384357e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,27702,0.00908100963937574,0.0019555751478473,0.00524808234959502,0.0129139369291564,3.43875620951357e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,27702,0.0219582592078371,0.00473875266122202,0.0126703039918419,0.0312462144238323,3.60711688284876e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,23775,0.0275391491699901,0.00596056796283906,0.0158564359628255,0.0392218623771547,3.85340211003112e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,27544,0.0159082677242814,0.00344677164116343,0.00915259530760108,0.0226639401409617,3.94087086996942e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,23795,0.0193618958374523,0.00419687099336518,0.0111360286904566,0.0275877629844481,3.98176367858163e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,28224,-0.00547450641138361,0.0011880981100555,-0.0078031787070924,-0.00314583411567482,4.08751040272217e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,27881,0.0210735610281035,0.00457402413603379,0.0121084737214772,0.0300386483347297,4.09882566754384e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,23337,0.0168083825455242,0.00365645448183857,0.00964173176112056,0.0239750333299278,4.31056127464563e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,28095,-0.0574144128194144,0.0124945078697364,-0.0819036482440978,-0.032925177394731,4.34271758231431e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",23725,0.0115157472799802,0.00250660570074718,0.0066028001065157,0.0164286944534447,4.36731537111953e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,28452,0.016669933100279,0.0036295560103548,0.00955600331998363,0.0237838628805744,4.39148608323608e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,23725,0.0135712727447059,0.00295552710106189,0.00777843962662458,0.0193641058627872,4.41635999297438e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,23725,0.0251531470044711,0.00548154516554728,0.0144093184799985,0.0358969755289438,4.48306535203072e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,27562,0.0113071646677615,0.00246584403848295,0.00647411035233493,0.0161402189831881,4.54859227264258e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,28218,-0.00669986071033607,0.00146617835772759,-0.00957357029148214,-0.00382615112919,4.90706451338136e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,23188,-0.00933871906472795,0.00204487662853395,-0.0133466772566545,-0.00533076087280141,4.97569269514971e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,27702,0.0123047622251437,0.00270411682270452,0.00700469325264286,0.0176048311976446,5.37761681905809e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,27965,0.0109359812027052,0.00240426070896577,0.00622363021313233,0.0156483321922781,5.42349354990456e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,27682,-0.0161280740058617,0.00354958822616928,-0.0230852669291535,-0.00917088108256996,5.55229273846333e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,28452,-0.0131737804653921,0.00290074285350906,-0.0188592364582698,-0.0074883244725143,5.60793274334014e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28391,0.00861262942942692,0.00189811264496453,0.00489232864529643,0.0123329302135574,5.71663672183641e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,23720,0.0131616416108741,0.00290118472387868,0.00747531955207185,0.0188479636696763,5.74367563863093e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,27702,0.0215028840608652,0.00474115294362847,0.0122102242913534,0.030795543830377,5.77435705607865e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,27682,0.0234822855403581,0.00517866525528129,0.0133321016400067,0.0336324694407094,5.80018717261594e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,28553,0.00694435833083059,0.00153353999324075,0.00393861994407871,0.00995009671758246,5.96951256306278e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,23188,0.0135712481465667,0.00299762380761117,0.00769590548364876,0.0194465908094845,6.0029356069765e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,27905,-0.00859597562270423,0.00189895051896977,-0.012317918639885,-0.00487403260552349,6.01599497595098e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,28091,0.0128271149149246,0.00283533087883509,0.00726986639240781,0.0183843634374414,6.09222521943573e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,23377,0.0133882897383858,0.00296472199527132,0.00757743462765399,0.0191991448491176,6.33665176464298e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,23795,0.0283995920536036,0.0063115850247353,0.0160288854051224,0.0407702987020848,6.84046953422305e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,28428,0.019794847125321,0.00439956267554394,0.0111717042812548,0.0284179899693871,6.84553771649079e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,27969,-0.0156726866886979,0.00348876930591366,-0.0225106745282886,-0.00883469884910711,7.07317012909437e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,23198,0.0233661113308807,0.00520517614156463,0.013163966093414,0.0335682565683474,7.18979156383946e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27489,0.0145589844744362,0.00324746631186299,0.00819395050318471,0.0209240184456876,7.38351379234938e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,23795,0.0202384125145105,0.00451920670481455,0.011380767373074,0.029096057655947,7.55858880396488e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23188,0.013511022851598,0.00302143953156153,0.00758900136973744,0.0194330443334586,7.79622826792474e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,23775,0.0111607158252878,0.00249860383113477,0.00626345231626365,0.0160579793343119,7.97713586109402e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,28428,0.0111673741485832,0.00250118660810956,0.00626504839668843,0.0160696999004779,8.04404193209318e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,28176,-0.0131330597696919,0.00294178738707816,-0.0188989630483651,-0.00736715649101866,8.06376709439093e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,23872,0.0179963847327522,0.00403504940364682,0.0100876879016044,0.0259050815639,8.2327551701421e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,27448,0.0142591419420754,0.00319957102461839,0.00798798273382333,0.0205303011503274,8.36072683541036e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,28187,0.0270351164870749,0.006074148349684,0.0151297857216943,0.0389404472524555,8.58593755684622e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,27795,-0.00871026461311025,0.00196615467557565,-0.0125639277772385,-0.00485660144898197,9.45484462535089e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27702,0.0108495506861266,0.00245144530710909,0.00604471788419278,0.0156543834880604,9.64624852594793e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,28307,0.00651505521398782,0.001472812256172,0.00362834319189071,0.00940176723608494,9.74551780595459e-06
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27544,0.0089953971697955,0.00204050682502726,0.00499600379274207,0.0129947905468489,1.0452454392792e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,23872,0.0159174625983462,0.00361308767887925,0.00883581074774287,0.0229991144489496,1.05998990141209e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,23846,0.0093498746346835,0.0021232325222395,0.00518833889109408,0.0135114103782729,1.06930616281595e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,27562,0.0166376466368708,0.00377921048135487,0.00923039409341526,0.0240448991803264,1.0745583508988e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,27829,0.00817840656940683,0.00186023154083985,0.00453235274936072,0.0118244603894529,1.10445581769169e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,23393,0.0200673600171075,0.00456449307367045,0.0111209535927134,0.0290137664415015,1.1054365962101e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,28430,0.00956657939473151,0.00217659502688814,0.00530045314203076,0.0138327056474323,1.11069544922489e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',23775,0.0123403514634086,0.00281865125456012,0.00681579500447076,0.0178649079223464,1.20226614160473e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,28181,0.0173747787895226,0.00397983510809731,0.00957430197765184,0.0251752556013933,1.27165688275743e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,23738,0.0177180190938027,0.0040587417722588,0.00976288522017549,0.02567315296743,1.27428576841479e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,22829,0.00965093406230906,0.00221487340945777,0.00530978217977184,0.0139920859448463,1.32233538056676e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,23256,0.019324140243982,0.00443852421411165,0.0106246327843232,0.0280236477036408,1.34411687720778e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,28176,0.0249448401624822,0.00573204895740523,0.013710024205968,0.0361796561189965,1.35487691490917e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,27682,0.00961296895466199,0.00221606026435109,0.00526949083653385,0.0139564470727901,1.44382862804481e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,23337,-0.0224398398469053,0.00517853574866363,-0.032589769914286,-0.0122899097795245,1.47544873403995e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,27544,0.021351975306735,0.00493945462553944,0.0116706442406777,0.0310333063727923,1.54644362925595e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,23893,0.00600511989838226,0.0013913371886007,0.00327809900872488,0.00873214078803965,1.59464632118618e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,27682,0.0151771211360701,0.00351876276224553,0.00828034612206889,0.0220738961500714,1.61466768063967e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,28307,0.0156006636330882,0.00362320997268652,0.00849917208662266,0.0227021551795538,1.66974883595806e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,28176,-0.0152485374578048,0.00354685155715361,-0.0222003665098259,-0.00829670840578375,1.72010469759788e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,23738,0.0103634179226408,0.00241320530230838,0.00563353553011638,0.0150933003151652,1.7581311457842e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,23738,0.010075475896242,0.00235311982116201,0.00546336104676444,0.0146875907457195,1.86155561103656e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,23188,0.0182785940069632,0.00427310997387272,0.00990329845817262,0.0266538895557537,1.89687956357768e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,23738,0.0312805120242907,0.00732346637066469,0.0169265179377879,0.0456345061107935,1.95117855192238e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,28471,-0.0103336548744934,0.00242144129537913,-0.0150796798134365,-0.0055876299355503,1.98258031089134e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,27544,0.0109904317067077,0.00257557445755491,0.00594230576990012,0.0160385576435154,1.98623314173557e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23139,0.00799148875328717,0.00187548075880751,0.00431554646602446,0.0116674310405499,2.04287279392281e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,28253,0.00567002716373334,0.00133166788542579,0.00305995810829879,0.0082800962191679,2.07079110937167e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,28380,-0.00727539201726114,0.00171474544192707,-0.0106362930834382,-0.00391449095108409,2.21407829130533e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,27562,0.0192361726560577,0.00453521574744292,0.0103471497910696,0.0281251955210459,2.22742974093391e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,23163,0.0124450226973465,0.00293511306135177,0.00669220109709698,0.0181978442975959,2.24337561872318e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,28428,0.01854214284513,0.00437510941582431,0.00996692839011432,0.0271173573001456,2.26131863939691e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,27562,0.0124900842084066,0.00295033516885146,0.00670742727745775,0.0182727411393555,2.30882754123053e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,23188,0.00756901374135531,0.00178896855783471,0.00406263536799927,0.0110753921147113,2.33613486905244e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,23198,-0.0148554017446875,0.00351191320787867,-0.0217387516321297,-0.00797205185724531,2.34585178584823e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,28235,-0.00785473027479633,0.00185734164117784,-0.0114951198915049,-0.00421434065808776,2.35452978210398e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,28187,0.0127561621145187,0.0030171475451073,0.00684255292610839,0.018669771302929,2.36638182525046e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,23056,0.0183666811996069,0.00434869689938528,0.00984323527681175,0.0268901271224021,2.41470293067398e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,27951,-0.00805156104609403,0.00190718194036039,-0.0117896376492004,-0.00431348444298767,2.43226406806467e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,23725,0.0178965170528152,0.00423956906412601,0.0095869616871282,0.0262060724185022,2.43795208677069e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",28176,0.0277469144407252,0.00657350363179674,0.0148628473224035,0.0406309815590468,2.43957059428926e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,23188,0.00841772316504302,0.0019961369081544,0.0045052948250604,0.0123301515050256,2.48505440575957e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",23777,0.0114157684565605,0.00271221982261981,0.00609981760422569,0.0167317193088953,2.57430576053885e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,23393,0.015159027328228,0.00360730964606343,0.00808870042194371,0.0222293542345124,2.65187205826591e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28320,-0.0121179578617021,0.00288481396747837,-0.0177721932379597,-0.00646372248544446,2.67019471950224e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,23795,0.0150035653189531,0.00357272427993608,0.00800102573027841,0.0220061049076279,2.68508190999083e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,23163,0.016881210035952,0.00402561664718347,0.00899100140747241,0.0247714186644316,2.75768562657011e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,23738,0.00802014566200134,0.00191269907184824,0.00427125548117879,0.0117690358428239,2.76161190055353e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,28210,0.0113128145959318,0.00269881659280368,0.00602313407403661,0.016602495117827,2.77631458480945e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,23163,0.0152694003069107,0.00364634513530791,0.00812256384170719,0.0224162367721142,2.82974002583412e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,23846,0.007745268205672,0.00185386664342746,0.00411168958455417,0.0113788468267898,2.9526114247792e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,28553,-0.00484591784612643,0.00116046028308135,-0.00712042000096588,-0.00257141569128698,2.97745060417051e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,23775,0.0177453522039462,0.00425355905260261,0.0094083764608451,0.0260823279470473,3.03164973944135e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,28224,0.00893734792962637,0.00214713204715087,0.00472896911721065,0.0131457267420421,3.1577282725206e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,23188,0.00477518369919012,0.0011474064396098,0.00252626707755491,0.00702410032082533,3.16999652826518e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23188,0.0122868641506266,0.00295516758824395,0.00649473567766846,0.0180789926235847,3.22544948700758e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,27544,0.0161655195265446,0.00389179090511942,0.00853760935251057,0.0237934297005787,3.28058800613072e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27910,0.0204439757177886,0.00492350314523586,0.0107939095531263,0.0300940418824509,3.30094778644425e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,23846,0.00945124496402003,0.00227907392678683,0.00498426006751784,0.0139182298605222,3.38074082638886e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,28363,0.01658946975725,0.00400766068558428,0.00873445481350485,0.0244444847009952,3.49160740485338e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28044,0.0210965198685129,0.00509753381957983,0.0111053535821364,0.0310876861548893,3.50491614702334e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",23071,0.017565289014228,0.00424523848701922,0.00924462157967036,0.0258859564487857,3.52133406588011e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,27702,0.0080381044294564,0.00194775361159006,0.00422050735073988,0.0118557015081729,3.68826921170988e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,23188,0.00567916820875599,0.00137671444387622,0.0029808078987586,0.00837752851875338,3.7176842367138e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,28082,0.011911489422272,0.00289062467843184,0.00624586505254559,0.0175771137919984,3.78753680801901e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,28176,0.0204538594620038,0.00496636552520585,0.0107197830326003,0.0301879358914073,3.82473297517778e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,23198,0.0130816031897791,0.00317746428288186,0.00685377319533068,0.0193094331842276,3.8517343931316e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23393,0.0293380618394246,0.00713622295251623,0.0153510648524928,0.0433250588263564,3.95042136669403e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,28276,0.00871311154608584,0.00212435089393474,0.00454938379397375,0.0128768392981979,4.11556663686338e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,27705,0.0217314969694023,0.00531601667100506,0.0113121042942323,0.0321508896445722,4.36469221747363e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,23198,0.0248971148322265,0.00609384120456991,0.0129531860712695,0.0368410435931835,4.4107184991195e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,27970,0.018656585197459,0.00457675307198106,0.00968614917637615,0.0276270212185419,4.5868617973442e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,28367,0.0055475754057946,0.00136481366736327,0.00287254061776258,0.00822261019382661,4.82212778454592e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,28428,0.0128156925670656,0.00315476905019267,0.00663234522868797,0.0189990399054432,4.87170421899544e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,23198,-0.0140371417116206,0.00345973235054424,-0.0208182171186873,-0.0072560663045539,4.98076895493375e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,23393,0.0192562764497671,0.0047700974288848,0.00990688548915287,0.0286056674103813,5.4340945429602e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,28224,-0.0104277399197964,0.00259215021059906,-0.0155083543325706,-0.00534712550702224,5.76565085442828e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,28072,0.0188493741861972,0.004687317845979,0.00966223120807839,0.0280365171643161,5.80153575326437e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,28224,-0.0143995867606382,0.00359014045636488,-0.0214362620551133,-0.00736291146616298,6.06511889637975e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,23893,0.00688083507441482,0.00171938167103937,0.00351084699917765,0.010250823149652,6.30189928873982e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,28091,0.010210632961999,0.00256477273722248,0.00518367839704295,0.0152375875269551,6.87677946444968e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,27544,0.0229226544144468,0.00575862247735606,0.0116357543588289,0.0342095544700647,6.8923748476852e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,23795,0.0158227710376974,0.00397549448995182,0.00803080183739184,0.023614740238003,6.90976041015512e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,23337,0.0186125003523296,0.0046768325471972,0.00944590855982308,0.0277790921448361,6.92041540731997e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,23056,0.0204980294896889,0.00515081208175119,0.0104024378094566,0.0305936211699212,6.92506737680995e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,23795,0.0155440804268097,0.00390613792869492,0.00788805008656771,0.0232001107670518,6.92946499925334e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,23862,0.00710760560542447,0.00178758738681801,0.00360393432726118,0.0106112768835878,7.02645814354782e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,23775,0.0169546398719346,0.00426441251343049,0.00859639134561084,0.0253128883982584,7.03374544323855e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,27831,-0.0102300361155095,0.00257370383150551,-0.0152744956252603,-0.00518557660575865,7.06071848219912e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27376,0.0232405553422913,0.00584983627646914,0.0117748762404118,0.0347062344441708,7.11979426795388e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,23284,0.0300253653927853,0.00756425918081531,0.0151994173983873,0.0448513133871833,7.22783441084478e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,23775,-0.0189129695625859,0.00476816658658454,-0.0282585760722916,-0.0095673630528802,7.31472281326553e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,28176,-0.00942634435462157,0.0023791146284176,-0.0140894090263201,-0.00476327968292307,7.44692559660569e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,28224,0.00965476625412353,0.00243705971524806,0.00487812921223733,0.0144314032960097,7.46179706807392e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,23725,0.0147885490619129,0.00373591479277916,0.00746615606806571,0.02211094205576,7.56477265688551e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,23071,0.00965397399453231,0.0024410370160313,0.00486954144311095,0.0144384065459537,7.6806397587946e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,23615,0.0160705050682784,0.00407949776137473,0.00807468945598394,0.0240663206805729,8.19430128436301e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27842,-0.015731659010785,0.00399487066686695,-0.0235616055178442,-0.0079017125037258,8.2375860171795e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,28428,0.0131131299137784,0.00333336629562061,0.006579731974362,0.0196465278531948,8.37771032431125e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,28091,0.00779425806103108,0.00198135904221997,0.00391079433827994,0.0116777217837822,8.38165121850327e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,27910,0.0192114003133163,0.0048907271448225,0.00962557510946422,0.0287972255171684,8.58158058406497e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",23790,0.00603697470998225,0.00153687499480996,0.00302469972015473,0.00904924969980977,8.58669484440935e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,27508,-0.00757103704169559,0.00193346980404624,-0.0113606378576262,-0.00378143622576497,9.03308538327437e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23198,0.00738451061610606,0.00188766848781531,0.00368468037998805,0.0110843408522241,9.18056784300661e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,23738,0.0257235811966124,0.00659293788319227,0.0128014229455555,0.0386457394476692,9.57880849788352e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,23188,0.00692545829705236,0.00177538493268412,0.00344570382899149,0.0104052127651132,9.6137666883467e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,28176,0.0201973924650358,0.00518477246733387,0.0100352384290614,0.0303595465010102,9.82140151443003e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,28521,0.00915537100532079,0.00235211028557461,0.00454523484559456,0.013765507165047,9.94802711292154e-05
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,28072,0.0155156718904136,0.00399481707311205,0.00768583042711395,0.0233455133537132,0.0001030084315654
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,27965,0.00916415479724104,0.00235969946876344,0.0045391438384647,0.0137891657560174,0.00010315327863343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,23738,-0.0297427823021473,0.0076619253484736,-0.0447601559851556,-0.0147254086191391,0.000103926535198603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,28313,0.0170558548708312,0.00439747586621441,0.00843680217305101,0.0256749075686115,0.000105316077135467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,28091,-0.00693798851013343,0.00179389120372301,-0.0104540152694305,-0.00342196175083632,0.000110175964938719
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,28174,0.0172272765271105,0.00446424732212879,0.0084773517757381,0.025977201278483,0.000114132282679214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,23393,-0.0141109016246975,0.00365887490706768,-0.0212822964425502,-0.00693950680684484,0.000115272223944126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,23198,0.0191420099898983,0.00497668540053054,0.00938770660485848,0.0288963133749382,0.000120217448996978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,27529,0.0154513287266371,0.00401952486038013,0.00757306000029201,0.0233295974529821,0.000121283309824537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,27615,0.0231116669389783,0.00601768245983886,0.0113170093176942,0.0349063245602625,0.000122995167769352
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,23731,0.00968760515442196,0.00252249734254609,0.00474351036303162,0.0146316999458123,0.000123112289387172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,23862,0.0112176917151468,0.0029228382219662,0.005488928800093,0.0169464546302005,0.000124388329610321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23188,0.01542342675177,0.00402410643069331,0.00753617814761113,0.0233106753559289,0.000127049097142464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,28091,0.00560339776019162,0.00146223404215821,0.00273741903756152,0.00846937648282172,0.000127341120205336
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,28292,0.00843550474950698,0.00220284044162408,0.00411793748392379,0.0127530720150902,0.000128745514865892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,23795,0.0143157180317759,0.00373980705341545,0.00698569620708166,0.0216457398564702,0.000129556638824021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,23725,0.00841783439181202,0.00219920563961614,0.00410739133816438,0.0127282774454597,0.000129693974629229
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,23815,0.0120359779999958,0.00314889869440164,0.00586413655896854,0.018207819441023,0.000132558925250718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,28521,0.0107543401212013,0.00281817796905294,0.00523071130185755,0.0162779689405451,0.000135885046545386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,28187,0.0148404149328158,0.00389231550864119,0.00721147653587902,0.0224693533297525,0.000137723291539957
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,27682,0.00880744963455194,0.00231069631212051,0.00427848486279574,0.0133364144063081,0.000138369284656535
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",23775,-0.0154474613321356,0.00405456939932975,-0.0233944173548219,-0.00750050530944925,0.000139378959078715
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,23738,0.0195983702838272,0.00514585719922967,0.00951249017333707,0.0296842503943174,0.000140123354998634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,28187,-0.00809780536465888,0.00212758819221214,-0.0122678782213947,-0.00392773250792308,0.000141476097949732
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,23775,0.00985387867886648,0.00258988648571651,0.00477770116686213,0.0149300561908708,0.000142301262787556
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,27562,0.016446448585846,0.00432453534082743,0.00797035931782424,0.0249225378538678,0.000143230472779439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",27544,0.0130916348103434,0.00344269880195288,0.00634394515851578,0.0198393244621711,0.000143422278282634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,28553,0.0134458103157145,0.00354865711898577,0.00649044236250234,0.0204011782689266,0.000151574279868634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,27918,-0.0133420214681446,0.00353352448662696,-0.0202677294619334,-0.00641631347435576,0.0001598001070829
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,23188,0.0115604361835619,0.00306677058719919,0.00554956583265144,0.0175713065344723,0.000163928238841625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,27562,0.0119486859475982,0.00317180437254429,0.00573194937741143,0.018165422517785,0.00016546059510735
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,27942,0.024889107254385,0.0066201855817941,0.0119135435140685,0.0378646709947014,0.000170546611510446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,23766,0.0119950957766725,0.00319648980201154,0.00572997576472985,0.0182602157886151,0.000175437676919215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,28307,-0.0061189189194424,0.00163640960693597,-0.00932628174903691,-0.00291155608984789,0.000184945308473992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,23337,0.0140869126146566,0.00377146289652559,0.00669484533746639,0.0214789798918467,0.000188063221909837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,23188,0.00822884161456117,0.00220416476755677,0.0039086786701499,0.0125490045589724,0.000189427878115488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,23862,0.0102513836957806,0.00274970743642585,0.00486195712038596,0.0156408102711753,0.000193319233374756
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,27562,0.0150602455164562,0.00404120627624459,0.00713948121501677,0.0229810098178956,0.000194413279983095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,23071,0.00821045758180812,0.00220332148338697,0.00389194747436966,0.0125289676892466,0.000194697573444106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,28322,0.0382471676132502,0.0102741147935612,0.0181099026178703,0.0583844326086301,0.00019750667163085
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,28307,-0.00620769672718528,0.00167301946029331,-0.00948681486936018,-0.00292857858501039,0.000207266731446093
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],27601,0.0120526580853845,0.00324967439956804,0.0056832962622311,0.0184220199085378,0.000208584585952217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,22885,0.0133957034810112,0.00361214797924324,0.00631589344169442,0.0204755135203279,0.000208971344810311
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,27682,0.00913157823239499,0.00246314511397722,0.00430381380899965,0.0139593426557903,0.000209902736002264
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,28236,0.00790162070002564,0.00213198142332508,0.00372293711030848,0.0120803042897428,0.000210766373424449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,23071,0.016868756001812,0.00457320239776043,0.00790527930220159,0.0258322327014225,0.000226001330843854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,27562,0.0114401177855946,0.00311084165731581,0.0053428681372556,0.0175373674339336,0.00023597950808674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,27562,0.0239020282182174,0.00650088430158328,0.0111602949871142,0.0366437614493206,0.000236687025380123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,23188,0.00830000365696892,0.002257927549691,0.00387446565957455,0.0127255416543633,0.000237510960704567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,23795,-0.00650047464822871,0.00177072935009798,-0.00997110417442076,-0.00302984512203666,0.000242063864222142
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",28237,-0.00835062298018289,0.00227665119264856,-0.0128128593177741,-0.00388838664259171,0.000244960533756558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23198,0.0104693679128162,0.00285735540044705,0.00486895132793999,0.0160697844976924,0.000248853981282871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,23707,0.0232513808757881,0.0063706664002308,0.0107648747313358,0.0357378870202405,0.000263053000128035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23198,0.0140820787456001,0.00386849265966917,0.00649983313264851,0.0216643243585517,0.000273020912071086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,23795,0.00805110378445096,0.00221202439407538,0.00371553597206321,0.0123866715968387,0.000273534785456978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,27641,-0.0146183987071805,0.00402312300725817,-0.0225037198014065,-0.00673307761295445,0.000280006158416324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,23163,0.0102367450185455,0.00281850131027914,0.00471248245039843,0.0157610075866926,0.000281860386154068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,23846,0.00859372529579997,0.00236721300014099,0.00395398781552363,0.0132334627760763,0.000283669833103683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23738,0.0200812325464709,0.00553512774523319,0.00923238216581384,0.0309300829271279,0.000286266739538937
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,23393,0.0182403617352561,0.00502982219796371,0.00838191022724727,0.028098813243265,0.000287963413338138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,28553,-0.00772611923473188,0.002131160259693,-0.0119031933437302,-0.00354904512573361,0.00028911556529169
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,23775,-0.0171333420152681,0.00473053872916633,-0.0264051979244341,-0.00786148610610204,0.000293102923014244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,23393,-0.00904071375646902,0.0024965171396296,-0.013933887350143,-0.00414754016279501,0.000293711485750386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,28176,0.0114262579109161,0.00316700552804826,0.00521892707594148,0.0176335887458907,0.000309212684420007
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",23846,0.00735043450335299,0.00204153553932624,0.00334902484627355,0.0113518441604324,0.000318318974546073
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,23775,0.0234421711059154,0.00652629266804588,0.0106506374765454,0.0362337047352853,0.000328864663279086
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,23188,0.0130280162456955,0.00363093115505884,0.00591139118178018,0.0201446413096108,0.000333828009135707
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,23725,0.00516783101501432,0.00144082124936998,0.00234382136624916,0.00799184066377948,0.000335529326401018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,23846,0.00714865438336742,0.00199369271551896,0.00324101666095026,0.0110562921057846,0.000336931067395333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,27702,0.0161411428124434,0.00450720889907999,0.00730701337024659,0.0249752722546401,0.000342626756245244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,28452,0.011112352917817,0.0031085061989541,0.00501968076786702,0.0172050250677671,0.000351048087256172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,23775,0.00741722370013794,0.00207523752001436,0.0033497581609098,0.0114846892393661,0.000352054672110878
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,28452,0.00942655952377238,0.00264245984634845,0.00424733822492942,0.0146057808226153,0.000361212402097244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27544,0.0154416877378756,0.00433180327171122,0.00695135332532156,0.0239320221504296,0.000364854288605562
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,28452,0.00509903767028981,0.00143195795830179,0.00229240007201831,0.00790567526856132,0.000370210067442638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23188,0.010721379320235,0.00301951813006878,0.00480312378530019,0.0166396348551698,0.000384980893849371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,27544,0.0146455300786533,0.00412962875025669,0.00655145772815024,0.0227396024291565,0.000391104199350484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,23071,0.00870581354187179,0.00245747929169611,0.00388915413014741,0.0135224729535962,0.000397017744446367
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,28373,-0.0138978684514614,0.0039276816766514,-0.0215961245376982,-0.00619961236522469,0.000403141072835521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,23775,0.00711208135984029,0.00201188861088799,0.00316877968249984,0.0110553830371807,0.000408507929538258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,23163,0.0107316702898613,0.00303688822512545,0.00477936936861541,0.0166839712111072,0.000410472740006408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,28091,0.0224799049272779,0.00637278166188931,0.00998925286997481,0.0349705569845809,0.000420193698857458
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,28224,-0.0122004951271728,0.00347467699081604,-0.0190108620291722,-0.00539012822517335,0.000446683817168578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,28120,0.00965547105879572,0.00275358490094265,0.00425844465294813,0.0150524974646433,0.000454733392823044
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,27544,0.00824675445419521,0.00235465140296998,0.00363163770437404,0.0128618712040164,0.000461947486983633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,23795,0.00838066398231708,0.0024089875096512,0.00365904846340072,0.0131022795012334,0.000504348059988563
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,28384,0.011559825745137,0.00332303234557489,0.00504668234781021,0.0180729691424638,0.000504611607663287
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,28488,0.0122771376062507,0.00353412890907737,0.00535024494445905,0.0192040302680423,0.000513753905664655
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,23188,0.00777527437144268,0.00224345951540665,0.00337809372124566,0.0121724550216397,0.000529707888607478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,28091,-0.00803447192876499,0.00231833973880585,-0.0125784178168245,-0.00349052604070552,0.000529811364942985
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27682,0.0133399787515811,0.0038541721133314,0.00578580140945155,0.0208941560937106,0.000538626897721273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,28187,-0.00787962325533623,0.00227696175794448,-0.0123424683009074,-0.00341677820976506,0.000539797999458066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,23163,0.00742880822710748,0.00214998422868717,0.00321483913888063,0.0116427773153343,0.000550696490893908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,23188,-0.00985565271133064,0.00285529299228751,-0.0154520269762142,-0.00425927844644713,0.000558032602842237
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,28195,0.00687270800498378,0.00200283460287127,0.00294715218335609,0.0107982638266115,0.000601135105040315
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,28320,0.00595943554374995,0.00174020910862785,0.00254862569083937,0.00937024539666053,0.00061668817913411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28521,0.00660454479798231,0.00192861468041899,0.00282446002436108,0.0103846295716035,0.000616794146176395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,28176,0.0174405524399927,0.00509451682163396,0.00745529946959018,0.0274258054103953,0.000619317297596172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,23396,0.00581042105695981,0.00169745928811324,0.00248340085225786,0.00913744126166175,0.000620377711090135
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",23795,0.00977362373921533,0.00286097451639705,0.00416611368707711,0.0153811337913536,0.000636108142844995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,23738,0.0126217313946943,0.00369986566428056,0.0053699946927044,0.0198734680966842,0.000647373366758932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23188,0.0161007229156753,0.00472105157529124,0.0068474618281045,0.0253539840032461,0.000649758112181861
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27544,0.0115440594046033,0.00339093798801935,0.00489782094808536,0.0181902978611212,0.000664076874262709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,22978,0.0129350951266059,0.00380306650120133,0.00548108478425127,0.0203891054689605,0.000671981968568656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,28091,0.00556171853871412,0.00163555496973708,0.00235603079802945,0.0087674062793988,0.000673542763984944
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,23647,0.0110825310799508,0.00326186764255817,0.0046892705005368,0.0174757916593648,0.00068091079915151
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,23775,0.0127369799372257,0.00375059372493541,0.00538581623635229,0.0200881436380991,0.000684927099675159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,23775,0.0154681197192803,0.00457635849924625,0.00649845706075764,0.024437782377803,0.000726008004908962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,23163,0.0149070877703287,0.0044166370062556,0.00625047923806778,0.0235636963025897,0.000738798853330406
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,23337,0.0192462750147139,0.00570685936916602,0.00806083065114848,0.0304317193782793,0.000746152771214122
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,28224,0.0144656033202696,0.00428997302907159,0.00605725618328927,0.0228739504572499,0.000747363936248413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,27702,0.00847459401099436,0.00251519651856902,0.00354480883459909,0.0134043791873896,0.000754466587162647
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,28336,0.00783245813251536,0.00232810593870358,0.00326937049265633,0.0123955457723744,0.000768384917285347
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28268,0.0129717601069881,0.00386386200579455,0.00539859057563077,0.0205449296383454,0.000788397950879037
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,23188,0.00486737062075693,0.00145255042996144,0.00202037177803251,0.00771436946348135,0.000806741398871526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,23775,0.00894292130024781,0.00267606153066455,0.00369784070014528,0.0141880019003503,0.000833587557200324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,23337,0.0120724502700962,0.00362195225776544,0.00497342384487595,0.0191714766953165,0.000860073460979057
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',23071,0.00971055444471869,0.00291413137367638,0.00399885695231298,0.0154222519371244,0.000862886398439776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,23543,0.0070070475973125,0.00210713214265368,0.00287706859771129,0.0111370265969137,0.000884282139878245
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,27544,0.00862392564389609,0.00259478713259735,0.00353814286400528,0.0137097084237869,0.000889928231332274
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,23198,0.00896837144688447,0.00270724819645916,0.00366216498182453,0.0142745779119444,0.000925328073373392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,23725,0.00891444193206941,0.00269573589047223,0.00363079958674385,0.014198084277395,0.000944856541883043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,22978,-0.00682887255694389,0.00206848028602367,-0.0108830939175503,-0.00277465119633749,0.000963517188009623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,27544,0.0115422522673634,0.00350499240028841,0.00467246716279808,0.0184120373719287,0.000992179532374979
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,27562,0.0105508272003607,0.00320453614414069,0.00426993635784495,0.0168317180428765,0.000994378001533014
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,23693,0.0130765145226049,0.00397528523115861,0.00528495546953401,0.0208680735756758,0.00100528761884282
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,23795,0.00989262229683729,0.00301080385459526,0.00399144674183059,0.015793797851844,0.00101873604462195
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,23795,0.00667521803065335,0.00203184610303549,0.00269279966870379,0.0106576363926029,0.00102022245706713
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,27562,0.00904214079378487,0.0027540771223155,0.0036441496340465,0.0144401319535232,0.00102769640486664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,27489,0.00938261256382203,0.00285803513488125,0.00378086369945479,0.0149843614281893,0.00102877329011019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27965,0.00787105020452596,0.00239960840542042,0.00316781772990193,0.01257428267915,0.00103882715571393
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,23738,0.0187093692629034,0.00570622152803123,0.00752517506796216,0.0298935634578446,0.00104411834248853
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,28237,0.00534711254325771,0.00163195563281035,0.00214847950294943,0.008545745583566,0.00105226864636869
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,28176,0.0197178859507636,0.00602301212509423,0.00791278218557888,0.0315229897159483,0.00106255276482121
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23056,0.0135898778160778,0.00416772570692153,0.00542113543051159,0.021758620201644,0.00111282475207671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,28176,0.0132967363647044,0.00407950436130994,0.00530090781653694,0.0212925649128719,0.00111780564458178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,28182,0.0251746049464069,0.0077293672753916,0.0100250450866394,0.0403241648061744,0.00112726721445634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27702,0.0131258400582623,0.00403657502627118,0.00521415300677075,0.0210375271097538,0.00114843307278012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,27910,-0.010623704221375,0.00326980941136237,-0.0170325306676453,-0.00421487777510479,0.00115936872226797
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,23198,-0.0137542556526748,0.00423691095745499,-0.0220586011292865,-0.00544991017606297,0.0011708428216099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,28091,0.0152352087766756,0.00470479400917421,0.00601381251869418,0.0244566050346571,0.00120413151684963
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,28091,0.00499338340180112,0.00154695892709392,0.00196134390469705,0.00802542289890519,0.00124858462050781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,27965,-0.012807098355833,0.00397584192248634,-0.0205997485239062,-0.00501444818775979,0.00127788031944839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,27562,0.0113349717223273,0.00355085336810158,0.00437529912084824,0.0182946443238064,0.00141360652061325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,23393,0.0150074710401951,0.00470547841386845,0.00578473334901288,0.0242302087313772,0.0014277554469219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,23071,0.00830205751732,0.0026052367288361,0.00319579352880124,0.0134083215058388,0.00144107410963112
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,23071,0.00790255034931244,0.0024873823988476,0.00302728084757114,0.0127778198510537,0.00148975010091806
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,28048,0.00661818493055987,0.00208751445920982,0.00252665659050862,0.0107097132706111,0.00152410797076024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,23188,0.0136418604245918,0.00431365646945784,0.00518709374445449,0.0220966271047292,0.00156632194057803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,23276,0.0115492786629281,0.00365219913731028,0.00439096835379999,0.0187075889720563,0.00156739670669471
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,27544,0.017998947920909,0.00569481350698495,0.0068371134472185,0.0291607823945995,0.00157622636961938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,23893,0.0066981344903675,0.00211941678884553,0.00254407758423027,0.0108521913965047,0.00157767332553732
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,28336,0.00590211749325866,0.00186808862056269,0.00224066379695579,0.00956357118956153,0.00158237793058876
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,27682,0.0122561393017935,0.00388449964266772,0.00464252000216473,0.0198697586014222,0.00160593017601373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,27544,-0.00946174084722855,0.00300692181618,-0.0153553076069413,-0.00356817408751576,0.00165326570158637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,28176,-0.00514561652062096,0.00163869714800463,-0.00835746293071004,-0.00193377011053188,0.00169084612074265
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,23198,0.0102169611521485,0.00325427126585075,0.00383858947108101,0.016595332833216,0.00169417430478796
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,23287,0.0064677155150928,0.00207002025171244,0.00241047582173643,0.0105249552084492,0.00178344654222451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,23071,0.0127319882901201,0.00407615801248807,0.00474271858564347,0.0207212579945967,0.00178918955356794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,23738,0.00722863122569519,0.00231432379618317,0.00269255658517617,0.0117647058662142,0.00178970743841506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,27544,0.0118787711989396,0.00383784480522437,0.00435659538069983,0.0194009470171794,0.00196899286229308
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,23188,0.00958243609961797,0.00310028039163539,0.0035058865320126,0.0156589856672233,0.00199835247849126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,27385,0.0145465374076753,0.00471327104172502,0.00530852616589429,0.0237845486494564,0.00202871022344465
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,23725,0.0100318821980866,0.00326242537850961,0.00363752845620776,0.0164262359399654,0.00210758304259767
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,23733,0.00797478402636375,0.0025947143299156,0.00288914393972918,0.0130604241129983,0.00211822985266249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,28224,0.00708508257689673,0.00230798070070559,0.00256144040351376,0.0116087247502797,0.0021439207981035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",28176,0.00893567782824248,0.00291686174081536,0.00321862881624437,0.0146527268402406,0.00219002888103361
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,28553,-0.00628400780241291,0.00205369375820122,-0.0103092475684873,-0.00225876803633851,0.00221648623861481
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,23846,0.00523556268196786,0.00171162873483023,0.00188077036170062,0.00859035500223511,0.00222457828017339
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,28388,0.00468058505886018,0.00153117857781985,0.00167947504633328,0.00768169507138708,0.00223883234310866
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,27702,0.012334774254468,0.00404026114871329,0.00441586240298998,0.0202536861059461,0.00226807543525625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,23725,-0.0163708306556396,0.00536785710978836,-0.0268918305908248,-0.00584983072045445,0.00229254950028532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,23846,-0.00727786544458256,0.00239339036165884,-0.0119689105534339,-0.00258682033573122,0.00236192269204019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23071,0.0102154858011546,0.00336784698461729,0.00361450571130469,0.0168164658910045,0.00242212735895514
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,23056,0.0226299108104563,0.0074904831086414,0.00794856391751914,0.0373112577033934,0.00252088552560318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,23198,0.00886055899850766,0.00294015888531642,0.00309784758328747,0.0146232704137278,0.00258418931522888
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,23056,0.00812270217349861,0.00269562601333622,0.00283927518735961,0.0134061291596376,0.00258712804431681
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,28428,-0.00590519522667705,0.00196366466881866,-0.00975397797756162,-0.00205641247579247,0.00263869011354078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,27682,0.0117132794896723,0.00390412053744487,0.00406120323628037,0.0193653557430643,0.0027001149957596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,23795,-0.00915001663331619,0.00305606107611026,-0.0151398963424923,-0.00316013692414008,0.00275578882859977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,27652,0.00862534295662105,0.00288192204868196,0.0029767757412044,0.0142739101720377,0.00276572324749726
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,28276,0.0167103503614931,0.00558944541093679,0.00575503735605695,0.0276656633669292,0.00279559732169968
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,23071,0.0238480110196966,0.00799303134210581,0.00818166958916921,0.039514352450224,0.00285176901922354
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,27562,0.0117045102759602,0.00392981510366312,0.00400207267278051,0.01940694787914,0.00290022163702594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,28336,-0.00606065569276747,0.00203628087133198,-0.0100517662005781,-0.00206954518495679,0.00291961685896825
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,23844,-0.00739899339937313,0.00248692918842253,-0.0122733746086813,-0.00252461219006497,0.00293136629532504
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,27544,0.0128132546206026,0.00431191810152722,0.00436189514160929,0.021264614099596,0.0029651760212687
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23071,-0.00676510209992253,0.00227684812735544,-0.0112277244295392,-0.00230247977030586,0.0029688886987811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,23587,0.0088055624017103,0.00296585277670389,0.00299249095937068,0.0146186338440499,0.00299089034201403
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,23056,0.0146668271161687,0.00494520475193489,0.00497422580237629,0.0243594284299611,0.0030213893702097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,28082,0.00522432117751318,0.00176166828130575,0.00177145134615391,0.00867719100887245,0.00302393174570229
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,23337,0.00458529031111501,0.00154667351445882,0.00155381022277573,0.0076167703994543,0.00303369197271814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,28224,-0.0232798657300097,0.00788350650404441,-0.0387315384779368,-0.00782819298208269,0.00314978032599671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23188,0.00717032642051716,0.00242818169663489,0.00241109029511278,0.0119295625459215,0.003150572733832
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,28091,-0.0030163380023664,0.00102154967250343,-0.00501857536047312,-0.00101410064425967,0.00315260425842712
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,27702,0.0089264509832556,0.0030243328310675,0.00299875863436331,0.0148541433321479,0.00316454688104262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,28176,-0.0121116340172372,0.0041078945551931,-0.0201631073454157,-0.00406016068905876,0.00319706405470464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,28336,0.00949452322256055,0.00322274745967091,0.00317793820160557,0.0158111082435155,0.00322074513382305
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23393,0.013989433226103,0.0047575831578784,0.00466457023666132,0.0233142962155447,0.00328057316795411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,28176,0.00546783642013463,0.00186120152126837,0.00181988143844861,0.00911579140182064,0.00330818827100041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28553,0.00543328914389862,0.00184970502993164,0.00180786728523261,0.00905871100256464,0.00331261265044522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,23188,0.00636347292500136,0.00216658425746154,0.00211696778037673,0.010609978069626,0.00331624038531814
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,27881,0.00594611350261587,0.00202623574535772,0.00197469144171473,0.009917535563517,0.00334291715000752
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,28176,0.0180693584300654,0.00617222176473758,0.00597180377117975,0.0301669130889511,0.00341940491056642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,28452,-0.0117950748475682,0.00403329891255422,-0.0197003407161745,-0.00388980897896192,0.00345367035181067
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",28109,0.0131152793751529,0.00449747566967925,0.00430022706258159,0.0219303316877242,0.00354668933626244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28384,0.00599187531477,0.00206213019912877,0.00195010012447761,0.0100336505050624,0.00366747821766239
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,23872,-0.00486970544226829,0.00167890844017017,-0.00816036598500182,-0.00157904489953476,0.00372885690883917
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,23337,-0.0183206563652044,0.00631777636636446,-0.0307034980432788,-0.00593781468713006,0.00373679779677852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,23725,0.00796750525989422,0.00274941696555623,0.00257864800740401,0.0133563625123844,0.00376027513392408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,23738,0.00660826616698506,0.00228822790487199,0.00212333947343595,0.0110931928605342,0.00388123645064434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,28251,0.00958557790869478,0.00332340451261722,0.00307170506396503,0.0160994507534245,0.00392625535829199
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,27562,0.0076606665063905,0.00265887212214657,0.00244927714698322,0.0128720558657978,0.00396505809598666
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,28320,0.00408825112220774,0.00142085329520934,0.00130337866359743,0.00687312358081806,0.00401367080760051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,28500,-0.0116312242905339,0.00404345484958747,-0.0195563957957253,-0.00370605278534247,0.00402339184945399
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23071,0.0054644060464296,0.00190109514131828,0.00173825956944577,0.00919055252341343,0.00405234744057463
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,22978,0.00988354754630135,0.00343867262583131,0.00314374919967198,0.0166233458929307,0.00405381326425715
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,23071,0.0148060201980907,0.00515558627909774,0.0047010710910591,0.0249109693051222,0.00408461117515195
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,27562,0.0118873737251485,0.00414164219174154,0.0037697550293351,0.0200049924209619,0.00410514366631551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,28553,-0.00582954205397106,0.00203298908389151,-0.00981420065839841,-0.00184488344954371,0.00414066591867048
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,23071,0.00744113763733291,0.00260533392365844,0.00233468314696236,0.0125475921277035,0.00429240665551105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,23725,0.00764740895117586,0.0026780395626552,0.00239845140837166,0.0128963664939801,0.00429929286829546
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,23071,-0.00690486303412109,0.00242010931995124,-0.0116482773012255,-0.00216144876701666,0.00433307600588218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",23071,0.00765847602212907,0.00268440209653583,0.00239704791291884,0.0129199041313393,0.0043353417671779
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,27544,-0.0130971931886244,0.00459725826339391,-0.0221078193848764,-0.0040865669923723,0.00439012689816187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,23775,0.0127505116282346,0.00448319944816119,0.00396344070983864,0.0215375825466305,0.00445799577245925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,26395,0.0093883698866064,0.00330349407611082,0.00291352149742919,0.0158632182757836,0.00448727008246436
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,23071,0.00826819934417214,0.0029142615894929,0.00255624662876605,0.0139801520595782,0.00455578177692738
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,28182,0.00711090090658605,0.00251099010559248,0.00218936029962479,0.0120324415135473,0.00463035127134837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,28224,-0.00609059655799729,0.0021507665025598,-0.0103060989030145,-0.00187509421298009,0.00463157899243204
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,28187,-0.0124209017496725,0.00438766912270407,-0.0210207332301725,-0.00382107026917253,0.00464550857757803
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,23188,0.00580341254154277,0.00205010625237486,0.00178520428688805,0.0098216207961975,0.004647370981981
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,23198,0.00989723901066659,0.003498610301318,0.00303996282008331,0.0167545152012499,0.00467475305266231
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,28182,-0.00922936805602747,0.00326348508717509,-0.0156257988268906,-0.00283293728516429,0.00468624399354978
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",28121,0.0125107684010133,0.0044273987887842,0.00383306677499625,0.0211884700270303,0.00472017812696721
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,23071,-0.0096411523915698,0.00341600506092776,-0.0163365223109882,-0.0029457824721514,0.00477143289448952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,23071,0.0133972521941107,0.00474905913081921,0.00408909629770503,0.0227054080905163,0.00479101856767416
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23393,0.0123256208595418,0.00437506846161597,0.00375048667477454,0.0209007550443091,0.00484788271633181
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,28148,0.0193159153964173,0.00685710055919233,0.00587599830040033,0.0327558324924343,0.00485201130621449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,27682,0.0071208314394454,0.00254477690441624,0.00213306870678957,0.0121085941721012,0.00514215135744396
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,27500,0.0101441250925013,0.00362860900167175,0.00303205144922471,0.0172561987357779,0.00518400323732837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,23725,0.011489207128698,0.00411483042037907,0.00342413950475504,0.019554274752641,0.00524016441532389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",23775,0.0103407030034288,0.00371092509247859,0.00306728982217079,0.0176141161846869,0.00533135515762105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,23198,-0.00801066445850223,0.0028751937507116,-0.013646044209897,-0.00237528470710749,0.00533847542859912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,28452,0.00712423405477769,0.00255976083154968,0.00210710282494032,0.0121413652846151,0.00538671089194815
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,23056,-0.00930028137605528,0.00335062053884155,-0.0158674976321847,-0.00273306511992585,0.00551292492883937
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,23299,-0.00690113171474278,0.00248678870114449,-0.011775237568986,-0.00202702586049958,0.00552257063514895
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,23738,-0.00556909528406365,0.00201068934158101,-0.00951004639356243,-0.00162814417456487,0.0056143917925686
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,27965,0.00799576040313076,0.00288695376252114,0.00233733102858933,0.0136541897776722,0.00561590054014061
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,23893,0.00403826596103609,0.00145869168897804,0.00117923025063913,0.00689730167143305,0.00563728554879352
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,23733,0.00599520663820049,0.00216815750039498,0.00174561793742634,0.0102447953389746,0.00569465503435705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,23893,0.00275385536266927,0.00100089671811552,0.000792097795162862,0.00471561293017569,0.00593880175006268
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,27562,0.00660893889557008,0.00240531937902494,0.0018945129126812,0.011323364878459,0.00600658840551392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",23862,0.00774457681587493,0.0028195063401492,0.0022183443891825,0.0132708092425674,0.00602277848873297
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,27109,0.00886343298245225,0.00322982811471151,0.00253296987761768,0.0151938960872868,0.00606905535688824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27562,0.0143496182040504,0.00522912796494277,0.00410052739276254,0.0245987090153382,0.00607033046405811
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,28176,0.0276447390362631,0.0100978631938344,0.00785292717634769,0.0474365508961785,0.00619127033975324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,23163,0.0125276861116663,0.00458250696489524,0.00354597246047167,0.021509399762861,0.00626544491847137
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23163,0.0191450622953909,0.0070246950752731,0.00537665994785559,0.0329134646429262,0.0064273048088128
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27544,0.0099237375036058,0.00364292850750028,0.00278359762890525,0.0170638773783064,0.00645157272514635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,28187,-0.00688021118423302,0.00253381448290337,-0.0118464875707236,-0.0019139347977424,0.00662446802169835
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",23725,0.0094408749095448,0.00348027443141416,0.00261953702397305,0.0162622127951166,0.00667894409308164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23071,0.00671114561086085,0.00247521465680696,0.00185972488351921,0.0115625663382025,0.00670617421783629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,23198,0.00992520097649169,0.00367088186849902,0.00273027251423362,0.0171201294387498,0.00686088045745987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,23725,0.00902778444578617,0.00334300464052452,0.00247549535035811,0.0155800735412142,0.00692844642101907
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,28204,0.0341317196802303,0.0126632803096961,0.00931169027322588,0.0589517490872348,0.00703606457018967
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,23893,0.0035190332367639,0.00130606876953595,0.000959138448473439,0.00607892802505436,0.00705710238012669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,28159,0.0232814276497941,0.00864903338047721,0.00632932222405877,0.0402335330755294,0.00711105603933882
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,28091,0.00592892804106215,0.00220260474831029,0.00161182273437397,0.0102460333477503,0.0071113868382122
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27562,0.00858730851135274,0.00320794408637176,0.00229973810206409,0.0148748789206414,0.00743533681759201
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27544,0.00860126032665721,0.00322608997605104,0.00227812397359718,0.0149243966797172,0.00767688088942196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,28176,0.0122561586590787,0.00459713543033662,0.00324577321561894,0.0212665441025385,0.007679379175398
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,28224,0.0138080575070815,0.00519741849356878,0.00362111725968672,0.0239949977544763,0.00789506234423496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,28187,0.00788666827225361,0.00296945720268257,0.00206653215499578,0.0137068043895114,0.00791347254836774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,28521,-0.00655910754684174,0.00247466173932964,-0.0114094445559278,-0.00170877053775564,0.0080415518563023
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,28195,-0.00609783484720379,0.00230746928121485,-0.0106204746383849,-0.00157519505602268,0.00823053702602985
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,28553,0.0072931042727806,0.00276185018631607,0.00187987790760111,0.0127063306379601,0.00827900253752875
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,27562,-0.00936538016030352,0.00355024205321834,-0.0163238545846115,-0.00240690573599558,0.00834544207176091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,23775,-0.00665457132689479,0.00252519914300169,-0.0116039616471781,-0.00170518100661149,0.00841259539375609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,27544,-0.0091201035165787,0.00348438447557409,-0.0159494970887039,-0.00229070994445348,0.00886452602595272
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,28529,0.00596654525861948,0.00228894418920496,0.00148021464777775,0.0104528758694612,0.00914722953116865
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,27682,0.0108432059222881,0.00416428619939706,0.00268120497146987,0.0190052068731063,0.00922304346186354
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",27682,0.00765778339494179,0.00294131411106862,0.00189280773724731,0.0134227590526363,0.00923199292502864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,23738,-0.0302357469772392,0.0116611767347153,-0.0530916533772812,-0.00737984057719722,0.00952411397719852
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,23738,0.00937353667174291,0.00362986453977283,0.00225900217378816,0.0164880711696977,0.0098192809633115
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,23198,0.0140831471977292,0.00546149590055294,0.00337861523264543,0.024787679162813,0.00992556215284015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,23056,0.00769773734671,0.00298531714471433,0.00184651574306991,0.0135489589503501,0.00992824215106623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,23163,0.0119527756302904,0.00463811187891123,0.0028620763476244,0.0210434749129564,0.00997008048421032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,28521,0.00493406094621668,0.00191562342823142,0.0011794390268831,0.00868868286555026,0.0100088850457391
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,23530,-0.00928635163953388,0.00361074169967739,-0.0163634053709016,-0.0022092979081662,0.0101212233997211
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23188,0.00605906153297087,0.00236290877498578,0.00142776033399873,0.010690362731943,0.0103464921770642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,23071,0.0136982845395565,0.00535611540838376,0.00320029833912434,0.0241962707399887,0.0105489854266607
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,23775,0.00803506383979798,0.0031424142860876,0.00187593183906629,0.0141941958405297,0.0105649424756844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,23725,0.00829709443657774,0.00324823539170167,0.00193055306884247,0.014663635804313,0.0106451544797278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27418,0.00948992027940236,0.00372162649873482,0.00219553234188212,0.0167843082169226,0.0107795729449712
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,23775,-0.0045343759585238,0.00178958342256503,-0.00804195946675125,-0.00102679245029635,0.0112909501156389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,28307,-0.00684228762300559,0.00270242324407693,-0.0121390371813964,-0.0015455380646148,0.0113497323048269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,23725,0.00585225144219654,0.00231782692180151,0.00130931067546558,0.0103951922089275,0.0115800106482313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,27544,0.011027520377295,0.00436992473286962,0.00246246790087054,0.0195925728537194,0.0116247706229751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,23725,0.00581877554650559,0.00230671893032341,0.00129760644307171,0.0103399446499395,0.0116577768308394
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,28195,-0.00610848971321176,0.0024260229461133,-0.0108634946875938,-0.00135348473882969,0.0118110886158642
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,27965,0.00951886344222305,0.00379012141734411,0.00209022546422859,0.0169475014202175,0.0120277585083712
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,28224,0.0177113574319137,0.00705922067541481,0.00387528490810063,0.0315474299557267,0.0121140122420249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23188,0.00528686500545672,0.00211719581218314,0.00113716121357776,0.00943656879733568,0.0125279915610751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,28452,0.00774277513234416,0.00310364156128378,0.00165963767222795,0.0138259125924604,0.0126106144640596
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,28428,0.00627829906770862,0.00251944382237985,0.00134018917584412,0.0112164089595731,0.0127104579718433
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,28237,0.0056103045916204,0.00225358069477375,0.00119328642986385,0.010027322753377,0.0127977574697279
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,28176,0.00828505897766225,0.00333074402153341,0.00175680069545677,0.0148133172598677,0.0128719975738674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,23738,0.0167242414361147,0.00674905886868649,0.00349608605348921,0.0299523968187402,0.013218616001569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,23337,0.00618172890055462,0.00250481493468878,0.0012722916285646,0.0110911661725446,0.0135964928517345
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,23071,-0.0074232839586026,0.00301809083587631,-0.0133387419969202,-0.00150782592028503,0.0139166376861255
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,28553,-0.00271964445292634,0.00110590792509692,-0.00488722398611631,-0.000552064919736367,0.0139307430662688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,27562,-0.00625165577284853,0.0025494647130429,-0.0112486066104126,-0.00125470493528444,0.0142069236000882
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27965,-0.0189353991246849,0.00772331352518119,-0.0340730936340401,-0.00379770461532978,0.0142236149406449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,23188,0.0109239504818551,0.00445696951320162,0.00218829023597993,0.0196596107277303,0.0142540556680416
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,27544,0.0239894002914635,0.00981540075255258,0.0047512148164604,0.0432275857664665,0.0145293570978444
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,23841,-0.0180896301102891,0.0074037636522935,-0.0326010068687844,-0.00357825335179385,0.0145607620342012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,23775,0.00661110640755564,0.00270910748947504,0.00130125572818456,0.0119209570869267,0.0146812539676837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,23188,0.00947378973324407,0.0038925215580663,0.00184444747943411,0.017103131987054,0.0149469407987013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,23653,-0.00462859894329134,0.00190275679639197,-0.00835800226421961,-0.000899195622363065,0.0149992471179051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,28553,0.00483408124565137,0.00198806232728761,0.000937479084167657,0.00873068340713508,0.0150403109963834
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,28091,-0.0107925808146175,0.00444265501340717,-0.0195001846408956,-0.00208497698833948,0.0151338725890091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,28224,-0.00648727530614099,0.00267142052278552,-0.0117232595308006,-0.00125129108148137,0.0151718505999633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,27544,-0.00697145872212358,0.00288159075131399,-0.012619376594699,-0.00132354084954816,0.0155564577729507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,27544,-0.00575550333211781,0.00237974492227429,-0.0104198033797754,-0.00109120328446019,0.0155894651024032
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,28521,0.00804799633936155,0.00333182487033994,0.00151761959349528,0.0145783730852278,0.0157202149783234
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,23725,0.00588941036361068,0.00244212630078828,0.00110284281406565,0.0106759779131557,0.01589062707451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23337,0.00665745593228946,0.00277055154734647,0.00122717489949039,0.0120877369650885,0.0162718282190213
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,23893,0.00491536232266545,0.0020511451396686,0.000895117848914994,0.0089356067964159,0.0165646955193906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,23188,0.00704748942643721,0.00294453670878132,0.00127619747722583,0.0128187813756486,0.0167003916885293
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,28336,0.0048059731177729,0.00200910897190577,0.000868119532837586,0.00874382670270821,0.016759130469334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,28091,0.00421762986697313,0.00176621495974508,0.000755848545872784,0.00767941118807348,0.0169492988065513
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,28336,-0.00485007334981232,0.0020442839153841,-0.00885686982396515,-0.000843276875659489,0.0176745745101019
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,28187,-0.00542894832069114,0.00228979542959812,-0.00991694736270346,-0.000940949278678822,0.0177500026156783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,23862,0.022179620700787,0.00935532628217564,0.00384318118772272,0.0405160602138512,0.0177574673607543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,27412,0.0177355045310925,0.00751425937962817,0.00300755614702132,0.0324634529151637,0.0182697621629083
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,23846,-0.00626528105607757,0.00265525246842235,-0.0114695758941854,-0.00106098621796976,0.0183036442639708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,28237,-0.00381058927288544,0.0016151906432581,-0.00697636293367131,-0.000644815612099566,0.018320191976719
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,28176,0.0149074923278313,0.00633352314700036,0.00249378695971059,0.027321197695952,0.0185922363175092
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,23188,0.00459828868514861,0.00195895805748543,0.000758730892477172,0.00843784647782006,0.0189177048159764
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,28224,-0.0107441146947582,0.0045816113853946,-0.0197240730101316,-0.00176415637938473,0.0190313435030408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,23198,-0.0101699181557614,0.00433853951921935,-0.0186734556134313,-0.00166638069809144,0.0190820700047251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,23872,0.0063638602381847,0.00271501468134119,0.00104243146275597,0.0116852890136134,0.0190888598884249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,27702,0.00500977820183237,0.00215524004895118,0.000785507705888051,0.00923404869777669,0.0201078268577119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,27682,0.0070164586278985,0.00302366385000149,0.00109007748189558,0.0129428397739014,0.0203202448152602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,23775,0.0059619313033011,0.00257869504607034,0.000907689013003236,0.011016173593599,0.0207864388390678
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,27562,0.00707048212811119,0.00305923431309597,0.0010743828744431,0.0130665813817793,0.0208295192214819
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,27702,0.00760340627916747,0.00329351774006777,0.00114811150863464,0.0140587010497003,0.0209732646142645
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,27791,0.00836304748769,0.00362554632712358,0.00125697668652779,0.0154691182888522,0.0210788747910648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,23725,0.00813286354739401,0.0035308814734819,0.00121233585936949,0.0150533912354185,0.021267645243149
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,23795,-0.00549269247950622,0.00238499409826597,-0.0101672809121075,-0.000818104046904916,0.0212862255846801
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,23393,0.00873937345760552,0.00380418082540134,0.00128317903981889,0.0161955678753921,0.0216100212459363
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,22783,-0.00609264695904426,0.00265479163463628,-0.0112960385629314,-0.000889255355157153,0.0217443308706133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,23198,0.0049604097121747,0.0021628270363417,0.000721268720944961,0.00919955070340444,0.0218290458960602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,28091,-0.00323455095528214,0.00141748305320913,-0.00601281773957203,-0.000456284170992249,0.0225028437340809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,23775,-0.00718243378028621,0.0031486042889248,-0.0133536981865788,-0.00101116937399359,0.0225484723710289
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,23775,0.0056711194333214,0.00248812083194911,0.000794402602701139,0.0105478362639417,0.0226593627572879
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,23795,0.00607407418955501,0.00266627596457757,0.000848173298982969,0.011299975080127,0.0227287599446649
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,28187,0.00488027097208477,0.0021466009054329,0.000672933197436297,0.00908760874673325,0.0230042920966371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,23393,0.00697257201970606,0.00306737788412576,0.000960511366819562,0.0129846326725926,0.0230269202761569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,27338,0.0154134939829633,0.00679661628952095,0.00209212605550226,0.0287348619104244,0.0233480274258189
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23198,0.00956556107139852,0.00423883606933609,0.00125744237549978,0.0178736797672973,0.0240393482244365
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23163,0.00832745304025222,0.00369821227295743,0.00107895698525565,0.0155759490952488,0.0243473486688776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,27562,0.00767834749940562,0.00342120238337206,0.000972790827996384,0.0143839041708149,0.0248183240145634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,23100,-0.00599634061852194,0.00267436252086374,-0.0112380911594149,-0.000754590077629012,0.0249606833058863
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,23663,0.00670492809772601,0.00299282904208025,0.000838983175248716,0.0125708730202033,0.0250786811886416
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,23872,0.0108274067854483,0.00483364686460613,0.00135345893082028,0.0203013546400763,0.0250995852478601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,23337,0.00422683634550586,0.00189692938378781,0.000508854753281753,0.00794481793772997,0.0258732234531635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,28553,0.00392099098443805,0.00176266000557224,0.000466177373516451,0.00737580459535964,0.0261243745922659
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,23738,0.00734490594152958,0.00331104430738445,0.000855259099056064,0.0138345527840031,0.0265434787910271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,28176,0.00615862590922017,0.0027855017328276,0.000699042512878084,0.0116182093055623,0.0270467854217541
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,23056,-0.00788208297695651,0.00357744712652234,-0.0148938793449403,-0.000870286608972725,0.0275855620134884
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,23071,0.00826702718362499,0.00376609997717334,0.000885471228365252,0.0156485831388847,0.0281651932708157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,23862,0.00906514848706,0.00413041488185358,0.000969535318626997,0.017160761655493,0.0281925248875818
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,22978,0.00790144877899027,0.00360346132110626,0.000838664589622011,0.0149642329683585,0.0283362125933794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,27544,0.0109383014447529,0.0049904137395261,0.00115709051528171,0.020719512374224,0.0283977711164417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,28187,-0.0117249975461742,0.00536268200585171,-0.0222358542776435,-0.00121414081470483,0.0287941479788567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,23893,-0.00286596662699941,0.00131309977591045,-0.0054396421877839,-0.000292291066214916,0.0290752652845585
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,27885,0.00434864748555031,0.00199270508197562,0.000442945524878089,0.00825434944622254,0.0290969335557318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,27702,0.00828606022854583,0.00380247574728608,0.00083320776386511,0.0157389126932265,0.0293309741753088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,23163,0.00700094752483485,0.00321854500489781,0.000692599315235154,0.0133092957344346,0.0296259526218133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,28176,0.00821861378922568,0.00379116935270257,0.000787921857928647,0.0156493057205227,0.030179909070214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23337,0.00320177018262763,0.00147778623993751,0.000305309152350113,0.00609823121290515,0.0302755365864291
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",23795,-0.00613341342531366,0.00283203265390764,-0.0116841974269726,-0.000582629423654688,0.0303418570769191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,23820,0.010656890409054,0.00494411690713698,0.000966421271065521,0.0203473595470425,0.031135148215583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23198,0.00478870201797444,0.00222525537279884,0.000427201487288712,0.00915020254866016,0.0314093296965905
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,28428,0.00436352751215856,0.00203196929947153,0.000380867685194363,0.00834618733912276,0.0317668838113674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,23663,0.00393672844274746,0.00183341028687651,0.000343244280469502,0.00753021260502542,0.0317862004622774
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",23795,0.0099207260882535,0.00462423310424437,0.000857229203934532,0.0189842229725725,0.0319327642290914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,23725,0.00534979730641175,0.00249407189293038,0.000461416396268201,0.0102381782165553,0.0319625555227319
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,27965,-0.00684401134659652,0.00319384767967755,-0.0131039527987645,-0.000584069894428519,0.0321318712573249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,23872,0.0105331053408786,0.00492100596346102,0.000887933652494986,0.0201782770292622,0.0323295404599625
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,27702,0.00708904602811963,0.00332060341019178,0.000580663344143747,0.0135974287120955,0.0327806441313477
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,23337,0.0109296917301934,0.00511982062149062,0.000894843312071781,0.020964540148315,0.0327893603434551
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27702,0.00611416361008532,0.00287154901493745,0.000485927540807921,0.0117423996793627,0.0332447450723068
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,23795,-0.00367396320509928,0.00172623107073119,-0.00705737610373242,-0.000290550306466145,0.033321240011749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28340,0.0147978786084927,0.00695532573797121,0.00116544016206909,0.0284303170549163,0.0333821250007701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,23862,0.00324936501097139,0.0015333980422771,0.000243904848108271,0.00625482517383451,0.034095562230191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,23862,-0.012614883215517,0.00595596577464166,-0.0242885761338146,-0.000941190297219339,0.0341832832622782
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28521,-0.00499237268210263,0.00236534330091377,-0.00962844555189362,-0.00035629981231165,0.0348125159260623
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23337,0.00977537551376165,0.00464016083634243,0.000680660274530497,0.0188700907529928,0.035155203523575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,22978,-0.0066403486199154,0.00315230632895539,-0.012818869024668,-0.000461828215162828,0.0351713411420241
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,23071,0.00536161160864055,0.00254784552392073,0.000367834381755924,0.0103553888355252,0.0353569146973463
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,23056,0.00683446005957918,0.00325198817958388,0.000460563227594784,0.0132083568915636,0.0355969558961992
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,27519,0.00657740172681779,0.00312981615440972,0.000442962064174739,0.0127118413894608,0.0356035624483794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,23775,0.00939903483750839,0.00448144752566725,0.000615397687200578,0.0181826719878162,0.0359756919400492
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,23071,-0.00513387883187061,0.00244912968261147,-0.0099341730097891,-0.00033358465395212,0.0360748466418799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,23725,0.00725296577866739,0.00346407771460208,0.000463373458047316,0.0140425580992875,0.0362914841651296
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,28174,-0.0137111555243283,0.00657847625913963,-0.026604968992242,-0.000817342056414599,0.0371468877565333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",27544,0.0075905198498517,0.0036583650914709,0.000420124270568732,0.0147609154291347,0.0380106932806702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,22978,0.00506781450447521,0.00244518366981824,0.00027525451163146,0.00986037449731897,0.0382234384203751
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,28553,-0.00486175932445953,0.00234648051019678,-0.00946086112444523,-0.00026265752447384,0.0382802956998977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22978,0.00933715014319288,0.00451055667597044,0.000496459058290825,0.0181778412280949,0.0384573142145153
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28452,-0.00361541773974476,0.00174821381437124,-0.00704191681591239,-0.000188918663577133,0.0386430424825562
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,23872,0.00881061350174407,0.00426310840686793,0.000454921024282922,0.0171663059792052,0.0387721473351364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,23071,-0.00468020808687016,0.00226911588168506,-0.00912767521497288,-0.000232740958767442,0.0391647693214846
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,23775,0.0105313341468092,0.00510918712195791,0.000517327387771674,0.0205453409058467,0.0392896359116477
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,23393,0.00473961442923423,0.00229949755009027,0.00023259923105731,0.00924662962741116,0.0392995550200935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,28142,0.0055949605328015,0.00271550942012283,0.000272562069360756,0.0109173589962423,0.0393721334549215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,23071,0.00554278137736814,0.00269701045477013,0.000256640886018692,0.0108289218687176,0.0398750301468359
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,23700,0.00567452804697877,0.00276214092236482,0.000260731839143716,0.0110883242548138,0.0399484401184613
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,23893,-0.0045021424729085,0.00219304324815535,-0.00880050723929298,-0.000203777706524018,0.0400912029553988
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,23795,0.00495808452502914,0.00242091958074831,0.000213082146762452,0.00970308690329583,0.0405692889222463
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,23795,0.00519455383745107,0.0025379951789895,0.000220083286631657,0.0101690243882705,0.0406970045270372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,27607,-0.00607912554881829,0.00297513114408919,-0.0119103825912331,-0.000247868506403487,0.0410308950445205
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,27562,-0.00454890475219715,0.00222764483668503,-0.00891508863209981,-0.000182720872294497,0.0411586301140386
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,22978,-0.00557330699496266,0.00274148215884346,-0.0109466120262958,-0.00020000196362947,0.0420686537496285
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,23862,-0.00496011041808988,0.00244007244233776,-0.0097426524050719,-0.000177568431107868,0.0420866393102202
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,22978,-0.0110271326816532,0.00542670602449115,-0.0216634764896559,-0.000390788873650599,0.0421639105764972
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,28091,-0.00328445821025908,0.00161705693864933,-0.00645388981001177,-0.000115026610506392,0.0422508743162801
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,27956,-0.0175038832448754,0.00862636947526862,-0.0344115674164019,-0.000596199073348902,0.0424561860159548
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,28091,-0.00468412437625409,0.00231814724852609,-0.00922769298336522,-0.000140555769142953,0.0433272645659962
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,27562,-0.0111237927248701,0.00550676176254558,-0.0219170457794594,-0.000330539670280738,0.0433905245336066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,22978,0.00835787694097225,0.00414040357816073,0.000242685927777214,0.0164730679541673,0.0435389475730731
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,23872,-0.00357743635719024,0.00177313469138824,-0.00705278035231118,-0.000102092362069295,0.0436464741746684
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,27702,-0.00641637698466753,0.00318061165454234,-0.0126503758275705,-0.000182378141764544,0.0436696130181927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,28195,0.0403221991740223,0.0199890637870126,0.00114363415147762,0.0795007641965669,0.0436827534958634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,27500,0.00833726824979214,0.00413536483132038,0.000231953180404195,0.0164425833191801,0.0438002610542508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,22492,0.0168313631292729,0.0083565389070811,0.000452546871393948,0.0332101793871519,0.04400517114198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,23393,0.00823493299474235,0.00408912805352362,0.000220242009836053,0.0162496239796486,0.0440356277968587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,27562,0.00700345775046913,0.00348438743982988,0.000174058368402561,0.0138328571325357,0.0444458104302278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,28500,0.0165193368892747,0.00823142380653744,0.000385746228461287,0.032652927550088,0.0447737222885539
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,27682,0.00822180576274394,0.00410959360049896,0.000167002305765974,0.0162766092197219,0.045441256256344
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",23071,0.0053212715340689,0.00266102232482854,0.000105667777404966,0.0105368752907328,0.0455433561316343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,27562,0.00722861535728063,0.00362980349223979,0.000114200512490639,0.0143430302020706,0.0464399877485812
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,28033,0.00300239660142726,0.00151054650298555,4.17254555755793e-05,0.00596306774727895,0.0468631453607158
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,22978,0.010305995984917,0.00519022407057932,0.000133156806581495,0.0204788351632524,0.0470834830796373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,23056,0.00792428727639602,0.00399503021465276,9.40280556766208e-05,0.0157545464971154,0.0473194107726064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,28176,-0.0044031120691071,0.00222011962540062,-0.00875454653489231,-5.16776033218855e-05,0.047346199928592
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,28553,-0.00405398142732242,0.00204570431507117,-0.00806356188486191,-4.44009697829172e-05,0.0475219031750966
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,27544,0.00643251438197146,0.00325423677650791,5.42103000159572e-05,0.012810818463927,0.0480902222517508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,27562,0.00738201633743307,0.00373702777465867,5.74418991020759e-05,0.0147065907757641,0.0482360254191544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,28176,0.00534063826534126,0.00270903628574792,3.09271452753352e-05,0.0106503493854072,0.0486860529105488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,22978,-0.0075181264142301,0.00381535868119507,-0.0149962294293724,-4.00233990877699e-05,0.0487942246860429
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,23795,0.00394350224032039,0.00200550649699315,1.27095062138188e-05,0.00787429497442696,0.0492712730446485
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,23056,0.0076696810948243,0.00390124137348451,2.32480027946525e-05,0.0153161141868539,0.0493153200050459
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,22978,-0.0155086994356665,0.00789689267380437,-0.0309866090763231,-3.07897950099587e-05,0.0495538535407873
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,28411,0.00402437095349153,0.00205603309974075,-5.45392200034314e-06,0.0080541958289834,0.0503164246497108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,23163,0.00921425986772552,0.00471008428615331,-1.75053331349755e-05,0.018446025068586,0.0504437814621118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,23071,0.00583679900185071,0.0029863423218776,-1.64319490293958e-05,0.0116900299527308,0.0506544630056495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,27562,0.0114481736199162,0.00585805598772828,-3.36161160312785e-05,0.0229299633558636,0.0506803952312849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27562,0.0111944774188649,0.00573020392523166,-3.67222745891634e-05,0.0224256771123189,0.0507596589512854
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,23393,-0.00404085898174511,0.00206915470399514,-0.00809640220157558,1.46842380853553e-05,0.050842972829682
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,23188,-0.00629236836210697,0.00322249461996393,-0.0126084578172363,2.37210930223346e-05,0.050874419622253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,27965,-0.00555336068261818,0.002847128059902,-0.0111337316800261,2.70103147897412e-05,0.0511249695911812
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",23163,0.00516440180225075,0.00265277758915329,-3.50422724896904e-05,0.0103638458769912,0.0515719535163123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,28414,-0.00567895405714068,0.00292645822272936,-0.0114148121736902,5.69040594088702e-05,0.0523221219368172
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,23188,-0.00608056647432952,0.0031432299462088,-0.0122412971688988,8.01642202397229e-05,0.0530643020843542
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,28091,-0.00703802182971739,0.00365332549277473,-0.0141985397955559,0.000122496136121088,0.0540558006472526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,23337,0.00912060910010321,0.00473716313392131,-0.000164230642382562,0.018405448842589,0.0542000522572136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27682,0.00354734576912428,0.00184323040500417,-6.53858246838844e-05,0.00716007736293245,0.054298864317357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22479,0.00651135586332552,0.00339361958220601,-0.00014013851779826,0.0131628502444493,0.0550342986338724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,28428,0.0098267085411175,0.00512452606010419,-0.00021736253668672,0.0198707796189217,0.0551738103480936
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,23188,-0.00727071341257497,0.00379629196279861,-0.0147114456596602,0.000170018834510311,0.0554774491436418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,27682,-0.0149503370345662,0.00782327946969153,-0.0302839647951616,0.000383290726029186,0.0560140828054569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,23071,-0.00732644723454952,0.00384244554863382,-0.0148576405098718,0.000204746040772757,0.0565699653797465
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,28140,0.00312981103428567,0.00164604999242803,-9.64469508732677e-05,0.00635606901944461,0.0572589281192413
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,23738,-0.00558806980416951,0.00294816001733049,-0.0113664634381373,0.000190323829798252,0.0580458555316302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,28091,0.00497720936271149,0.00262669182194078,-0.000171106608292441,0.0101255253337154,0.0581214123128545
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,23198,-0.00306521664931704,0.00161892579572696,-0.00623831120894188,0.000107877910307791,0.0583218513312136
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,28224,0.00447999770103568,0.002379268174594,-0.000183367921168553,0.00914336332323992,0.059720005665118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,23163,0.00962311072117759,0.00511709189333357,-0.00040638938975621,0.0196526108321114,0.0600413504784555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,23071,0.00610002661806007,0.00324468378319605,-0.000259553597004186,0.0124596068331243,0.0601197885780993
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,22978,-0.0062604575937046,0.00333507406910999,-0.0127972027691602,0.000276287581750971,0.0605092475050035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",22940,0.00328924893134923,0.00175265142544355,-0.000145947862520134,0.0067244457252186,0.0605681575353435
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,28521,0.00773282472797587,0.004121481497116,-0.000345279006371486,0.0158109284623232,0.0606346623626742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,23846,-0.00377144120271206,0.00201175108257288,-0.0077144733245549,0.000171590919130787,0.0608454443897284
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,27562,0.00392445388504923,0.0021023573592261,-0.00019616653903393,0.0080450743091324,0.0619552119838495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,23393,0.00665388557091791,0.00356611381349403,-0.000335697503530397,0.0136434686453662,0.062072822836266
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,27682,0.00672330407543385,0.00360676662768847,-0.000345958514835558,0.0137925666657033,0.0623209546204795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,23188,0.00469678926766218,0.00252096093997616,-0.00024429417469109,0.00963787271001544,0.0624615682022571
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,28428,0.00301810442467333,0.00162023160314733,-0.000157549517495428,0.00619375836684209,0.0625061950554995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23071,0.00830871111436641,0.0044735928827233,-0.000459530935771254,0.0170769531645041,0.063284180306051
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,23056,0.00549558892320738,0.00296471968488043,-0.000315261659158254,0.011306439505573,0.0638002695462579
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,27136,0.00394034682604241,0.00213188345933995,-0.000238144754263894,0.00811883840634872,0.0645707409884547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,27682,0.0166914843574658,0.0090406987629272,-0.00102828521787148,0.0344112539328031,0.0648650746226286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,23725,0.00506238751048666,0.00274961276424994,-0.00032685350744322,0.0104516285284165,0.0656153701305272
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,28091,0.00865200032271437,0.00470031153656239,-0.000560610288947924,0.0178646109343767,0.0656718095393178
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,28176,0.00431144962344715,0.00234331244148622,-0.000281442761865832,0.00890434200876014,0.0657941229366263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,28553,0.0069104252244501,0.00376079364988948,-0.000460730329333281,0.0142815807782335,0.066147804814245
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,27544,-0.00632210240950274,0.00345523945108463,-0.0130943717336286,0.000450166914623136,0.0673034201610676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,23846,0.00677091847639682,0.00370938996220113,-0.000499485849517396,0.014041322802311,0.0679614092045338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,23862,-0.00728097728259083,0.00399011114848708,-0.0151015951336255,0.000539640568443854,0.0680504373127703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,28553,-0.00390158665752172,0.00214447468594851,-0.0081047570419808,0.000301583726937357,0.0688659179355374
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,28524,0.00704563539587163,0.00387754036834855,-0.000554343726091524,0.0146456145178348,0.0692218995912423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,23071,-0.00494444293752445,0.00272470215274069,-0.0102848591568962,0.000395973281847307,0.0695871932544859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,28087,0.00424391402832728,0.00234993067281525,-0.000361950090390615,0.00884977814704517,0.070933085087683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,27702,0.00707972552783489,0.00392148155275928,-0.000606378315573306,0.0147658293712431,0.0710276451295153
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,23188,0.00472941256351647,0.00261992655689258,-0.000405643487992978,0.00986446861502592,0.0710610731204468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,28091,0.0230018536526749,0.0127581743131582,-0.00200416800111525,0.048007875306465,0.0714129006889638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,28278,0.00341879238243165,0.00189805731709469,-0.000301399959073947,0.00713898472393725,0.0716810584211745
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,23738,0.005209967804236,0.00289507779405589,-0.00046438467211355,0.0108843202805855,0.0719372970017738
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,23165,0.00843394398503101,0.0047166504172357,-0.000810690832750961,0.017678578802813,0.0737694820333113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,28496,0.00633394098506489,0.00354934247667679,-0.000622770269221608,0.0132906522393514,0.0743467223673013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23071,-0.00381876037256287,0.00214141639248334,-0.00801593650183021,0.000378415756704479,0.0745527195533734
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,23163,0.00378764544929654,0.00212476425328257,-0.000376892487137306,0.00795218338573038,0.0746614214508383
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23163,-0.00620094801307719,0.00348242741837295,-0.0130265057530882,0.000624609726933786,0.0749844640787773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,28068,0.00433656734607904,0.00244042732966293,-0.000446670220060306,0.00911980491221838,0.0755839282245824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,28270,-0.00589453374367728,0.00331837689609351,-0.0123985524600205,0.000609484972665993,0.0756892340334765
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,28362,0.00984505030473293,0.00554437481200372,-0.00102192432679437,0.0207120249362602,0.0757959597602337
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23071,-0.00700929287702234,0.00395226312787327,-0.014755728607654,0.000737142853609271,0.0761610065560523
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,22978,-0.00405445453742989,0.00228808087000318,-0.00853909304263613,0.000430183967776344,0.0764096112631335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,23056,0.00748475550372441,0.0042262002796375,-0.000798597044365089,0.0157681080518139,0.0765678274948403
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,23163,0.00480169254821306,0.00271238029623348,-0.000514572832404556,0.0101179579288307,0.0766924422906927
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,27489,0.00414627984973367,0.00234426181716574,-0.000448473311911175,0.00874103301137852,0.0769561872555587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,27702,0.00981175140646422,0.00555099833699995,-0.00106820533405568,0.0206917081469841,0.0771446348968368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,23738,0.00555276188592832,0.00314486307489759,-0.00061116974087095,0.0117166935127276,0.077465610798258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23071,0.00576878721063119,0.00326848162396106,-0.00063743677233249,0.0121750111935949,0.077581262266479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,23188,0.00464508377621298,0.00263407536559326,-0.000517703940349806,0.00980787149277577,0.0778362910046505
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,28494,-0.00738959647117848,0.00419950891084316,-0.0156206339364311,0.000841440994074102,0.0784807063661328
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,23738,0.00357778240298711,0.00203707533468064,-0.000414885252986945,0.00757045005896117,0.0790444860777719
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,23198,-0.00504770880976862,0.00287867729736354,-0.0106899163126011,0.000594498693063912,0.0795325212285794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,23738,0.00529487464750099,0.00302058704066653,-0.000625475952205396,0.0112152252472074,0.0796271087818187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22978,-0.00524862774531597,0.00299715630788374,-0.0111230541087681,0.00062579861813617,0.0799243778683646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23136,0.00456187805370116,0.00261470965864179,-0.000562952877236756,0.00968670898463907,0.0810507814589859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,28137,0.0097573198684045,0.00559615018977445,-0.00121113450355341,0.0207257742403624,0.0812437693402532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28363,-0.00836457184050653,0.00479885122262991,-0.0177703202368611,0.00104117655584809,0.0813381174851418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,23071,0.00538016453914963,0.00309505067528132,-0.000686134784401761,0.011446463862701,0.0821691562659214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",27544,0.00499371448759393,0.00287413711505646,-0.000639594257916743,0.0106270232331046,0.0823161966348475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,28195,-0.00294466148250279,0.0016976481362113,-0.00627205182947695,0.000382728864471361,0.0828308595583552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,23337,-0.00610559841049539,0.00352858517055358,-0.0130216253447804,0.000810428523789618,0.0835854898883465
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,27237,-0.00700705220427835,0.00405131542483353,-0.0149476304369521,0.000933526028395367,0.0837176449047866
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,27928,0.00560514532406133,0.0032490778392057,-0.000763047240781841,0.0119733378889045,0.0845115848149243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,28224,0.00817321152569717,0.00474192749614193,-0.001120966366741,0.0174673894181353,0.0847900719202698
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27965,0.00709239619853424,0.00411674318131598,-0.000976420436845077,0.0151612128339136,0.0849326377903081
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,23846,0.00855421861085802,0.00498268603387213,-0.00121184601553136,0.0183202832372474,0.0860307971730161
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23636,0.00351196143832766,0.00204901986755036,-0.000504117502071051,0.00752804037872638,0.0865470985587619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,28224,-0.00432601788109457,0.00252532173088368,-0.00927564847362657,0.000623612711437436,0.0867132009191457
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23188,-0.00341149066975788,0.00199151499366302,-0.0073148600573374,0.000491878717821642,0.0867235611129308
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,23725,-0.00552011770317798,0.00323108951028343,-0.0118530531433335,0.000812817736977542,0.087568097511987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,28521,0.0043004644507206,0.00253063653359797,-0.000659583155131425,0.00926051205657263,0.0892621389718371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,27965,0.0047915299758906,0.00282347234338447,-0.000742475817142953,0.0103255357689242,0.089701271637569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,23188,-0.00697374107165754,0.00411483556477638,-0.0150388187786192,0.00109133663530417,0.0901305958305429
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,23725,-0.00457949551131857,0.00270363107154538,-0.00987861241154751,0.000719621388910365,0.0903104378192606
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,23393,0.00334337956328645,0.00197619077317126,-0.00052995435212922,0.00721671347870211,0.090691648092326
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23188,-0.00411182697870438,0.00243575190215575,-0.00888590070692965,0.000662246749520878,0.0914027957206637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,27657,0.00629301114774716,0.00374705568515793,-0.00105121799516238,0.0136372402906567,0.0930747162245478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27965,-0.00792069731414174,0.00471678303065053,-0.0171655920542168,0.00132419742593329,0.0931128801993669
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,23188,0.0056028094802258,0.00333795871283422,-0.000939589596929268,0.0121452085573809,0.0932603380392877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23393,0.00403298881547927,0.00240274486598196,-0.000676391121845358,0.00874236875280391,0.093264392202156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,23163,0.00687021514571484,0.00410241340144917,-0.00117051512112554,0.0149109454125552,0.094011236514023
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",28091,0.0116497124009457,0.00698754985929271,-0.00204588532326801,0.0253453101251594,0.095483824834637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,23071,0.00537761089761311,0.00324502103931857,-0.000982630339451278,0.0117378521346775,0.097495016473754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,27702,0.00377585589146791,0.0022804649455259,-0.000693855401762851,0.00824556718469866,0.0977859164695114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",23725,0.00483006985529372,0.00291934367574575,-0.000891843749167944,0.0105519834597554,0.0980381042404526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22978,0.00642016075170172,0.00388161853726509,-0.00118781158133785,0.0140281330847413,0.0981430807650601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,23872,-0.00575918543721069,0.00348344599743722,-0.0125867395921877,0.00106836871776626,0.0982827363111552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,23738,0.00291770142389672,0.00176802706588379,-0.000547631625235508,0.00638303447302895,0.0989033451401156
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,23198,-0.00813245469124024,0.00494011591449953,-0.0178150818836593,0.00155017250117885,0.0997346491342387
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,27281,0.00292840364594847,0.00177916389483269,-0.000558757587923597,0.00641556487982055,0.0997868710715636
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,23071,-0.00509347404824139,0.00309613066033446,-0.0111618901424969,0.000974942046014154,0.0999608574227042
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28553,-0.00301296559015653,0.00183312219026836,-0.00660588508308252,0.00057995390276945,0.10026468727742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,23188,0.00608054685372954,0.00370041801067757,-0.00117227244719851,0.0133333661546576,0.100354009498104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,28336,-0.00509404010809094,0.00310132410916914,-0.0111726353620624,0.00098455514588057,0.100489832209759
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,23163,-0.00347099607609775,0.0021158070071276,-0.00761797781006785,0.000675985657872345,0.100913393177717
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,23738,0.00284353767189474,0.0017363249899897,-0.000559659308485077,0.00624673465227455,0.101502572987877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,28187,0.00330969662848495,0.00203062006622922,-0.00067031870132433,0.00728971195829423,0.10313495983739
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27562,-0.0135640069845832,0.00834609424938031,-0.0299223517133686,0.00279433774420222,0.104133058718462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,23738,0.00435795191827541,0.0026830969974597,-0.000900918196745596,0.00961682203329642,0.104341185490636
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23795,0.00261010620461581,0.00160921611938462,-0.000543957389378039,0.00576416979860966,0.104822238333851
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23188,0.00486864299980891,0.0030020311004095,-0.00101533795699371,0.0107526239566115,0.104863423815787
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,28187,0.00263621452499353,0.00162728538023967,-0.000553264820276219,0.00582569387026327,0.105241857432522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,23071,0.00411959425479328,0.00254998177445448,-0.000878370023137501,0.00911755853272406,0.106207767423096
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,23337,-0.00450653604957745,0.00279055045704686,-0.00997601494538929,0.000962942846234389,0.106339971301608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23862,0.00432619677899439,0.00268103566512117,-0.000928633124643107,0.00958102668263189,0.106621163082249
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,28176,0.00665076021963909,0.00412461809559762,-0.00143349124773224,0.0147350116870104,0.106874214856954
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,22978,-0.00275079663637529,0.00171371062897845,-0.00610966946917304,0.000608076196422469,0.108470180896555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,28144,-0.00911560449647525,0.00568605899773404,-0.020260280132034,0.00202907113908348,0.10891280683982
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,22978,-0.00798179473502706,0.00498079541476028,-0.0177441537479572,0.00178056427790309,0.109055732231453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,23481,0.00368861778941404,0.00231208371998887,-0.000843066301764147,0.00822030188059223,0.110644070582185
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,23056,0.00513363990627916,0.0032189339624991,-0.00117547066021907,0.0114427504727774,0.110764843093656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,28182,0.00801158225504585,0.00503559574299652,-0.00185818540122734,0.017881349911319,0.111623057782701
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,23893,0.00242219627886741,0.00152538166804147,-0.000567551790493865,0.00541194434822869,0.112315858331159
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,23725,0.00481198717186375,0.00303048657064409,-0.00112776650659867,0.0107517408503262,0.112331426046809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,28224,-0.00304655442006922,0.00192199250285636,-0.0068136597256677,0.000720550885529248,0.112954339410847
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,23795,0.00733322408478373,0.00462661316601411,-0.00173493772060393,0.0164013858901714,0.112977557557621
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,28091,0.0144231100512832,0.00910350546814012,-0.00341976066627148,0.0322659807688378,0.113126076269209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,23795,-0.00235596460413376,0.00148800545331303,-0.0052724552926273,0.000560526084359769,0.113365547763833
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,27910,-0.00250967415880619,0.00158882593124532,-0.00562377298404703,0.00060442466643464,0.114214926036903
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,23872,0.0154045906487601,0.00975476020294475,-0.00371473934901162,0.0345239206465318,0.11430642456084
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,27682,-0.00648481956498678,0.00411362298681665,-0.0145475206191474,0.00157788148917385,0.114939242425862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,23337,0.00413997061661451,0.00262634461274498,-0.00100766482436565,0.00928760605759467,0.114964666022409
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,27702,0.00377196528602565,0.00239845411825332,-0.000929004785750855,0.00847293535780216,0.115807791729713
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,22978,-0.00994275662311796,0.00634661359497102,-0.0223821192692612,0.00249660602302524,0.117216403749441
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,23393,-0.00358383002433651,0.00229218552347321,-0.00807651365034399,0.000908853601670975,0.117948779948206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,23071,0.00703312509421334,0.00450710943827414,-0.00180080940480397,0.0158670595932307,0.118666978115283
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,27562,0.00585839053523478,0.00375888150144247,-0.00150901720759246,0.013225798278062,0.119115308931576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,23188,0.00614024445366442,0.00394006228033152,-0.00158227761578535,0.0138627665231142,0.119149021852816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,23795,0.00488745904407606,0.00313909607037803,-0.00126516925386488,0.011040087342017,0.11949237999425
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,23370,-0.0104025988447673,0.00668331774309587,-0.0235019016212352,0.00269670393170062,0.119602266511849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23393,-0.00752285672663864,0.0048502806049315,-0.0170294067123044,0.00198369325902711,0.120911686758278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,27544,-0.00627814551136734,0.00405401097191637,-0.0142240070163234,0.00166771599358874,0.121483223009388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23071,-0.00549995639947507,0.00355752996853136,-0.0124727151377965,0.0014728023388464,0.122117269225494
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,23337,0.0042066004530932,0.00273667373974005,-0.0011572800767973,0.0095704809829837,0.124277087639674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,28176,-0.00361839023906023,0.00235475739621593,-0.00823371473564346,0.000996934257522994,0.124395240440049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",26796,0.00301978449033098,0.00196619350690149,-0.000833954783195947,0.00687352376385791,0.12458621374417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27562,0.00616309030007477,0.00402430404069054,-0.00172454561967868,0.0140507262198282,0.12566540917469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,27544,0.00405678840705887,0.00265117316513879,-0.00113951099661315,0.00925308781073089,0.125982153119416
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,23188,-0.0049146336957984,0.0032228257704184,-0.0112313722058185,0.00140210481422168,0.127286334991215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,23163,0.00737145803581213,0.0048368267591527,-0.00210872241212715,0.0168516384837514,0.127515448325064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,23056,0.0051497837230497,0.00340117977864775,-0.00151652864309989,0.0118160960891993,0.130009913525192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,28237,-0.00300445223142039,0.00200401593817209,-0.00693232347023768,0.000923419007396899,0.133828858819957
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,23188,0.00471511714611461,0.00315737645437627,-0.00147334070446287,0.0109035749966921,0.135355146375985
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,23725,-0.00383238474976121,0.00256693807556414,-0.00886358337786693,0.00119881387834451,0.135455978337744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,23056,0.00566380181089455,0.00379978107915309,-0.0017837691042455,0.0131113727260346,0.13609073231301
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,27544,0.00558522775372811,0.00375644022831497,-0.00177739509376923,0.0129478506012255,0.13706837409177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27562,0.0098617943786522,0.00663696097080199,-0.00314664912411969,0.0228702378814241,0.137319644946615
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,23188,-0.0037865732171507,0.00255320447836452,-0.00879085399474516,0.00121770756044376,0.138070218771271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23188,0.00618401203402445,0.00419286236431984,-0.00203399820004243,0.0144020222680913,0.140255623337464
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,23393,0.00712571538458415,0.00484495490450921,-0.0023703962282539,0.0166218269974222,0.14137231112518
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,28470,-0.00461039379657289,0.00313484847972342,-0.0107546968168308,0.00153390922368502,0.141385728010425
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,28452,-0.00454437591637286,0.00309223966762255,-0.0106051656649131,0.00151641383216734,0.141679386031974
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,23826,-0.00356144005263792,0.00242636020893163,-0.00831710606214392,0.00119422595686807,0.142168569805849
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,23198,0.0261056873765931,0.017835062872884,-0.0088510358542596,0.0610624106074458,0.14328174040881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,23337,-0.00212284005148707,0.00145255439102514,-0.00496984665789633,0.0007241665549222,0.143904622140864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,23071,-0.00498521470764569,0.0034145624347783,-0.0116777570798112,0.00170732766451979,0.144307436921478
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27702,-0.0116303314294319,0.00796706152824281,-0.0272457720247878,0.00398510916592404,0.144355876011812
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,23056,-0.00899385999447592,0.0061825478900343,-0.0211116538589432,0.00312393386999132,0.145761135108546
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,23725,-0.00581122696498681,0.00400329771032362,-0.0136576904772211,0.00203523654724747,0.146623308782323
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,28176,-0.00458075631411874,0.00315666623602226,-0.0107678221367224,0.0016063095084849,0.14675275314428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,27965,-0.00352863907227014,0.00243825369447317,-0.00830761631343755,0.00125033816889727,0.147852323647634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,22978,-0.00304267304822476,0.00210430257124527,-0.0071671060878655,0.00108175999141598,0.148210639396088
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,23056,0.00829742520965001,0.00573984319138346,-0.00295266744546157,0.0195475178647616,0.148307530307219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,23846,-0.00259533463709342,0.00179626610547824,-0.00611601620383078,0.000925346929643942,0.148513240379468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,22978,-0.00622869953145324,0.00431366736739583,-0.0146834875715491,0.00222608850864259,0.148768017199793
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,23198,-0.00322999679777705,0.00223917199388961,-0.00761877390580069,0.0011587803102466,0.149175988993914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,27702,0.00440430732376411,0.00305528233173028,-0.00158404604642724,0.0103926606939555,0.149443898489152
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,28195,0.00226985146899454,0.00157476720464731,-0.000816692252114195,0.00535639519010328,0.149486045404507
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,27965,-0.00226712589812155,0.0015755212221048,-0.00535514749344696,0.000820895697203867,0.150170557567943
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,27520,0.00842029064781385,0.00586353671058917,-0.00307224130494092,0.0199128226005686,0.151001487923724
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,23056,-0.00743946760431455,0.0051846228762608,-0.0176013284417857,0.00272239323315662,0.151326296502795
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23331,-0.00621407865032257,0.0043306774852036,-0.0147022065213216,0.00227404922067649,0.151329697235871
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,28224,0.00274880889328483,0.00191640666065029,-0.00100734816158974,0.00650496594815939,0.15148185611603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,23056,0.00720055389725003,0.00504096815040275,-0.00267974367753937,0.0170808514720394,0.153188316628276
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,23071,-0.00482464559149016,0.00338020498244508,-0.0114498473570825,0.00180055617410219,0.153500247607541
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,23240,0.00411998325176894,0.0028906260851049,-0.00154564387503666,0.00978561037857454,0.154086547699821
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,22978,-0.00539101525067676,0.00378840190530021,-0.0128162829850652,0.00203425248371164,0.154740608067652
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,22978,-0.00250295808594858,0.0017600474084428,-0.00595265100649647,0.00094673483459931,0.155011684086183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,23188,0.00830838683071029,0.00584533095724287,-0.00314846184548575,0.0197652355069063,0.155222243758802
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,28320,0.00270874251325315,0.00190659354035412,-0.00102818082584092,0.00644566585234723,0.155408132581045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,23075,0.0039758903223382,0.00279925920330444,-0.0015106577161385,0.0094624383608149,0.155523227540722
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23188,0.00468685311088437,0.00330994546069941,-0.00180063999208647,0.0111743462138552,0.156791568146698
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,23163,-0.00462761069492385,0.0032739304871822,-0.011044514449801,0.00178929305995326,0.157530289525357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,23393,0.00506805226321652,0.00359445889943701,-0.00197708717968002,0.0121131917061131,0.158564058493922
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,27651,-0.00390183116098616,0.0027787410844654,-0.00934816368653834,0.00154450136456601,0.160278796091713
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,22936,0.00826384164328954,0.00592405115364168,-0.00334729861784815,0.0198749819044272,0.163040031326671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,27562,0.00556668032014979,0.0039914331003176,-0.00225652855647271,0.0133898891967723,0.163130527547574
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,28320,-0.00269305926826402,0.00193140173905783,-0.00647860667681737,0.00109248814028933,0.163221436503487
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,23188,-0.00320994518968472,0.00230349440644784,-0.00772479422632248,0.00130490384695304,0.163478633075579
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,28113,-0.00644129960282984,0.00462431663686904,-0.0155049602110932,0.00262236100543347,0.163655234319777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,23319,-0.00306550857805347,0.00220236252438507,-0.00738213912584821,0.00125112196974126,0.163960439594837
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,23163,0.00545174290582159,0.00392258985973252,-0.00223653321925415,0.0131400190308973,0.164593108838916
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,27702,0.00406579808071908,0.00292730129719168,-0.00167171246177661,0.00980330862321477,0.164867131087375
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,22978,0.00683056458633565,0.0049193205091978,-0.00281130361169205,0.0164724327843633,0.164992865387984
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,28176,0.00469215358687491,0.00339202385041933,-0.00195621315994698,0.0113405203336968,0.166586845900709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,23725,0.00264717760929649,0.0019140553916941,-0.00110437095842394,0.00639872617701692,0.166671640891994
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,22978,0.00818978180106545,0.00592623554233451,-0.00342563986191019,0.0198052034640411,0.166999429363977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,23846,-0.00275582906430001,0.00200138947669529,-0.00667855243862277,0.00116689431002275,0.168538195995824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,23071,0.00313063423027794,0.00229253778002906,-0.00136273981857902,0.0076240082791349,0.17208545179607
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,23337,0.00317045146266907,0.00232503733660851,-0.00138662171708361,0.00772752464242175,0.172702515470744
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,28224,0.00312571958046955,0.00229535025733636,-0.00137316692390972,0.00762460608484882,0.173284043950785
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,23775,0.00633408811097373,0.00465704212425789,-0.00279371445257173,0.0154618906745192,0.173808119422476
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28553,0.00641861549793685,0.00472735576188318,-0.00284700179535418,0.0156842327912279,0.174550523146411
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,28521,0.00311242895798854,0.00229413956163369,-0.0013840845828135,0.00760894249879058,0.174891478128349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,23056,-0.00864058311626941,0.006377768428819,-0.0211410092367547,0.00385984300421583,0.175495446350714
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,23775,0.00204529088220066,0.00150997579802357,-0.000914261681925534,0.00500484344632685,0.175583740890965
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,27562,0.00503215234172366,0.0037368815896045,-0.00229213557390116,0.0123564402573485,0.178114344202816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,23188,-0.00379445742656768,0.00281947725143115,-0.00932063283937273,0.00173171798623737,0.178379625975552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23337,-0.00341917182491144,0.00254444376887252,-0.00840628161190158,0.00156793796207871,0.179032715715317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,27623,0.0066362069247795,0.00494138455056806,-0.00304890679433389,0.0163213206438929,0.179287766400388
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,27965,-0.00459785172296514,0.00342375098452535,-0.0113084036526348,0.00211270020670455,0.179306130982614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27682,-0.00318831156403637,0.00238288053320403,-0.00785875740911628,0.00148213428104353,0.180905051418405
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,23795,0.00248660966844556,0.00185917575777054,-0.0011573748167847,0.00613059415367581,0.181078924676176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,22978,-0.00401631692882088,0.00300922649794533,-0.00991440086479372,0.00188176700715196,0.181998414292005
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,23188,0.00561425581805626,0.00421481071095985,-0.00264677317542505,0.0138752848115376,0.182863312714016
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,27442,-0.00810621120922165,0.00608649448049447,-0.0200357403909908,0.00382331797254751,0.182925220152651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,28390,0.00571637716442756,0.00429718809315194,-0.00270611149815026,0.0141388658270054,0.183443332953395
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,23795,0.00420029285750627,0.003161948943665,-0.00199712707207713,0.0103977127870897,0.184062936340225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",23795,0.00328225351338187,0.00247185088889999,-0.00156257422886211,0.00812708125562584,0.184239566571773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,23056,0.00866455636479461,0.00655919981987074,-0.00419147528215203,0.0215205880117413,0.186521934654494
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,23071,0.00401098761501188,0.00303820266417028,-0.00194388960676187,0.00996586483678562,0.186786580613417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,27562,0.00561375844482903,0.0042551272944218,-0.00272629105223771,0.0139538079418958,0.187082237098446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,23775,0.0116348141670959,0.00881916414753067,-0.00565074756206426,0.028920375896256,0.187093262960404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,27702,0.00424257031385833,0.00321593924702414,-0.00206067061030898,0.0105458112380256,0.18710243632097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,27682,0.00432410837804041,0.0032925268799802,-0.00212924430672077,0.0107774610628016,0.189089411284682
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,22978,-0.00711102507627138,0.00541871653876848,-0.0177317094922576,0.00350965933971484,0.189429349608078
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27682,0.00272726300749743,0.0020813495822275,-0.00135218217366848,0.00680670818866334,0.190093766623288
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23071,-0.00589641864664546,0.00452245320742455,-0.0147604269331976,0.00296758963990666,0.192311469677125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27544,0.00595497629808029,0.00459854683639184,-0.00305817550124771,0.0149681280974083,0.195341731065118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,23071,0.00969022777640219,0.00748800249293291,-0.00498625710974631,0.0243667126625507,0.195643670205346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,26907,0.00245204731440711,0.00189508705812827,-0.00126232331952429,0.00616641794833852,0.19571213909095
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23163,0.00333495939148951,0.00257915988747392,-0.00172019398795938,0.0083901127709384,0.196009795002746
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,23140,0.00508995604702601,0.00393707323135389,-0.00262670748642761,0.0128066195804796,0.196083686086741
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,22978,-0.00263721908211509,0.00204880429967934,-0.0066528755094866,0.00137843734525641,0.198037869057369
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,23071,0.00421724513464584,0.00327903476456962,-0.00220966300391062,0.0106441532732023,0.198412722608323
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,23862,-0.00381212128955561,0.00296424599624444,-0.00962204344219472,0.00199780086308349,0.198443663820253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,28471,0.005974889606577,0.00464911971912817,-0.00313738504291421,0.0150871642560682,0.198744815668126
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,22978,-0.00296495588320674,0.00230799134885197,-0.0074886189269566,0.00155870716054312,0.198928364352773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,23393,-0.00389715136994782,0.00303533501823976,-0.00984640800569775,0.00205210526580212,0.199179901857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,28187,-0.00461222197133335,0.00359453816234003,-0.0116575167695198,0.00243307282685311,0.199460771652783
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,22043,-0.00461954511830342,0.00360269617430612,-0.0116808296199434,0.00244173938333659,0.199769627783868
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,23393,-0.00297003965383893,0.00232563742593081,-0.00752828900866331,0.00158820970098546,0.201584470460698
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,23071,-0.00519180585056499,0.00407753017785303,-0.0131837649991569,0.00280015329802694,0.2029343020629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22978,0.00498520097604525,0.00392150984345429,-0.00270095831712517,0.0126713602692157,0.203654269749894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,23071,-0.00432584949552338,0.00341003559568928,-0.0110095192630744,0.0023578202720276,0.204609303038857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,27682,0.00488915568135542,0.00385936982426546,-0.00267520917420488,0.0124535205369157,0.205227653880588
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,22978,-0.00316766566663199,0.00250446413487252,-0.00807641537098212,0.00174108403771815,0.205953085002679
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,27544,0.00328294115484931,0.00260555854350417,-0.00182395359041887,0.00838983590011749,0.207688711227988
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,23071,0.00285291612684491,0.00226537319643117,-0.00158721533816017,0.00729304759185,0.207913758026514
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,28224,-0.00259887134960166,0.00208236704973715,-0.00668031076708646,0.00148256806788314,0.212027826971333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,22978,-0.00310561215589026,0.00249709681730402,-0.00799992191780615,0.00178869760602562,0.213626695539877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,23163,-0.00572626924958125,0.00461951897564803,-0.0147805264418514,0.00332798794268888,0.215142874027971
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23188,-0.00372620433650888,0.00300748744110915,-0.00962087972108281,0.00216847104806505,0.215366986804044
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,23071,-0.00402369151999818,0.00324816925658706,-0.0103901032629088,0.00234272022291246,0.215448214044404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,23056,-0.00288283604102006,0.00232748828767638,-0.00744471308486576,0.00167904100282564,0.215504845550232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,28494,-0.00384280193528314,0.00310686567447816,-0.00993225865726034,0.00224665478669405,0.216143995795474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,23337,-0.002385869123578,0.00193373598390775,-0.00617599165203718,0.00140425340488119,0.217284925247878
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,23393,-0.00333030945313031,0.00270681321433718,-0.00863566335323119,0.00197504444697056,0.218580962155354
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,23056,-0.00288977285533097,0.00234962604716217,-0.00749503990776884,0.00171549419710689,0.218752246959899
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,27702,0.00508836434255135,0.00414143952041431,-0.00302885711746069,0.0132055858025634,0.219214890873196
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,23163,0.0039050079072255,0.00318652720885933,-0.00234058542213878,0.0101506012365898,0.220408951728015
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",28091,-0.00349983614912945,0.00285787915615363,-0.00910127929519057,0.00210160699693167,0.220726041989754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,23188,-0.00454936675934035,0.0037377396404755,-0.0118753364546723,0.00277660293599164,0.223561889679345
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22978,0.00218105462825092,0.00179288091882024,-0.00133299197263674,0.00569510122913859,0.223803831116742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,23775,0.00506073505032876,0.00416361181763205,-0.00309994411223006,0.0132214142128876,0.224199894831784
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,23056,-0.00309649042999574,0.00254965160965603,-0.00809380758492155,0.00190082672493007,0.224578493784935
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,23163,-0.00238827938281588,0.00197122181649873,-0.00625187414315339,0.00147531537752163,0.225688193136521
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,23056,-0.00696135477876499,0.00574769768084877,-0.0182268422332286,0.00430413267569861,0.225848294108663
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,23163,0.00495249026681218,0.00409307497056069,-0.00306993667548678,0.0129749172091111,0.226303477698305
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,23188,-0.00740540286269431,0.00612226173163542,-0.0194050358566997,0.00459423013131112,0.226450082876657
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,28091,0.003685036005263,0.00304976166850824,-0.00229249686501316,0.00966256887553915,0.22694093270705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,27872,0.0020761641720118,0.00172595741632237,-0.00130671236398005,0.00545904070800365,0.229023001962062
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27682,0.00259463674971254,0.00215931996178465,-0.00163763037538537,0.00682690387481045,0.229529206412207
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,23071,0.00678369089894813,0.00565232287532988,-0.00429486193669845,0.0178622437345947,0.230089601165594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23198,0.00301107095280092,0.00251239110508174,-0.0019132156131593,0.00793535751876114,0.230739286494368
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,23725,0.00785769987910732,0.00656889435637148,-0.00501733305938077,0.0207327328175954,0.231631168201235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,23198,-0.00201202931643757,0.0016848911821095,-0.00531441603337218,0.00129035740049704,0.232427682601117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,23846,-0.00850501075627301,0.00713864864928368,-0.022496762108869,0.00548674059632301,0.233507097029401
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,22594,-0.00562890203034855,0.00473078982531946,-0.0149012500879747,0.00364344602727759,0.234120210676176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,23163,-0.00305180306642427,0.00256808136475527,-0.0080852425413446,0.00198163640849605,0.234704122323408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23188,-0.00353345911996119,0.00297596474592063,-0.00936635002196564,0.00229943178204325,0.235108735351976
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,23071,-0.00538311254361794,0.00454150252736579,-0.0142844574972549,0.00351823241001901,0.23590501257824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,28092,0.00869229661884948,0.00733742587630409,-0.00568905809870653,0.0230736513364055,0.236165074874756
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,23725,-0.00363121814227405,0.00307072245225507,-0.00964983414869399,0.0023873978641459,0.237007750301033
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23056,-0.0047647046646999,0.00403302060179136,-0.012669425044211,0.00314001571481116,0.237446784266965
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,23071,-0.00406220617148317,0.00345415401124169,-0.0108323480335169,0.00270793569055054,0.2395930140694
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,23188,0.00233649646532609,0.00198724475229466,-0.00155850324917144,0.00623149617982363,0.23970818852705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,23766,0.00203665331340606,0.00174129707018946,-0.00137628894416528,0.0054495955709774,0.242166255002531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,28091,-0.00159324294636624,0.00136259211894472,-0.00426392349949789,0.00107743760676542,0.242303356088362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,27544,0.003159665130153,0.00270253922098994,-0.00213731174298727,0.00845664200329328,0.24235460663914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,28091,-0.00671892492696187,0.00579306594525855,-0.0180733341796686,0.00463548432574488,0.246131175960559
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,28091,-0.00261087528604153,0.00226471753615023,-0.00704972165689598,0.00182797108481291,0.248982556418495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,23393,-0.00341354904765899,0.00296275750259769,-0.00922055375275046,0.00239345565743248,0.249270112828661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,22978,-0.00325852997790412,0.00282868019322202,-0.00880274315661929,0.00228568320081104,0.249348988499604
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,23029,-0.00268163757695134,0.00232798871237485,-0.00724449545320605,0.00188122029930336,0.249369300310018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,23163,0.00493155192178246,0.00428211607676925,-0.00346139558868527,0.0133244994322502,0.249471737826941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,23071,-0.00402638455854453,0.00349715193517374,-0.0108808023514851,0.00282803323439599,0.2496074246385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,23393,0.00580069139313373,0.00504987907677121,-0.00409707159733785,0.0156984543836053,0.250700010502641
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,23163,-0.00283040027953261,0.0024758909173748,-0.00768314647758723,0.002022345918522,0.252973791883448
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,27544,-0.00252240025016663,0.00220658018547251,-0.00684729741369275,0.00180249691335948,0.252996020078727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,27489,0.00511569002759819,0.0044776455999942,-0.00366049534839044,0.0138918754035868,0.253258063985453
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,23393,0.00581891372268277,0.00509871668781843,-0.00417457098544136,0.0158123984308069,0.253777322704828
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,27544,0.00442728818640459,0.00388233491571254,-0.00318208824839199,0.0120366646212012,0.254143187870414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,23738,0.00469783282346451,0.0041238334772178,-0.00338488079188237,0.0127805464388114,0.254635118055257
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,27702,0.00404131892920165,0.00355432786293784,-0.00292516368215651,0.0110078015405598,0.255542462517466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,28198,-0.00488803833926603,0.0043039095505098,-0.0133237010582652,0.00354762437973317,0.25608321250594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,23071,-0.00482002272311573,0.00424665305680225,-0.0131434627144481,0.00350341726821667,0.256380062405206
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,23738,0.00551584785951629,0.00487150493696691,-0.00403230181693886,0.0150639975359714,0.257533334463862
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,23393,-0.00458974141378848,0.00406257725713464,-0.0125523928377724,0.0033729100101954,0.25858852953506
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,23071,-0.00239429361043548,0.00212452445139098,-0.0065583615351618,0.00176977431429085,0.259763253615791
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,23163,0.00523523365090371,0.00464553649186948,-0.00387001787316047,0.0143404851749679,0.259780190441049
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,27682,-0.00542312239934567,0.00482280282745731,-0.014875815941162,0.00402957114247065,0.260821221102451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27965,-0.00539479543687742,0.00480264067016445,-0.0148079711503997,0.00401838027664489,0.261320708905609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,23846,-0.00199295920115871,0.00177444376620018,-0.00547086898291105,0.00148495058059364,0.261386858295907
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,23056,-0.00555671194793989,0.00496674466237823,-0.0152915314862012,0.00417810759032143,0.26324417796161
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,22978,-0.00313311318614201,0.00280803429855535,-0.00863686041131049,0.00237063403902648,0.264533378121243
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,23862,0.00247937507629907,0.0022225860684358,-0.0018768936178351,0.00683564377043324,0.264631982447973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,22978,0.00275777917843859,0.00247445450002494,-0.00209215164161029,0.00760770999848747,0.265076471052702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23056,-0.00343246592481174,0.00309455042792319,-0.00949778476354119,0.00263285291391771,0.267356800412819
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,28091,-0.00409632490883367,0.00369693561502944,-0.0113423187142914,0.00314966889662402,0.267857260603488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,23725,-0.00330060873421539,0.00298284727545095,-0.00914698939409926,0.00254577192566848,0.268508595472258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,28307,0.0059124557879017,0.00535984582862964,-0.0045928420362124,0.0164177536120158,0.269992324914555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,23163,0.00337341539231246,0.00306702613547838,-0.00263795583322517,0.00938478661785009,0.271388077955914
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,23775,0.00697405717190117,0.0063861448850663,-0.00554278680282879,0.0194909011466311,0.274817541341705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,22978,0.00437330465232755,0.00400768868921136,-0.00348176517852671,0.0122283744831818,0.275183740440877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,23071,-0.00336326763644134,0.00308905980229527,-0.00941782484894006,0.00269128957605738,0.276267846886294
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,28204,-0.00425703879043317,0.00391866758480043,-0.011937627256642,0.00342354967577567,0.277334110571489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27544,0.00348001146114759,0.0032087452783264,-0.00280912928437216,0.00976915220666733,0.278135096874477
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,23795,-0.00329129080653195,0.00303721336715926,-0.00924422900616411,0.00266164739310021,0.278528875556742
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,23071,0.00313887628806355,0.00289693357693965,-0.00253911352273816,0.00881686609886526,0.278590414587474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,23872,0.00233137435509589,0.00215421713335302,-0.00189089122627604,0.00655363993646781,0.279157990812653
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,23393,-0.00632718096870849,0.00584960306214946,-0.0177924029705214,0.00513804103310445,0.279422440382995
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,27965,0.0018657999630159,0.00173527052043435,-0.00153533025703543,0.00526693018306724,0.282284906825615
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22936,0.00380388366486359,0.00354037656646632,-0.0031352544054104,0.0107430217351376,0.282641708391827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,23198,0.00628606944339649,0.00585172819034893,-0.00518331780968741,0.0177554566964804,0.282733280609021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",22978,0.00673128193813742,0.00627386152632577,-0.00556548665346109,0.0190280505297359,0.283323261871219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,22978,0.00390439318736556,0.00364986723539831,-0.00324934659401512,0.0110581329687462,0.284749547541558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,23056,-0.00455893419710829,0.0042640132375415,-0.0129164001426896,0.00379853174847305,0.285006475651335
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,27600,0.00352523467082764,0.00329996751745156,-0.00294270166337743,0.0099931710050327,0.28541104048974
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,23056,-0.00356916446893526,0.00334578140558338,-0.0101268960238787,0.00298856708600817,0.286088878199449
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,23188,0.00293353081848917,0.00275639232580074,-0.00246899814008028,0.00833605977705863,0.287219931769503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,23163,-0.00298610927109384,0.00280607599995614,-0.00848601823100787,0.00251379968882018,0.28726806075861
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27281,-0.00613511397336835,0.00577702310377327,-0.017458079256764,0.00518785131002726,0.288251736089718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,22978,-0.00229017174492897,0.00216194910359413,-0.00652759198797346,0.00194724849811551,0.289470303098602
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23056,0.00389865751148331,0.00368270499637798,-0.00331944428141753,0.0111167593043841,0.28977502177964
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27544,0.00559979276020165,0.00529177039555757,-0.00477207721509119,0.0159716627354945,0.289969996367893
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,23056,-0.00529838683119496,0.00501422061990746,-0.0151262592462136,0.00452948558382367,0.290672358887389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28277,0.00362672983897203,0.00344298812528545,-0.00312152688658747,0.0103749865645315,0.292181858759001
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,28033,0.00428054185238293,0.00407333351016238,-0.00370319182753534,0.0122642755323012,0.293327604353426
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,23725,0.00298662408175066,0.00284653439080656,-0.0025925833242302,0.00856583148773152,0.294090274388075
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,23163,0.00359859867353116,0.00343382713243417,-0.00313170250603981,0.0103288998531021,0.294656547019342
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,27544,0.0021141746295033,0.00201936894129696,-0.00184378849543873,0.00607213775444533,0.295132672404338
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,23393,-0.00203491984309614,0.00194393271886609,-0.00584502797207368,0.0017751882858814,0.295200024899826
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,28336,0.00327769702151936,0.00313873462755095,-0.0028742228484805,0.00942961689151921,0.296367837663314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,23188,0.00212071986755078,0.0020356856064737,-0.00186922392113768,0.00611066365623923,0.29752835720967
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,23163,-0.00255703910142983,0.00246762941299116,-0.0073935927508925,0.00227951454803284,0.300104265423114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23163,-0.0039084353155589,0.00377200318882676,-0.0113015615656594,0.00348469093454155,0.300133815375696
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,23795,-0.0110526706468445,0.010712177524137,-0.032048538594153,0.00994319730046406,0.302183053659125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,23056,0.00243238376364984,0.00235961552237382,-0.00219246266020285,0.00705723018750252,0.302627134311619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23198,-0.00280301910241232,0.0027211035158392,-0.00813638199345715,0.00253034378863251,0.302972022460609
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,23795,0.00526144681415906,0.00512349130634031,-0.00478059614626795,0.0153034897745861,0.304465720381483
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23056,-0.0022175487481622,0.00216263212774502,-0.00645630771854244,0.00202121022221805,0.305188357206996
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,23188,0.00704781507762606,0.00688494460084975,-0.00644667634003946,0.0205423064952916,0.30600845447503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,23775,0.00265088853298649,0.00259058660621242,-0.00242666121518985,0.00772843828116283,0.306187159161188
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,23725,0.00385645699262807,0.00376988110457338,-0.00353250997233576,0.0112454239575919,0.306334759729382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,23198,0.00393783480943355,0.00386573050414475,-0.00363899697869016,0.0115146665975573,0.308378751685462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,23188,0.00726133440674195,0.00716096557472358,-0.00677415811971627,0.0212968269332002,0.310585655140859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,22940,-0.00334134776214079,0.00329609800781225,-0.0098016998574528,0.00311900433317122,0.310723124375179
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,28452,0.00201522425710215,0.00199130748526551,-0.00188773841401826,0.00591818692822255,0.311541601638439
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,23071,0.00322630487265783,0.00319361943834847,-0.00303318922650517,0.00948579897182083,0.312393504655002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,23188,0.00249177286077542,0.00246825089461389,-0.00234599889266781,0.00732954461421865,0.312731152181255
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,27702,0.0029277947914429,0.00290765765123317,-0.00277121420497412,0.00862680378785992,0.313979350247777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,22978,-0.00177630644073517,0.00176695135718725,-0.00523953110082218,0.00168691821935184,0.314765666179392
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,23163,-0.0025092680237861,0.00249902344667498,-0.00740735397926907,0.00238881793169686,0.315341184507209
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,27702,0.00440133360190899,0.00439746240984402,-0.00421769272138529,0.0130203599252033,0.316893416872601
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,23775,0.00457737125168267,0.00458021221747942,-0.00439984469457699,0.0135545871979423,0.317620952161529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,27702,0.00621035885525305,0.00621435837063513,-0.0059697835511918,0.0183905012616979,0.317630802736433
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,27411,0.00452096305127398,0.00452533076161783,-0.00434868524149696,0.0133906113440449,0.317786642109316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,22978,-0.00457973576727926,0.00458488390742061,-0.0135661082258237,0.00440663669126514,0.317864731943034
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,23393,0.00390996169950174,0.00392467722051084,-0.00378240565269951,0.011602329051703,0.319138752093021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,22878,-0.00295430708260639,0.00296956584346529,-0.00877465613579836,0.00286604197058558,0.319814100560573
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,27969,-0.00485092370352214,0.00488834939264668,-0.0144320885131096,0.00473024110606535,0.321038384036572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,23725,0.00583374827732342,0.00588691330581125,-0.00570460180206663,0.0173720983567135,0.321710856102017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,23775,0.00212124968401284,0.00215246195230493,-0.00209757574250483,0.00634007511053051,0.324388924232349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,27702,0.00434078589840697,0.00440611206085057,-0.00429519374086015,0.0129767655376741,0.324547345714768
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23056,-0.00362753375664458,0.00369076435040561,-0.0108614318834396,0.00360636437015042,0.32568278463561
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,23071,-0.00651491545075342,0.00664326221120421,-0.0195357093847137,0.00650587848320682,0.326760780164805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,28184,-0.00208991745834078,0.00213295521926008,-0.00627050968809053,0.00209067477140897,0.327182171401474
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23071,0.00339857936030452,0.00347437199689785,-0.00341118975361526,0.0102083484742243,0.327992984633941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,23738,0.00464823625645363,0.00476062866820586,-0.00468259593322986,0.0139790684461371,0.32888056332621
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,22936,-0.00522697157762452,0.00538944779868387,-0.0157902892630449,0.00533634610779585,0.332130053383489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,23163,-0.00271531732692912,0.00280266253196921,-0.00820853588958878,0.00277790123573054,0.332637683137018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,28143,0.00167948666036512,0.00174686887653929,-0.0017443763376519,0.00510334965838213,0.336345848077519
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,27965,-0.000790627141470561,0.000822426667545243,-0.00240258340985924,0.000821329126918116,0.336392314974544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,23056,0.00485545283606563,0.00507306335212687,-0.00508775133410303,0.0147986570062343,0.33852444740611
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,28091,0.00232665241999783,0.00243191550638862,-0.00243990197252387,0.00709320681251952,0.338718869024443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,23198,-0.00116370774102566,0.00121712335920867,-0.00354926952507467,0.00122185404302334,0.339025002954735
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,23188,0.00303614989318914,0.00317831368998182,-0.00319334493917522,0.00926564472555351,0.339450793100941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,23261,0.00536899335152595,0.0056806972168755,-0.00576517319355003,0.0165031598966019,0.344602694259099
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,22978,0.00548875072507012,0.00586817052079614,-0.00601286349569031,0.0169903649458305,0.349621528459256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,23071,0.00252207837848833,0.00270378111667776,-0.00277733261020008,0.00782148936717674,0.350934660344682
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,22978,0.00393827281610316,0.00422787216079388,-0.00434835661905284,0.0122249022512592,0.351603566757304
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,28176,0.00352367855598523,0.00378302263170958,-0.00389104580216555,0.010938402914136,0.351631264871106
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,23198,0.00254165023167937,0.00274123156667636,-0.00283116363900629,0.00791446410236504,0.353836081119973
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,28097,0.00192377308230314,0.00208154805874905,-0.002156061112845,0.00600360727745127,0.355388544417543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,23071,0.00203490569612079,0.00220180634432643,-0.002280634738759,0.00635044613100058,0.355392748632242
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,27702,0.00337728880454436,0.00365654912929031,-0.00378954748886465,0.0105441250979534,0.355688414679434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,23071,0.00286944669670537,0.00310759283318623,-0.00322143525633964,0.00896032864975038,0.35582597648872
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,23725,0.00325101280821528,0.00352158000316581,-0.00365128399798972,0.0101533096144203,0.355928635835475
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,22978,-0.00295327057434348,0.00320075885784957,-0.00922675793572864,0.00332021678704168,0.356184598768902
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27562,-0.00272398949312624,0.00296695948163945,-0.00853923007713956,0.00309125109088709,0.358570319602192
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23163,-0.00483378137571089,0.00527046870008203,-0.0151639000278717,0.0054963372764499,0.359076480234191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",23795,-0.00260884839284023,0.00284686475469571,-0.00818870331204383,0.00297100652636336,0.359469829243896
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,23163,-0.00222366618951706,0.00242827615288374,-0.00698308744916919,0.00253575507013508,0.359813556571107
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,23846,-0.00187812277334732,0.00205666489515404,-0.00590918596784924,0.00215294042115461,0.361152638104269
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,23056,-0.00400603571288317,0.00438879338893752,-0.0126080707552007,0.00459599932943436,0.361363867772138
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,28176,0.00432116213702283,0.00473542925027407,-0.00496027919351434,0.01360260346756,0.361504164429553
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,22978,0.00207447663229927,0.00227661027973568,-0.00238767951598266,0.00653663278058119,0.362192778393235
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,28452,0.00129825068273973,0.00143372355463948,-0.00151184748435364,0.00410834884983311,0.365203059125005
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,27702,0.00464946679728382,0.00515488210592216,-0.00545410213032363,0.0147530357248913,0.367089122792843
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,28415,0.00567879854415559,0.00630669197576243,-0.00668231772833877,0.01803991481665,0.367893707675708
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,23163,-0.00139803753418491,0.00155696341804352,-0.0044496858335502,0.00165361076518038,0.369234477930911
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,23071,-0.00250526775398112,0.00280151708697674,-0.00799624124445553,0.00298570573649329,0.371195360565079
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",23163,0.00510871667163688,0.00572044056376673,-0.0061033468333459,0.0163207801766197,0.371832451755379
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,23163,0.00304021674952111,0.00340816612788275,-0.00363978886112907,0.00972022236017129,0.37238135673316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23071,0.00156039703580674,0.00175094049375896,-0.00187144633196083,0.00499224040357431,0.372843784233547
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,22978,0.00246829113454359,0.00277791118068719,-0.0029764147796033,0.00791299704869049,0.374258507654987
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,27562,0.00434650820824004,0.00491362883234222,-0.00528420430315071,0.0139772207196308,0.376389774079754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,23216,-0.00166598725240552,0.00188368052322598,-0.00535800107792844,0.00202602657311739,0.376472242754809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,23198,-0.00364744591358424,0.004137496164471,-0.0117569383959474,0.00446204656877892,0.3780246138648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,23188,-0.00192954080602321,0.00219205108825898,-0.00622596093901081,0.00236687932696438,0.378736026186977
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,27176,-0.00379404458249424,0.00432305855876467,-0.012267239357673,0.00467915019268451,0.380152469167824
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,23188,-0.00517792882275266,0.00590975390709383,-0.0167610464806566,0.00640518883515124,0.380948567812177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,22978,-0.00465609379751714,0.00532297783084156,-0.0150891303459666,0.00577694275093232,0.381737608195549
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,23393,0.00244372183933096,0.00280977319314825,-0.00306343361923961,0.00795087729790152,0.384461221381769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,23056,-0.00177925779294057,0.00204895080411426,-0.00579520136900452,0.00223668578312339,0.385198083388945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,28224,0.00249032886861922,0.00287133014688278,-0.00313747821927103,0.00811813595650946,0.385780411088332
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,23188,-0.00606161252413445,0.00699511623713417,-0.0197720403489174,0.00764881530064853,0.386198018185118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,23738,-0.00295156202533495,0.00340995948104415,-0.00963508260818148,0.00373195855751157,0.386734219382472
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,22978,-0.00248020108343178,0.00286802090140906,-0.00810152205019354,0.00314111988332998,0.387169738206286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,23163,0.00212565329050977,0.00245870234672455,-0.00269340330907035,0.0069447098900899,0.387298764507778
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,23775,0.00227054637219159,0.00264622913753761,-0.00291606273738212,0.00745715548176531,0.390884055058644
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23071,0.00493451106792774,0.00577574027246506,-0.00638593986610378,0.0162549620019593,0.392919260911438
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,28553,0.00183194411167873,0.00214658636886641,-0.00237536517129944,0.00603925339465689,0.393432467745573
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,27544,-0.0037682945990793,0.00441810732115427,-0.0124277849485417,0.00489119575038307,0.393710775968911
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,23893,0.00107912970098009,0.00126536884772099,-0.00140099324055305,0.00355925264251323,0.393768631445743
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,23795,0.00437734237222319,0.00517187643467822,-0.00575953543974611,0.0145142201841925,0.397352586994715
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,23188,0.0024715124756796,0.00292116998134219,-0.00325398068775109,0.00819700563911029,0.397522777074041
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,23795,-0.00292596529073569,0.00348131201625857,-0.00974933684260249,0.00389740626113112,0.400649021789703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,23725,0.00239141962436055,0.00284575485907183,-0.00318625989942023,0.00796909914814133,0.400722710778174
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,23056,0.00278812812962029,0.00332807096747754,-0.00373489096663569,0.00931114722587627,0.402173624327591
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,22978,-0.00391755896749671,0.00469898369694136,-0.0131275670135018,0.00529244907850835,0.404456779313277
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,23862,-0.00167873138120438,0.00201475998074118,-0.00562766094345708,0.00227019818104833,0.404730949069471
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23056,0.00180623876792295,0.00217870992421825,-0.00246403268354482,0.00607651021939072,0.407090077319643
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,27702,0.00218161543515878,0.00263213715845213,-0.0029773733954074,0.00734060426572497,0.407203197717385
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,23071,-0.00266512415876846,0.00321733388146775,-0.00897109856644525,0.00364085024890832,0.407472857366522
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,23862,-0.00186340749472518,0.00225220413670256,-0.0062777276026622,0.00255091261321184,0.408035316017263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,28176,0.00435024365511248,0.00526480338780346,-0.00596877098498231,0.0146692582952073,0.408647761424422
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,27562,0.00296226577292655,0.00358777460477704,-0.00406977245243645,0.00999430399828955,0.409006702108961
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,23056,-0.00230233922058443,0.0027972564884527,-0.00778496193795174,0.00318028349678287,0.410476436802117
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,27702,0.00166852968291214,0.00202757410451374,-0.00230551556193478,0.00564257492775907,0.410561024233562
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27562,0.00696328826411622,0.00846282480703738,-0.00962384835767704,0.0235504248859095,0.410623750230738
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,23725,-0.0062028663836509,0.00755174015133385,-0.0210042770802652,0.00859854431296344,0.41143674881508
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,23071,-0.00281436208664206,0.00343452140441301,-0.00954602403929156,0.00391729986600744,0.412547566475273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23393,-0.00273573241296282,0.00334527554031018,-0.00929247247197078,0.00382100764604514,0.413485523797043
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,23163,0.00269130995870644,0.00330064891368188,-0.00377796191211005,0.00916058182952293,0.414858563412405
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,22978,-0.00193297432753166,0.0023742971411263,-0.0065865967241392,0.00272064806907589,0.415581867349125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,23071,0.0053787095318168,0.00669926991548074,-0.00775185950252545,0.0185092785661591,0.422052398446162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23071,-0.00219924113780495,0.00274885582651976,-0.00758699855778368,0.00318851628217377,0.423686059636604
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23163,0.00266740898701959,0.00334374569884619,-0.00388633258271894,0.00922115055675811,0.425034899284494
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23056,0.00176615475584911,0.002224306899961,-0.00259348676807444,0.00612579627977266,0.427189193379692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,22978,-0.00221133629970593,0.00278724578671843,-0.00767433804167405,0.00325166544226218,0.427566487904105
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,23549,-0.0057958471161869,0.00730955873301776,-0.0201225822329017,0.0085308880005279,0.427836268723633
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,27562,-0.00314535976266755,0.00397608523102819,-0.0109384868154828,0.0046477672901477,0.428910245595324
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,28091,-0.00238863571341963,0.0030340885201531,-0.00833544921291972,0.00355817778608045,0.431132624798538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,23056,-0.00410250378628048,0.0052163894338598,-0.0143266270766457,0.00612161950408474,0.431603645330198
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,23071,0.00268551417583106,0.00342554358662909,-0.00402855125396196,0.00939957960562409,0.433067348075617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,23056,0.00574294074915717,0.00733235212828913,-0.00862846942228952,0.0201143509206039,0.433498301892299
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,23188,0.00239113269043692,0.00306077176971986,-0.00360797997821402,0.00839024535908785,0.434681752415817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",23071,-0.00206393436922843,0.00264730737576594,-0.00725265682572968,0.00312478808727283,0.43561355429826
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,27562,0.00543147981950461,0.00697875526699331,-0.00824688050380228,0.0191098401428115,0.436406072865608
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,27544,0.00247268988300944,0.00319662522700982,-0.0037926955619298,0.00873807532794867,0.439214614206461
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27881,-0.00212536823371628,0.00275757474365387,-0.00753021473127786,0.0032794782638453,0.440868650472111
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23071,0.00225214070830699,0.00293359415981266,-0.00349770384492582,0.00800198526153981,0.442669151009397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,27965,0.00269565989259704,0.00351368216147947,-0.00419115714390273,0.00958247692909681,0.442975363387215
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",23198,-0.00438599316017424,0.00574710138657841,-0.0156503118778679,0.00687832555751944,0.445372086927362
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,27702,0.00305226040638653,0.00400660098697957,-0.00480067752809342,0.0109051983408665,0.44618113524226
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,27965,0.00173101955580197,0.00227731395752614,-0.00273251580094926,0.00619455491255319,0.447192505958087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,23188,0.00145251147344669,0.0019177163364162,-0.00230621254592907,0.00521123549282245,0.448807613481612
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,23337,0.00164819498906491,0.00217704049407138,-0.00261880437931499,0.00591519435744482,0.449009260922748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,23862,0.00118647610337081,0.00156969404916838,-0.00189012423299921,0.00426307643974082,0.449737869407139
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,27562,-0.00388163224439993,0.0051471169300431,-0.0139699814272844,0.00620671693848455,0.450773300309233
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,23795,0.00187903065527521,0.00252165077321658,-0.00306340486022928,0.00682146617077969,0.45618299663363
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,23846,0.00150081676373777,0.00201590300657811,-0.00245035312915533,0.00545198665663086,0.456588289236525
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",23071,0.00201041029294407,0.00270139321140291,-0.00328432040140563,0.00730514098729377,0.456755578911844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,22978,0.00468916789021482,0.00631398509091593,-0.00768624288798041,0.01706457866841,0.457692874062533
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,27544,0.00190364522391532,0.00258140637120324,-0.00315591126364302,0.00696320171147367,0.460858062853872
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23188,0.0024226757702456,0.00328928067674277,-0.00402431435617024,0.00886966589666144,0.461411627715091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,27702,0.00218117529935082,0.00297433806464346,-0.00364852730735037,0.008010877906052,0.463362577394732
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,23163,-0.00166089706400849,0.00227423702519462,-0.00611840163338995,0.00279660750537296,0.465208370369467
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,22978,-0.0031451321914116,0.00432080768497405,-0.0116139152539607,0.00532365087113754,0.466679918490499
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,27324,-0.00373489451753976,0.00516306821330421,-0.013854508215616,0.0063847191805365,0.469448578283114
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,27682,0.00259432089131073,0.00359622094424155,-0.00445427215940271,0.00964291394202416,0.470668327712098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,23725,-0.00170492765460007,0.00237155614606811,-0.00635317770089357,0.00294332239169343,0.472205479028119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,28091,-0.000923699253867573,0.00128815750772104,-0.00344848796900082,0.00160108946126567,0.473336798853171
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,23188,0.00311690539184677,0.00434959120259656,-0.00540829336524248,0.011642104148936,0.473629821127839
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,27887,0.00302087884448601,0.00422177109765468,-0.00525379250691715,0.0112955501958892,0.474276635232912
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,23393,0.00110790821904533,0.00155929731886314,-0.00194831452592642,0.00416413096401709,0.477390296152065
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,27562,0.00275651556018556,0.00389369510337312,-0.00487512684242577,0.0103881579627969,0.478986426569317
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,23725,-0.00166655744180848,0.00235421407850569,-0.00628081703567963,0.00294770215206268,0.479011865787166
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23071,-0.00191533226184696,0.00271068525719931,-0.00722827536595761,0.0033976108422637,0.479830929693545
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,23393,-0.00282929821979365,0.00400519973436747,-0.0106794896991539,0.00502089325956659,0.479942560156162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,23725,0.00318639597813885,0.00451528722645505,-0.00566356698571303,0.0120363589419907,0.480387469627692
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,23738,-0.00145392387864466,0.00208203983122352,-0.00553472194784275,0.00262687419055343,0.484985793713371
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,23862,-0.00352716567668838,0.00505388261682999,-0.0134327756056752,0.0063784442522984,0.485238990223587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,23687,0.00243487218532984,0.0034975966373737,-0.00442041722392262,0.0092901615945823,0.48633809923216
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23071,-0.00172988055413617,0.00249748528446337,-0.00662495171168438,0.00316519060341203,0.488536860618526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,23056,0.00158817489307191,0.0023191373965515,-0.00295733440416903,0.00613368419031285,0.493468967379491
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",23071,-0.00220267640869627,0.00322963962695716,-0.00853277007753231,0.00412741726013977,0.495233627129939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,27682,-0.00152955502812544,0.00225174915464042,-0.00594298337122066,0.00288387331496977,0.496969844644002
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,23862,0.00401398237074863,0.00593865365590877,-0.00762577879483256,0.0156537435363298,0.499105734789635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,27702,0.00254022572012954,0.00375966814317224,-0.00482872384048806,0.00990917528074713,0.499267527769075
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,28031,-0.0013024247677945,0.00193600981736507,-0.00509700400983004,0.00249215447424103,0.501120392193638
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28428,-0.00125264860141909,0.00186325046537495,-0.004904619513554,0.00239932231071581,0.501403213303804
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28411,0.00135244608894782,0.00201557052494893,-0.00259807213995208,0.00530296431784773,0.502226534912418
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23071,-0.00299638406870911,0.00446847809419911,-0.0117546011333394,0.00576183299592113,0.50250738860228
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,23056,-0.00278686207708173,0.00418141379920003,-0.0109824331235138,0.00540870896935034,0.505105910881775
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,28305,0.00172302308569936,0.00259955611389534,-0.0033721068975355,0.00681815306893422,0.507454864296382
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",22978,-0.00218386743954896,0.00329771420073307,-0.00864738727298578,0.00427965239388785,0.507826169439097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,22978,0.00282254177931375,0.00429266793482183,-0.00559108737293704,0.0112361709315645,0.510849198873484
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,23188,0.00334709979751251,0.00509260026647783,-0.00663439672478403,0.0133285963198091,0.511028188382546
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,23393,-0.00237748586167602,0.00361820542236267,-0.00946916848950686,0.00471419676615481,0.511129648165524
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,23393,-0.00346379750238845,0.00529281457155366,-0.0138377140626336,0.00691011905785673,0.512838710756776
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,27682,0.00214778374155144,0.00328795900638104,-0.0042966159109554,0.00859218339405828,0.513615346053004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,23056,-0.00341095893190408,0.00524397399612757,-0.0136891479643141,0.00686723010050595,0.515406098376094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,23163,-0.00273911717107239,0.0042448776567302,-0.0110590773782636,0.0055808430361188,0.518754814858667
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",23056,-0.00322040383222437,0.0049921446465116,-0.0130050073393871,0.00656419967493837,0.5188725293119
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,23775,-0.00132434773057323,0.0020574700294292,-0.00535698898825446,0.002708293527108,0.519790617215064
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,23775,0.00144186122727193,0.00224543892350584,-0.00295919906279952,0.00584292151734338,0.520795687296013
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27562,-0.00154758968363481,0.00241478967103472,-0.00628057743886286,0.00318539807159324,0.521606176002412
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,23163,0.0012895844661698,0.00201595692005479,-0.00266169109713758,0.00524086002947718,0.522381461178651
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,27702,0.00208756993760548,0.00327771492997281,-0.00433675132514123,0.00851189120035219,0.524196580168017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23393,0.00224707579623817,0.00353606508481377,-0.00468361176999682,0.00917776336247317,0.525125838499123
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,23188,0.00245465228739159,0.00386433906058057,-0.00511945227134632,0.0100287568461295,0.525300185276423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,22978,0.00239887995050984,0.00377810441508647,-0.00500620470305963,0.00980396460407932,0.525472089843769
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,23393,0.00189338817103631,0.0029832675287063,-0.00395381618522803,0.00774059252730066,0.525650362027754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,23862,0.00389936558575994,0.00617170128581746,-0.00819716893444228,0.0159959001059622,0.527514659655322
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,23393,0.00164231083594581,0.00262037299139464,-0.00349362022718768,0.00677824189907929,0.530831228639495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,23198,-0.0012842504024786,0.00205159860017882,-0.00530538365882908,0.00273688285387189,0.531337191910054
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,23071,-0.00198295117862544,0.00316781479289865,-0.00819186817270678,0.00422596581545591,0.531342025830094
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,22978,0.00306776284834104,0.00490097504728888,-0.00653814824434516,0.0126736739410273,0.531354290784877
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,23056,-0.00381550240233,0.00610038866057149,-0.0157722641770501,0.00814125937239012,0.531680409427671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,23393,-0.00224538778690184,0.00359716531904664,-0.00929583181223325,0.00480505623842958,0.532495547932929
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,27702,-0.00210669096228948,0.00340086967685734,-0.00877239552892987,0.00455901360435091,0.53562074106044
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,27918,-0.00167260065420785,0.00270136027999896,-0.00696726680300581,0.0036220654945901,0.535809571715497
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,23355,-0.0022756124361339,0.00368934312614628,-0.0095067249633806,0.0049555000911128,0.537368091410315
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,22978,0.00331143465178819,0.00537314196096324,-0.00721992359169976,0.0138427928952761,0.537706668411488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,23188,-0.00375945782941038,0.00615479301943038,-0.0158228521474939,0.00830393648867317,0.541326123551941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23163,-0.00196399227090629,0.00321732647784104,-0.00826995216747474,0.00434196762566215,0.5415748276237
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,20725,0.0043471304416912,0.00714134395293415,-0.00964990370605974,0.0183441645894421,0.542711938672349
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,28307,-0.00155437791296476,0.00255565506734329,-0.00656346184495762,0.00345470601902809,0.543052321304038
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,23725,0.00194296086413248,0.003222518269247,-0.00437317494359163,0.0082590966718566,0.546559388255132
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23188,0.00353562444065862,0.00586990867851554,-0.00796939656923184,0.0150406454505491,0.54696012249938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,23188,0.00141382023286305,0.00237796729621863,-0.00324699566772546,0.00607463613345156,0.552150177851892
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,23235,-0.00137495641390525,0.00232028296797862,-0.00592271103114335,0.00317279820333286,0.55346713359788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,23393,0.0016432784232358,0.00277462461585914,-0.00379498582384812,0.00708154267031972,0.553687231924223
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,27544,-0.00252902811247024,0.00427770088685145,-0.0109133218506991,0.00585526562575861,0.554383234871938
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,27702,-0.00148288195378422,0.0025150107603804,-0.0064123030441298,0.00344653913656135,0.555455234640576
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,27544,0.00209582489458637,0.00358034862678898,-0.00492165841392003,0.00911330820309276,0.558304464112021
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23071,0.00341144144064417,0.00584280569274384,-0.00804045771713376,0.0148633405984221,0.55931320426313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,27544,0.00264592932451325,0.00454261188003754,-0.00625758996036032,0.0115494486093868,0.560255775701683
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,23056,-0.00182099179045378,0.00313015010733126,-0.00795608600082304,0.00431410241991549,0.560734975020428
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,23163,-0.00197983582575392,0.00341241089031054,-0.00866816117076258,0.00470848951925473,0.561794287242881
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,28452,-0.00225164218402283,0.00388469542742684,-0.00986564522177944,0.00536236085373378,0.562176358984321
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,23725,0.00201130434053617,0.00347066706344134,-0.00479120310380886,0.0088138117848812,0.562247094717578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,23163,0.002573002114652,0.00447109095448955,-0.00619033615614751,0.0113363403854515,0.564975528853515
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,22978,0.00215340360332193,0.00374435384362807,-0.00518552993018909,0.00949233713683295,0.565224659304552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23056,0.00191281060237832,0.00333398826910039,-0.00462180640505843,0.00844742760981508,0.566155816676357
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,23056,0.00298175292488722,0.00521132236525825,-0.00723243891101895,0.0131959447607934,0.567213612489634
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,23725,0.00172543255040551,0.0030270912806053,-0.00420766635958089,0.0076585314603919,0.568685222541258
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23071,0.00188237232195344,0.00330537705536153,-0.00459616670655517,0.00836091135046205,0.56903061052446
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,23163,0.00146119310125651,0.00256695066849443,-0.00357003020899258,0.0064924164115056,0.569203532539617
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,23071,-0.00135460022133852,0.00238757339952924,-0.00603424408441583,0.0033250436417388,0.570478962701908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,23775,0.00107663866023399,0.00190179145283602,-0.00265087258732462,0.00480414990779259,0.571318811794408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,27562,0.00529103018488693,0.00935266014072169,-0.0130401836909276,0.0236222440607014,0.571585597876564
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,23893,0.000884396891733354,0.00156348125334305,-0.00218002636481902,0.00394882014828573,0.571631079131072
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,23757,0.000912856745497859,0.0016146699704955,-0.00225189639667332,0.00407760988766903,0.571839771965432
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,23071,0.00237340240214924,0.00420285921045937,-0.00586420165035112,0.0106110064546496,0.572275589888024
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,23393,0.00166051241920975,0.00296482608297813,-0.00415054670342739,0.00747157154184689,0.575436535097619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,23056,0.00202719468563969,0.0036309811830476,-0.00508952843313361,0.009143917804413,0.576641605577821
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23188,0.00106273458463031,0.00190573870100616,-0.00267251326934176,0.00479798243860239,0.577089008822168
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,23198,0.00155895466689063,0.00283079866318686,-0.00398941071295561,0.00710732004673688,0.581836454153983
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,27965,0.0048594051216096,0.00882783774248536,-0.0124431568536617,0.0221619670968809,0.582005697549727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23393,0.0020714518543689,0.00378323247109088,-0.00534368378896921,0.00948658749770702,0.584016519628331
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,23163,-0.00247438769216744,0.00453617419932951,-0.0113652891228533,0.00641651373851839,0.585429386747483
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,23110,-0.00248715970810137,0.00458519625784619,-0.0114741443734799,0.00649982495727717,0.587525793569671
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,27965,-0.00123785775303049,0.00229798822502205,-0.00574191467407371,0.00326619916801272,0.590118736427955
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,23725,-0.00279434602968834,0.0051895291224053,-0.0129658231096027,0.00737713105022604,0.590265608070867
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,23071,-0.0017830659476752,0.00331510527591927,-0.00828067228847697,0.00471454039312657,0.590678183613489
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,23163,0.00300977986808797,0.00561339437465663,-0.00799247310623902,0.014012032842415,0.591840528657631
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23393,0.00227057996638601,0.00427642210443932,-0.00611120735831506,0.0106523672910871,0.59545625974858
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,28122,0.00212663301466936,0.00401672317537591,-0.00574614440906743,0.00999941043840615,0.596501140281536
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,28176,0.00152935353772957,0.002890996641207,-0.00413699987903614,0.00719570695449529,0.596805704484833
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,28224,0.00224634495571805,0.00427914660564081,-0.00614078239133793,0.010633472302774,0.599620946766911
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,23188,0.00152119408124357,0.00291034162811617,-0.00418307550986412,0.00722546367235127,0.601197956806798
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,28199,-0.00341619344773508,0.00654176631578734,-0.0162380554266783,0.00940566853120811,0.601526348883313
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,23393,0.00245517188366408,0.00470366927142854,-0.00676401988833586,0.011674363655664,0.601696513851629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,23775,-0.0018080357003244,0.00348231989163466,-0.00863338268792834,0.00501731128727953,0.603623068828122
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,23071,-0.00247693148208757,0.00480132034137876,-0.0118875193511899,0.0069336563870148,0.605939337763866
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,23163,-0.00272862258699168,0.0052897121341498,-0.0130964583699253,0.00763921319594194,0.605974062984073
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28521,0.000901823832705808,0.00174837378018651,-0.00252498877645975,0.00432863644187136,0.605993054243567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,23393,-0.00197034076741067,0.00384432683268669,-0.00950522135947658,0.00556453982465524,0.608283527472688
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,23056,0.00166067805802098,0.00324028275613001,-0.00469027614399385,0.00801163226003581,0.608298875659957
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,23862,0.00128839898539383,0.00252238992450146,-0.00365548526662903,0.00623228323741669,0.609506328544356
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,23684,0.00138103602986308,0.00270719946380834,-0.00392507491920126,0.00668714697892743,0.609961945346494
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,23725,0.00153170673125625,0.0030107230580514,-0.00436931046252448,0.00743272392503699,0.61093188382408
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,27232,0.00123019759054333,0.00242674729430088,-0.00352622710628639,0.00598662228737305,0.612206138012589
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,23163,-0.00118586285695866,0.00234539755307096,-0.00578284206097774,0.00341111634706042,0.613133358198133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23393,0.00218327672669535,0.00435861507672904,-0.00635960882369357,0.0107261622770843,0.616438720193314
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,28176,0.00198378483310906,0.00396377991990428,-0.00578522380990333,0.00975279347612146,0.616742421105394
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,23846,-0.00200565195444633,0.00401129295258423,-0.00986778614151142,0.00585648223261876,0.617078732317079
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,23393,-0.00118996980079498,0.00238778813340439,-0.00587003454226759,0.00349009494067763,0.618237460553558
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,23393,-0.00139841615940219,0.00280759760310664,-0.0069013074614912,0.00410447514268683,0.618430347254773
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,23725,0.00193932645909871,0.00389747405707057,-0.00569972269275961,0.00957837561095702,0.61878086159122
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,23071,0.00302470830763761,0.00608228749655377,-0.00889657518560777,0.014945991800883,0.618983791419661
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,23023,0.00285331881875578,0.00577151695107521,-0.00845885440535164,0.0141654920428632,0.62104301234397
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,23444,-0.00140481628696672,0.00285267825230744,-0.0069960656614893,0.00418643308755586,0.62240218750373
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,27840,-0.00126227563265162,0.00256649368966677,-0.0062926032643985,0.00376805199909525,0.622844221448109
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,22978,-0.00144868166157264,0.00295521049810361,-0.00724089423785572,0.00434353091471044,0.623988091652965
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,23725,0.0012258736083867,0.0025236490049232,-0.00372047844126277,0.00617222565803618,0.627145797082587
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,27702,-0.00103401185221154,0.00213379982486102,-0.00521625950893914,0.00314823580451606,0.62797310505183
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,23665,-0.00163171422126556,0.00337052063027042,-0.00823793465659557,0.00497450621406446,0.628309870397087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,28553,0.00163733508568645,0.00338722393918479,-0.00500162383511574,0.00827629400648865,0.628825719164026
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,23071,-0.00144093300883788,0.00299192282786006,-0.0073051017514436,0.00442323573376784,0.630089240950223
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,28091,0.000642452619286345,0.00133485542887449,-0.00197386402130766,0.00325876925988035,0.630314127461754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,23872,-0.00139463353560965,0.00290652199448487,-0.0070914166448,0.0043021495735807,0.631353390419826
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,27702,-0.00201903493402979,0.00422716506753569,-0.0103042784663997,0.00626620859834015,0.632914973355764
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,28044,-0.00180591879416046,0.00378210235413734,-0.00921883940826964,0.00560700181994872,0.633016447192619
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,23795,0.00285952415995102,0.00599055469614819,-0.00888196304449943,0.0146010113644015,0.633125276539053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,23188,0.00130823319964035,0.00275147197538668,-0.00408465187211755,0.00670111827139825,0.634458870391462
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28428,-0.00149268711611201,0.00315406990941923,-0.0076746641385737,0.00468928990634968,0.636033143052343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,23163,0.00135396090743987,0.00287956034520095,-0.00428997736915398,0.00699789918403373,0.638218639454864
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,23393,-0.00264078911877144,0.00565747340494875,-0.013729436992471,0.00844785875492811,0.640662434997415
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,28428,0.000943172110218048,0.00202308248508344,-0.0030220695605455,0.00490841378098159,0.64107201199124
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,27702,-0.000903829524435937,0.00193951067338635,-0.00470527044427317,0.0028976113954013,0.641212689224053
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,23355,0.00166342412456766,0.00358346762990438,-0.00536017243004493,0.00868702067918025,0.64251309849219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,23198,-0.00186173853213472,0.00401692111778092,-0.00973490392298533,0.00601142685871589,0.643028991933883
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23071,-0.00159549933604216,0.0034433236422445,-0.00834441367484137,0.00515341500275706,0.643110532835281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,23846,-0.00153477060239965,0.00332068670919406,-0.00804331655242,0.0049737753476207,0.643953090804251
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,23188,0.0016964584378423,0.00369351806073047,-0.00554283696118942,0.00893575383687402,0.646018080885859
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,23188,0.00108653245680433,0.00237380136009781,-0.00356611820898739,0.00573918312259604,0.647159089639348
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,23393,-0.00203995989033497,0.00446803295504009,-0.0107973044822135,0.00671738470154361,0.647985983352208
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,23163,0.00238211954430153,0.00523137497928643,-0.00787137541509986,0.0126356145037029,0.648859950795307
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,28428,0.000714286616612818,0.0015753781549856,-0.00237345456715895,0.00380202780038459,0.650259555304674
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,23056,-0.00163836839917772,0.00361605241528218,-0.00872583113313079,0.00544909433477535,0.650493934847984
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,23775,-0.00167328055389187,0.00374989238009684,-0.00902306961888168,0.00567650851109795,0.655441714719594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,27985,-0.00149066605038644,0.00334725171354164,-0.00805127940892805,0.00506994730815517,0.656077301787091
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28336,0.00131103059073804,0.00294818776968173,-0.00446741743783815,0.00708947861931424,0.656546956942603
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,23056,-0.00131944316715369,0.00297555513893163,-0.00715153123945969,0.0045126449051523,0.657460665467012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27702,-0.00164839358892638,0.00375871642953702,-0.00901547779081894,0.00571869061296618,0.660989416204038
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,23071,-0.00163748005509977,0.0037433695514126,-0.00897448437586846,0.00569952426566893,0.661800158901469
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,27562,0.00134718952619541,0.00312413995867823,-0.00477612479281392,0.00747050384520474,0.666312277477503
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,23188,-0.000754235876968219,0.00175852465792265,-0.00420094420649662,0.00269247245256018,0.66799806212182
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,23056,-0.000960754019117085,0.00224604266247991,-0.0053629976375777,0.00344148959934353,0.668834135323214
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,23738,0.00122861846208242,0.00289429771630942,-0.00444420506188404,0.00690144198604888,0.671207805300343
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23056,0.001665250397941,0.00393040744778942,-0.00603834819972626,0.00936884899560825,0.671800305325165
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,23056,-0.00200980008724101,0.00475495086940535,-0.0113295037912755,0.00730990361679347,0.672536153707244
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23725,0.00177804648356283,0.00421184033910546,-0.00647716058108388,0.0100332535482095,0.672916228098646
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23071,-0.00169653233567593,0.00402301739170676,-0.00958164642342118,0.00618858175206933,0.673243235902913
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,23846,0.000985942639916852,0.00234168182044321,-0.00360375372815183,0.00557563900798554,0.673729381404108
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22978,0.0023478239016059,0.00565073062744379,-0.00872760812818394,0.0134232559313957,0.677786878820286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,23393,-0.0023608090367774,0.00570288591058287,-0.0135384654215198,0.00881684734796502,0.678901755678264
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,23725,0.00188525727573614,0.00461344232160956,-0.00715708967461861,0.0109276042260909,0.682804347436363
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,23370,0.00277132059003972,0.00679449620995262,-0.0105458919814674,0.0160885331615468,0.683367517038287
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,23071,-0.00162880394256857,0.00400888959818621,-0.00948622755501354,0.0062286196698764,0.684527404125312
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23163,-0.00173488517110623,0.00427448403460206,-0.0101128738789263,0.0066431035367138,0.684841815513162
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,28307,-0.00269032791596187,0.00666052065305475,-0.0157449483959492,0.0103642925640254,0.686273451746565
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",23393,-0.00124658753445646,0.00309520738355775,-0.00731319400622965,0.00482001893731672,0.687137550454808
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,27544,0.00112139198554448,0.0027885046657888,-0.00434407715940156,0.00658686113049052,0.687578122492293
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,23163,-0.00226314371058842,0.00566757396338339,-0.0133715886788199,0.00884530125764302,0.689665265924466
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23071,-0.00124029921474768,0.0031554254334186,-0.00742493306424813,0.00494433463475277,0.694272318576227
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,27791,-0.00453380240144292,0.011593079639797,-0.0272562384954451,0.0181886336925592,0.695742326103401
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,23188,-0.00181663081381998,0.00468664339620367,-0.0110024518703792,0.00736919024273921,0.698301757707365
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,23056,0.0023895386514862,0.00617053809606198,-0.00970471601679528,0.0144837933197677,0.698574981128026
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,23056,-0.000988888386672596,0.00257673522534084,-0.00603928942834065,0.00406151265499546,0.701148234762177
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,23795,-0.000928504675735643,0.00242323040123152,-0.00567803626214942,0.00382102691067813,0.701598527175656
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,23071,-0.000997012925039939,0.0026020870960364,-0.00609710363327128,0.0041030777831914,0.701605455001572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,23071,-0.000963728496779608,0.00252339606541771,-0.00590958478499833,0.00398212779143911,0.702526261278191
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,27702,-0.00364609684720403,0.00957211617753653,-0.0224074445551756,0.0151152508607676,0.703274344030693
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,27702,-0.000842035313330162,0.0022318323239178,-0.00521642666820906,0.00353235604154873,0.705965224244983
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,23071,-0.000901753982909042,0.0024206838303697,-0.00564629429043365,0.00384278632461557,0.709508888832493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23198,-0.000657604651153698,0.00176873989406515,-0.0041243348435214,0.002809125541214,0.710050567501679
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,23725,0.00139711240535265,0.00376001764050428,-0.00597252217003573,0.00876674698074103,0.710215824035118
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,23795,-0.000847838750445861,0.00228567810990079,-0.00532776784585141,0.00363209034495969,0.710689008355939
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,23071,-0.00151662947308826,0.00412025694196893,-0.00959233307934737,0.00655907413317084,0.712808765017055
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,28091,0.00147891385950134,0.00402891744723609,-0.00641776433708141,0.00937559205608408,0.713566028588664
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,22978,-0.00117764146862141,0.00325208791385182,-0.00755173377977098,0.00519645084252816,0.717266749232058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,23862,-0.000523738099782062,0.00144961249026836,-0.00336497858070805,0.00231750238114393,0.717881948527727
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,23163,0.000667550163114149,0.00185546811122133,-0.00296916733487965,0.00430426766110795,0.71901903542218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,23725,-0.00164226087716824,0.00456499459471761,-0.0105896502828147,0.00730512852847827,0.719036634125614
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,28320,-0.00187015709697483,0.00520162975850039,-0.0120653514236356,0.00832503722968594,0.719199142871777
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,23393,0.00152394852260264,0.00424128616779002,-0.0067889723662658,0.00983686941147108,0.71936432478689
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,27500,-0.00172267420960324,0.00480311456417581,-0.0111367787553878,0.00769143033618134,0.719853901744077
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,27500,0.000873613720176774,0.00243772736786567,-0.00390433192083994,0.00565155936119348,0.720067545274104
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,27544,0.00132467715202246,0.00370948650881634,-0.00594591640525756,0.00859527070930248,0.721015742444714
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,23188,0.00138940596920773,0.00389341019758216,-0.00624167801805331,0.00902048995646878,0.721199171797496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,27918,-0.00080884283319264,0.00227226896705233,-0.00526249000861521,0.00364480434222992,0.721871243935705
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,23862,0.000746738731613107,0.00211481254283953,-0.00339829385235238,0.00489177131557859,0.724017152879079
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,27682,0.00186064804087676,0.00528628086759697,-0.0085004624596133,0.0122217585413668,0.724858368033278
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,23056,0.000683665378321098,0.00195556598191899,-0.00314924394624012,0.00451657470288232,0.726642293573843
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23056,-0.00174064386255736,0.00499281646716389,-0.0115265641381986,0.00804527641308387,0.727370549704749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23071,0.00107962000855993,0.0030990869304215,-0.0049945903750662,0.00715383039218606,0.727567667982747
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,22978,-0.00109307336932425,0.00315441614744239,-0.00727572901831134,0.00508958227966284,0.728953919790788
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,23507,0.00130257713656898,0.00378596629013246,-0.00611791679209063,0.0087230710652286,0.730808697600366
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,23071,0.00164988278366839,0.00486306665433318,-0.00788172785882464,0.0111814934261614,0.734410954402781
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,28187,0.0011142761918405,0.00331230821911781,-0.00537784791763041,0.00760640030131141,0.736568179559866
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,23188,-0.000665597658199081,0.00198160428595364,-0.00454954205866821,0.00321834674227005,0.736958155090404
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,27918,-0.000725446169795088,0.00216651015757585,-0.00497180607864376,0.00352091373905359,0.737744155093456
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,22936,-0.000926268664242086,0.00276903150261256,-0.00635357040936271,0.00450103308087853,0.737997824096703
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",23846,-0.00156819000225686,0.00471995291711762,-0.0108192977198074,0.00768291771529367,0.739705709776084
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23393,-0.0015403755224106,0.00466328069779777,-0.0106804056900942,0.00759965464527303,0.741161038233921
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,23188,-0.00135918506556199,0.00414125924550179,-0.00947605318674551,0.00675768305562153,0.742759071485512
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,22936,-0.000783289522720577,0.00240838544453679,-0.00550372499401268,0.00393714594857153,0.745006729181557
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,23738,0.00123998664919245,0.00383592275406241,-0.00627842194876987,0.00875839524715477,0.746503906113809
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,23872,0.000562236139890132,0.00176866270554657,-0.00290434276298114,0.0040288150427614,0.750572896449468
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,23163,0.000808330367104893,0.00254601233736987,-0.00418185381414005,0.00579851454834983,0.750875610346749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",23775,0.000548518466633593,0.00173311538726812,-0.00284838769241193,0.00394542462567912,0.751631302395845
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,23795,0.00132220508169003,0.00418141894389418,-0.00687337604834257,0.00951778621172263,0.751846147787925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,28145,-0.000423975192804874,0.0013438473526523,-0.00305791600400339,0.00220996561839364,0.75238927611187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,23163,0.00107462117697025,0.00345210026205985,-0.00569149533666705,0.00784073769060756,0.755579253527169
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,22978,-0.0010336477425603,0.00334128466576008,-0.00758256568745005,0.00551527020232946,0.757053251307455
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,23188,-0.00101511791866073,0.00328166668550586,-0.00744718462225222,0.00541694878493076,0.757073302198823
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,23393,0.00352143584411902,0.0114037890359634,-0.0188299906663693,0.0258728623546073,0.757480036960379
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,22978,-0.00138208186493463,0.00447858410394242,-0.0101601067086618,0.00739594297879251,0.757630181201526
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,23163,0.00143576044603993,0.00466017807300319,-0.00769818857704632,0.0105697094691262,0.758015612619648
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,23056,0.00058306343276722,0.00190775222627103,-0.003156130930724,0.00432225779625844,0.759890286584784
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,27702,-0.000850615935105884,0.00278558292000186,-0.00631035845830953,0.00460912658809777,0.760091453302082
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,23163,0.00189643922822234,0.00622591419329038,-0.0103063525906268,0.0140992310470715,0.760670405997164
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,23071,-0.000565520983023503,0.00186702748493351,-0.00422489485349319,0.00309385288744618,0.76196947425066
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,23071,0.00110097955718479,0.00365330711871406,-0.00605950239549477,0.00826146150986435,0.763138760859702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23071,-0.00126776539850206,0.00421274639826214,-0.00952474833909585,0.00698921754209173,0.763466310450456
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,23795,0.000980352886152167,0.00328294307267114,-0.00545421553628326,0.00741492130858759,0.765232513767303
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,23056,-0.00117727456984794,0.00398371678681012,-0.00898535947199578,0.0066308103322999,0.767598076720923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,23188,-0.00153545345642412,0.00522983745988655,-0.0117859348778018,0.00871502796495353,0.769070124356197
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,23348,-0.000988293064278369,0.00342815824541899,-0.0077074832252996,0.00573089709674286,0.773129705504709
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23071,0.000397452224121004,0.00138413938704532,-0.00231546097448783,0.00311036542272984,0.774001930603229
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,22978,-0.000558996140691221,0.0019838111304219,-0.00444726595631814,0.0033292736749357,0.778115581361224
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,23056,0.00134863430509444,0.00480009647556316,-0.00805955478700935,0.0107568233971982,0.77874373049113
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,23198,-0.000560903273294209,0.00200414944551322,-0.00448903618650011,0.0033672296399117,0.779578987777543
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,23188,-0.000437001086363531,0.00158946132121972,-0.00355234527595419,0.00267834310322712,0.783367401014334
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,28275,0.000503698152941256,0.00183758362098047,-0.00309796574418046,0.00410536205006298,0.784002884350857
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,23163,-0.00111522069143932,0.00408183159700583,-0.00911561062157074,0.0068851692386921,0.784689809012176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,23163,-0.00128535806708134,0.00471657920867163,-0.0105298533160777,0.00795913718191506,0.785225314029975
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,23163,0.000792904452781134,0.0029242456277384,-0.00493861697758613,0.0065244258831484,0.78627933374303
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,23862,-0.0016211173465319,0.00601763445995271,-0.0134156808880392,0.0101734461949754,0.787628484617256
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,23026,-0.00179313737216165,0.00665829352070036,-0.0148433926727344,0.0112571179284111,0.787694436774555
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23163,0.000754323936723709,0.00281951309277901,-0.00477192172512316,0.00628056959857058,0.789058151176702
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,23188,0.000791705348968315,0.00296519237355802,-0.0050200717032054,0.00660348240114202,0.789471800408058
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,22978,-0.000732801269056682,0.00274912448417082,-0.00612108525803148,0.00465548271991812,0.789811849744575
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,28237,-0.000588875066740421,0.00221836798075957,-0.00493687630902919,0.00375912617554834,0.790661537190537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,23832,0.000612600607638608,0.00232764638373001,-0.00394958630447221,0.00517478751974943,0.792410601255807
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,28176,0.000688282667502317,0.00261951082376511,-0.00444595854707729,0.00582252388208193,0.792743373974372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,27346,0.00118723205240249,0.00452284770008847,-0.0076775494397709,0.0100520135445759,0.792940600201932
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",27682,0.00147764858427543,0.00567050996427268,-0.00963655094569901,0.0125918481142499,0.794414668318952
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,23056,0.00105402598778426,0.00405370475847741,-0.00689123533883146,0.00899928731439997,0.79485415621498
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,23071,0.000690474528542353,0.00270282417594779,-0.00460706085631531,0.00598800991340001,0.798366951517225
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,23725,-0.000765158210739651,0.0030578241298904,-0.00675849350532483,0.00522817708384553,0.802411937908928
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,23795,-0.000494376589833179,0.00199645582838867,-0.00440743001347497,0.00341867683380861,0.80442506988689
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,23071,0.00188417835036328,0.00767435177152455,-0.0131575511218249,0.0169259078225514,0.806058884165263
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,22882,0.00056987810861928,0.00234560978081369,-0.00402751706177555,0.00516727327901411,0.808042276955538
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,23188,-0.000656497815079736,0.00271642654172442,-0.0059806938368596,0.00466769820670013,0.80903259168218
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,23056,-0.00102806793135299,0.00429214226965577,-0.0094406667798783,0.00738453091717232,0.810701988819364
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,23188,-0.000347865893554164,0.00147920916569455,-0.00324711585831548,0.00255138407120715,0.814078723733772
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,27562,0.000883565002091992,0.00386190394822115,-0.00668576673642146,0.00845289674060544,0.819033838264794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,23056,-0.00148220488245734,0.0064838760718927,-0.014190601983367,0.0112261922184523,0.819182954643583
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,27682,0.000420800882624428,0.00185693220706043,-0.00321878624321401,0.00406038800846287,0.820728071995635
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,23393,-0.00102714999612823,0.00455196136467648,-0.00994899427089412,0.00789469427863767,0.821475636330434
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,23071,-0.000501279957834806,0.0023367993810297,-0.00508140674465301,0.0040788468289834,0.830146887925495
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,23188,0.000479207432876708,0.00223903163634448,-0.00390929457435847,0.00486770944011188,0.830529901980941
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,27702,-0.000751870295140106,0.00352460895074147,-0.00766010383859339,0.00615636324831317,0.831078787457699
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,27562,-0.00124027706364488,0.00586287860154864,-0.0127315191226802,0.0102509649953905,0.832461668966509
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,27562,-0.000731895618813795,0.00349888759704645,-0.00758971530902483,0.00612592407139724,0.834309648209133
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,28192,0.000598539244505791,0.00292962542537265,-0.0051435265892246,0.00634060507823618,0.838116072477355
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,23738,0.00203472866190429,0.00997774446338514,-0.0175216504863306,0.0215911078101392,0.83841251651827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23056,0.000775789169767638,0.00383907592560355,-0.00674879964441532,0.0083003779839506,0.839858266651412
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,22978,0.000689089078744304,0.00346660775970147,-0.00610546213027058,0.00748364028775919,0.842437325981537
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,23393,-0.000584293672627828,0.00296358005347154,-0.00639291057743205,0.00522432323217639,0.843705569206035
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22978,0.0007649124623461,0.00388191696490719,-0.006843644788872,0.0083734697135642,0.843794039963808
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",23188,0.000381066428008688,0.00196620677694973,-0.00347269885481279,0.00423483171083016,0.846327991048817
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,23071,0.00127923436372354,0.00665937917988696,-0.0117731488288549,0.014331617556302,0.847669374837794
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,27562,0.000632558297947418,0.00329841595122421,-0.00583233696645203,0.00709745356234686,0.847918780585157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,23188,-0.000531653022912042,0.00277539314029259,-0.00597142357788551,0.00490811753206143,0.848088919097262
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23071,0.000893804872669696,0.00467937727941173,-0.0082777745949773,0.0100653843403167,0.848519939503488
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,23163,0.000456276476696861,0.00239193551081032,-0.00423191712449137,0.00514447007788509,0.848718295636552
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,22978,-0.000780844652278898,0.00409469562124981,-0.00880644806992853,0.00724475876537074,0.848764965530414
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,23188,0.000359439414955248,0.0018892622015891,-0.00334351450015939,0.00406239333006989,0.849111878800805
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,22978,-0.000762138792935967,0.00403124204828823,-0.00866337320758089,0.00713909562170896,0.850048984250128
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,23198,0.000371098019423412,0.0019701906706665,-0.00349047569508293,0.00423267173392976,0.850598925270316
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,23163,-0.000718996882622546,0.00400392619506082,-0.00856669222494175,0.00712869845969666,0.857489405240281
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23393,0.000533494284041969,0.00298304796240198,-0.00531327972226592,0.00638026829034985,0.858063310011749
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,23393,-0.000641036183915757,0.00364119012774814,-0.00777776883430212,0.0064956964664706,0.860255180480157
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,23163,0.000614242356861917,0.00349674714417628,-0.00623938204572358,0.00746786675944742,0.860561755048089
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,23163,-0.000577934140100551,0.00329129943929522,-0.00702888104111917,0.00587301276091807,0.860614044940637
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,23056,0.000589917107033691,0.0034123908746304,-0.00609836900724189,0.00727820322130927,0.862751193317908
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,23872,0.000259867692759632,0.00152425394065545,-0.00272767003092506,0.00324740541644432,0.864627462110473
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,23056,0.00135279839432814,0.0080022563053309,-0.0143316239641204,0.0170372207527767,0.865757129288203
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,23071,-0.000481265400334882,0.00284917486421645,-0.00606564813419912,0.00510311733352936,0.865865802602325
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,27544,-0.000370699787346355,0.0021966327970205,-0.00467610006950653,0.00393470049481382,0.865988081439816
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,23198,0.000593628991559814,0.00353611874885598,-0.00633716375619791,0.00752442173931754,0.866682402355017
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,23393,-0.000967334226156014,0.00581446747067284,-0.0123636904686748,0.0104290220163627,0.867869754594578
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,28224,-0.000744685037835191,0.00451493013124828,-0.00959394809508181,0.00810457801941143,0.868993704042958
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,23393,-0.000594233741582119,0.00361588571036307,-0.00768136973389374,0.00649290225072951,0.869465114420813
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,27682,0.000666284706029608,0.00408068689683878,-0.00733186161177441,0.00866443102383362,0.870301073309417
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23071,-0.000668047753416877,0.00412572742139862,-0.00875447349935817,0.00741837799252442,0.871368368864541
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,22978,-0.000694446112090714,0.00429153738927896,-0.00910585939507747,0.00771696717089604,0.871450947465097
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,23198,-0.000652640503268529,0.00405979225917633,-0.00860983333125414,0.00730455232471709,0.872286101390493
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,23188,0.000290031373212169,0.0018049031990251,-0.00324757889687703,0.00382764164330137,0.872338321521723
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23188,0.000384180074553492,0.00239794835713525,-0.00431579870543159,0.00508415885453857,0.872715482328479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23071,0.000406112687167336,0.00255182710195096,-0.00459546843265654,0.00540769380699121,0.873555361201045
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,23056,-0.000432506948154639,0.00272500416094458,-0.00577351510360602,0.00490850120729674,0.87389252280042
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,23188,-0.000345448940808757,0.00218842742106398,-0.00463476668609417,0.00394386880447665,0.874574331026639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,23738,-0.00275199157762301,0.0175272562908136,-0.0371054139076177,0.0316014307523717,0.875236636387754
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,22978,0.00152018517628121,0.0097366491257584,-0.0175636471102053,0.0206040174627677,0.875931750243216
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,22978,0.000659452053450103,0.00430757279637545,-0.00778339062744578,0.00910229473434599,0.878327597122789
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23056,0.0006694062333317,0.00440986319931466,-0.00797392563732503,0.00931273810398843,0.879347978604582
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27682,0.000217215889740421,0.00144955375202551,-0.00262390946422958,0.00305834124371042,0.880883911134176
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,23056,-0.000433615300771013,0.0029057414860964,-0.00612886861351995,0.00526163801197793,0.88137576291553
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27562,-0.000324004039173868,0.00217339368610933,-0.00458385566394815,0.00393584758560042,0.881493592201372
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,28553,-0.000246182206097015,0.00166348767729305,-0.00350661805359139,0.00301425364139736,0.882350441491447
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,28367,0.000269780564327016,0.0018742369949973,-0.0034037239458677,0.00394328507452173,0.885547653962318
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,23163,0.00076116105622413,0.00531314968921443,-0.00965261233463616,0.0111749344470844,0.886086206398012
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,23337,0.000373970182529355,0.00262761984921956,-0.00477616472194099,0.0055241050869997,0.88682627694405
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,28224,0.00058996981937562,0.00424519432674156,-0.00773061106103783,0.00891055069978908,0.889472024884497
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,23163,0.00039383326469947,0.00283750375894363,-0.00516767410283004,0.00595534063222898,0.889612814860531
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,23056,0.000519934653034324,0.00380824056637554,-0.00694421685706173,0.00798408616313038,0.891404422640027
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,28224,0.000256779486730864,0.00191357599667427,-0.0034938294667507,0.00400738844021243,0.893254644324844
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,27544,0.000461243500095099,0.00345445371023557,-0.00630948577196662,0.00723197277215682,0.893782015967572
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,23393,0.000715279643447409,0.00539849725690088,-0.00986577498007832,0.0112963342669731,0.894593075513923
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,23056,-0.000656041257555653,0.00498767233663032,-0.0104318790373511,0.00911979652223978,0.895355187989389
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,22978,0.000272519398074951,0.00207217848954509,-0.00378895044143342,0.00433398923758332,0.895370278189154
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,23163,-0.000458287725630099,0.00354232718974476,-0.00740124901752983,0.00648467356626963,0.897062243407421
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,23188,0.000482660021028339,0.00388609105398587,-0.00713407844478397,0.00809939848684065,0.901156468933629
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,28224,-0.000369814014217691,0.0030334165596494,-0.00631531047113052,0.00557568244269514,0.902968500789217
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,23393,-0.000232272133597328,0.00190769427450456,-0.00397135291162627,0.00350680864443161,0.90309376067712
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23188,-0.000276783862188189,0.00228849421507953,-0.00476223252374406,0.00420866479936768,0.903734979719676
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,22978,0.000333550140677628,0.00277489290589433,-0.00510523995487526,0.00577234023623052,0.904323481784264
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,22978,0.000492018981664704,0.00409931214732541,-0.00754263282709311,0.00852667079042252,0.904464579250187
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23163,-0.00040052631439271,0.00333703380416779,-0.00694111257056158,0.00614005994177616,0.904464662827496
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,23071,-0.000594607499780804,0.00498766081051702,-0.0103704226883942,0.00918120768883255,0.905105503205748
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27682,0.000233610278425615,0.00212370994572865,-0.00392886121520254,0.00439608177205377,0.912409356979479
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,22978,-0.000387125162398653,0.00360858409468624,-0.00745994998798369,0.00668569966318639,0.914568609854346
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,23071,-0.000285976769907357,0.00266771244446948,-0.00551469316106754,0.00494273962125282,0.914631844095333
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,27562,-0.000231806986158959,0.00216297772124607,-0.00447124331980126,0.00400762934748335,0.914654651830087
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,28176,0.000189802392834846,0.0017930149546676,-0.00332450691831366,0.00370411170398335,0.915696915402772
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,23056,-0.000301988053663505,0.00291340891397621,-0.00601226952505687,0.00540829341772986,0.917444408113951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",23056,0.000586250501552206,0.00570332183701692,-0.010592260299001,0.0117647613021054,0.918129694658771
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,23188,-0.000516091103788159,0.00506451893433631,-0.0104425482150873,0.009410366007511,0.918834326106163
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,27562,0.00112971364155219,0.0111769364866937,-0.0207770818723675,0.0230365091554719,0.919491319156456
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,28187,-0.000130214330697792,0.00132899935428301,-0.00273505306509249,0.00247462440369691,0.921949484693639
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23071,0.000308391010975381,0.00321425168955404,-0.00599154230055054,0.0066083243225013,0.923565179185799
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,23163,0.000420907046013456,0.00443869157262604,-0.00827892843633357,0.00912074252836049,0.924453197312158
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,28091,-0.000273866533329734,0.00293548908566071,-0.00602742514122473,0.00547969207456526,0.925669848450945
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,27702,-0.000367827301145036,0.00401844842491037,-0.00824398621396936,0.00750833161167928,0.927068431117189
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,23795,0.000214111314913915,0.00238707680193878,-0.0044645592168861,0.00489278184671393,0.928529525363893
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,23862,-0.000149364107248255,0.00171672494151811,-0.00351414499262374,0.00321541677812723,0.930668058151232
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,27554,0.000288716111323859,0.00334294667977744,-0.00626345938103992,0.00684089160368763,0.931176297213423
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,23071,-0.000417428219683063,0.00491056223875481,-0.0100421302076425,0.00920727376827636,0.932257202318018
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,23163,0.000572746966229976,0.00701205246139405,-0.0131708758581024,0.0143163697905623,0.934901603130718
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,23056,0.00034123209066053,0.00419524661632328,-0.0078814512773331,0.00856391545865416,0.935174027454726
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,23738,0.000265119968378565,0.0033855174479376,-0.00637049422957913,0.00690073416633626,0.937582100681437
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23056,0.000311018165292037,0.00415893806286416,-0.00784050043792172,0.0084625367685058,0.940387959737827
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,23393,-0.000195725512802679,0.00266056864420766,-0.0054104400554497,0.00501898902984434,0.941356917522532
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23071,-0.000240303694556456,0.00348478876503721,-0.00707048967402939,0.00658988228491648,0.945023733312253
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28553,0.000106932568549873,0.00156088261309619,-0.00295239735311867,0.00316626249021841,0.945381924428529
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,27682,-0.00048903394263617,0.00722821640439626,-0.0146563380952528,0.0136782702099805,0.946059773876851
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,28091,9.43562596423497e-05,0.00142518288346218,-0.00269900219194353,0.00288771471122823,0.947213955232677
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,23795,-0.000217447985753076,0.00337733767150849,-0.00683702982190971,0.00640213385040356,0.94866466266186
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22978,-0.000217377157481887,0.00346777953987247,-0.00701422505563193,0.00657947074066816,0.950018026190327
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,23725,0.00046410294801817,0.00743222652425987,-0.0141030610395312,0.0150312669355675,0.950209247526273
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,23725,0.000111932179419174,0.00182974264051765,-0.00347436339599542,0.00369822775483376,0.951221367786685
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,27562,-0.000348969971467008,0.00616410852128395,-0.0124306226731835,0.0117326827302495,0.954853721779906
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27682,0.000326784739905512,0.00595891085480463,-0.0113526805355116,0.0120062500153226,0.95626658711544
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,23393,0.000267756822561549,0.00496400147962428,-0.00946168607750203,0.00999719972262513,0.956983655998125
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,23795,8.62179167456579e-05,0.00182893154702035,-0.00349848791541422,0.00367092374890554,0.96240113523219
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23056,-0.000182292739414709,0.00387036383097742,-0.00776820584813046,0.00740362036930104,0.962434223203567
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,23188,-0.000199822263622265,0.0044402380594939,-0.00890268886023031,0.00850304433298578,0.964105623171011
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,23071,-0.000196065664486031,0.00441900791313475,-0.00885732117423014,0.00846518984525808,0.964610890001947
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22978,0.000160080971255132,0.00370386497731982,-0.00709949438429171,0.00741965632680197,0.965526553781998
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,28390,-0.000116396343647811,0.00275103929049104,-0.00550843335301024,0.00527564066571462,0.966251908567212
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,23775,-6.2742421382226e-05,0.00152239635333744,-0.00304663927392361,0.00292115443115916,0.967126488365286
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,27702,0.000125579317583968,0.00327006037667438,-0.00628373902069781,0.00653489765586575,0.969366843709974
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,23795,-0.000296650663010103,0.00781676705565285,-0.0156175140920897,0.0150242127660695,0.969727422021271
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,23393,-0.000105260172999403,0.00282010472595488,-0.00563266543587097,0.00542214508987217,0.97022625763443
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,22978,0.000103322976577502,0.00284379978901736,-0.00547052460989653,0.00567717056305153,0.971017377541925
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,23738,-0.000129361358423791,0.00374363842009555,-0.00746689266181106,0.00720816994496348,0.972434889868675
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,23198,0.000146331144832281,0.00477445443629407,-0.0092115995503041,0.00950426183996866,0.975549913230615
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,23071,-6.87193711391442e-05,0.00271956168663433,-0.00539906027694244,0.00526162153466415,0.979840980786951
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,27562,-6.47255486356947e-05,0.00268989118786351,-0.00533691227684818,0.00520746117957679,0.980802917169894
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,23862,-7.75453272578665e-05,0.00335979361792431,-0.00666274081838952,0.00650765016387379,0.981586345826004
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,27702,9.58385488811387e-05,0.00426721639350923,-0.00826790558239694,0.00845958268015922,0.982081766508569
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,23795,4.29489349425431e-05,0.00216974678482217,-0.00420975476330891,0.004295652633194,0.984207514760098
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23163,-3.72294732187283e-05,0.00214280826915178,-0.00423713368075622,0.00416267473431876,0.986138280740594
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,27702,-3.31950432890305e-05,0.0021273451883008,-0.0042027916123586,0.00413640152578054,0.987550446098302
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,23188,2.36265498556059e-05,0.0018247229327748,-0.00355283039838301,0.00360008349809422,0.989669374507451
NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,23188,6.67232182670294e-05,0.00624909956119274,-0.0121815119216707,0.0123149583582048,0.99148103829973
